{"text": "The samples were from the liver wedge and to avoid fibrosis overestimation , the subcapsular fibrosis was not considered in the evaluation process .The criteria for the diagnosis of NAFLD was found in all biopsies samples and only 12 ( 8 % ) did not have fibrosis .", "label": "", "metadata": {}, "score": "30.821087"}
{"text": "Numerous test panels have been developed for non - invasive tests to diagnose advanced liver disease , of which only 4 have been evaluated in NAFLD .", "label": "", "metadata": {}, "score": "31.388165"}
{"text": "[Links ] .Guha IN , Parkers J , Roderick P , et al .Non - invasive markers of fibrosis in non - alcoholic fatty liver disease : Validating the European liver fibrosis panel and exploring simple markers .", "label": "", "metadata": {}, "score": "33.178482"}
{"text": "C. D. Williams , J. Stengel , M. I. Asike et al . , \" Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle - aged population utilizing ultrasound and liver biopsy : a prospective study , \" Gastroenterology , vol .", "label": "", "metadata": {}, "score": "33.938065"}
{"text": "Affiliated with .Abstract .Background .Liver biopsy is considered the gold standard for assessing histologic lesions of non - alcoholic fatty liver disease ( NAFLD ) .", "label": "", "metadata": {}, "score": "34.25142"}
{"text": "used liver biopsies .Both studies found NAFLD prevalence to exceed 40 % in individuals over 70 years old .The weakness of the Kagansky study was reliance on clinical examination for detection of advanced liver disease , which has very low sensitivity especially in the absence of decompensated cirrhosis [ 38 ] .", "label": "", "metadata": {}, "score": "34.360207"}
{"text": "Notably , as in other chronic liver diseases , there is high sampling variability ; and high intra- and inter - pathologist variability [ 12 - 14 ] .", "label": "", "metadata": {}, "score": "34.906982"}
{"text": "View Article PubMed .Dixon JB , Bhathal PS , O'Brien PE : Nonalcoholic fatty liver disease : predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese .", "label": "", "metadata": {}, "score": "35.057594"}
{"text": "The risk of liver disease , such as non - alcoholic fatty liver disease , ( NAFLD ) is also increased .Simple steatosis is present in 70%-90 % morbidly obese patients and steatohepatitis in 20%-40 % [ 7 , 8 ] , 10%-30 % of the latter will progress to cirrhosis and a small proportion to liver failure .", "label": "", "metadata": {}, "score": "35.485744"}
{"text": "In this paper , we will first review the epidemiology and pathophysiology of NAFLD , with particular focus on age - related aspects .We will then examine risk factors for developing progressive liver injury and how known age - related changes in liver biology might contribute to severity of the disease among older people .", "label": "", "metadata": {}, "score": "35.679657"}
{"text": "[Links ] .Dixon JB , Bhathal PS , O'Brien PE .Nonalcoholic fatty liver disease : predictors of non - alcoholic steatohepatitis and liver fibrosis in the severely obese .", "label": "", "metadata": {}, "score": "35.77781"}
{"text": "The present study has several limitations .First , the variability of the end point , histological steato - hepatitis , is even greater than for the other features of chronic liver disease , fibrosis and steatosis .", "label": "", "metadata": {}, "score": "36.028446"}
{"text": "View Article PubMed .Sorbi D , Boynton J , Lindor KD : The ratio of aspartate aminotransferase to alanine aminotransferase : potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease .", "label": "", "metadata": {}, "score": "36.50816"}
{"text": "Nonalcoholic fatty liver disease ( NAFLD ) is the most common , chronic liver disease worldwide .Within this spectrum , steatosis alone is apparently benign , while nonalcoholic steatohepatitis may progress to cirrhosis and hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "36.658035"}
{"text": "S11-S67 , 2013 .View at Google Scholar . E. Fassio , E. \u00c1lvarez , N. Dom\u00ednguez , G. Landeira , and C. Longo , \" Natural history of nonalcoholic steatohepatitis : a longitudinal study of repeat liver biopsies , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "36.674778"}
{"text": "Also , efforts attempts are made to identify noninvasive indicators of liver fibrosis by using routinely determined and easily available clinical and biochemical variables [ 44 ] .", "label": "", "metadata": {}, "score": "36.98347"}
{"text": "6 , pp .1356 - 1362 , 1999 .View at Google Scholar .J. B. Dixon , P. S. Bhathal , and P. E. O'Brien , \" Nonalcoholic fatty liver disease : predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese , \" Gastroenterology , vol .", "label": "", "metadata": {}, "score": "37.020325"}
{"text": "There is a significant research effort in developing noninvasive monitoring of disease progression to fibrosis and response to therapy with potential novel biomarkers , in order to facilitate diagnosis for the detection of advanced cirrhosis and to minimize the need of liver biopsy .", "label": "", "metadata": {}, "score": "37.123695"}
{"text": "Most of the patients with fibrosis do not have symptoms and there are no specific laboratory tests to detect liver fibrosis to date .Liver biopsy remains the only way to determine fibrosis ' grade and prognosis , but this is an invasive procedure and can be associated with a number of complications ( 23 , 30 ) .", "label": "", "metadata": {}, "score": "37.15008"}
{"text": "Liver biopsy is regarded as the gold standard in the assessment of patients with NAFLD / NASH for advanced disease.22However , liver biopsy is an invasive procedure with potential complications , and sampling error can result in substantial misdiagnosis and staging inaccuracies .", "label": "", "metadata": {}, "score": "37.50841"}
{"text": "[ Google Scholar ] [ CrossRef ] .Kelly , D. Intestinal failure associated liver disease : What do we know today ?Gastroenterology 2006 , 130 , s70-s77 .", "label": "", "metadata": {}, "score": "37.720726"}
{"text": "[PubMed ] [ DOI ] .Adams LA , Feldstein AE .Non - invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis .J Dig Dis .", "label": "", "metadata": {}, "score": "37.81301"}
{"text": "Epidemiology .Diagnosis .The current diagnosis of NAFLD is based on detection of hepatic steatosis by liver biopsy or imaging , exclusion of other liver diseases , particularly alcohol and hepatitis C , and recognition of metabolic risk factors .", "label": "", "metadata": {}, "score": "37.952827"}
{"text": "Figure 1 Diagnosis and staging of non - alcoholic fatty liver disease .NAFLD : Non - alcoholic fatty liver disease ; NASH : Non - alcoholic steatohepatitis ; ALT : Alanine aminotransferase ; AST : Aspartate aminotransferase .", "label": "", "metadata": {}, "score": "37.968067"}
{"text": "Scores based on serum markers give a better estimation of the disease in the hepatic tissue ( 33 ) .Many fibrosis scores had already been evaluated mostly for hepatitis C patients ( 12 , 31 , 39 ) .", "label": "", "metadata": {}, "score": "38.32271"}
{"text": "165 - 169 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . E. K. Speliotes , J. M. Massaro , U. Hoffmann et al . , \" Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat : the Framingham heart study , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "38.48123"}
{"text": "[Links ] .Ekstedt M , Franzen LE , Mathiesen UL , et al .Long - term follow - up of patients with NAFLD and elevated liver enzymes .", "label": "", "metadata": {}, "score": "38.552414"}
{"text": "[Links ] .Ratziu V , Charlotte F , Heurtier A , et al .Sampling variability of liver biopsy in non - alcoholic fatty liver disease .", "label": "", "metadata": {}, "score": "38.6087"}
{"text": "Characteristics are given in Table 1 .Validation group .These were patients from a prospective multicentric study ( CYTOL study ) .For the present study only the CYTOL patients with hepatic steatosis at biopsy with suspicion of NAFLD were considered for inclusion .", "label": "", "metadata": {}, "score": "38.69954"}
{"text": "The score sensibility and specificity was 83 % and 97 % respectively .CONCLUSIONS : The nonalcoholic fat liver disease fibrosis score has high accuracy to identify and exclude advanced liver fibrosis in morbidly obese patients subjected to bariatric surgery .", "label": "", "metadata": {}, "score": "38.71357"}
{"text": "Clin Gastroenterol Hepatol 2005 , 3 : 167 - 74 .View Article PubMed .Callewaert N , Van Vlierberghe H , Van Hecke A , Laroy W , Delanghe J , Contreras R : Noninvasive diagnosis of liver cirrhosis using DNA sequencer - based total serum protein glycomics .", "label": "", "metadata": {}, "score": "38.740864"}
{"text": "10 , pp .739 - 746 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. D. Williams , J. Stengel , M. I. Asike et al . , \" Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle - aged population utilizing ultrasound and liver biopsy : a prospective study , \" Gastroenterology , vol .", "label": "", "metadata": {}, "score": "38.794"}
{"text": "The incidence of liver disease may be greater in our population .We do not have specific information about dietary intake , e.g. , fat or specific PN requirements .", "label": "", "metadata": {}, "score": "38.864597"}
{"text": "Angulo et al [ 53 ] validated NFS to a liver biopsy and found that this accurately classifies NAFLD patients with and without advanced fibrosis .", "label": "", "metadata": {}, "score": "38.89052"}
{"text": "In the first case there was a dramatic decrease in ApoA1 ( 0.05 g / L ) , as observed in alcoholic steato - hepatitis .", "label": "", "metadata": {}, "score": "38.990685"}
{"text": "[Links ] .Wai CT , Greenson JK , Fontana RJ , et al .A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518 - 526 .", "label": "", "metadata": {}, "score": "39.020004"}
{"text": "View Article PubMed .Bedossa P , Darg\u00e8re D , Paradis V : Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003 , 38 : 1449 - 57 .", "label": "", "metadata": {}, "score": "39.140915"}
{"text": "Other imaging techniques such as computed tomography and nuclear magnetic resonance imaging can also detect liver steatosis , but neither of these more expensive techniques provide more information then ultrasonography [ 46 , 47 ] except for fat quantification [ 48 ] .", "label": "", "metadata": {}, "score": "39.15811"}
{"text": "4 , pp .820 - 826 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. B. Dixon , P. S. Bhathal , and P. E. O'Brien , \" Nonalcoholic fatty liver disease : predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese , \" Gastroenterology , vol .", "label": "", "metadata": {}, "score": "39.203766"}
{"text": "132 - 138 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .L. A. Adams , J. F. Lymp , J. S. Sauver et al . , \" The natural history of nonalcoholic fatty liver disease : a population - based cohort study , \" Gastroenterology , vol .", "label": "", "metadata": {}, "score": "39.26157"}
{"text": "[PubMed ] [ DOI ] .Wong VW , Vergniol J , Wong GL , Foucher J , Chan HL , Le Bail B , Choi PC , Kowo M , Chan AW , Merrouche W. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease .", "label": "", "metadata": {}, "score": "39.317818"}
{"text": "Radiographic evidence of fatty liver in the obese group was similar to controls after SBS ( 23 % vs .Fibrosis and cirrhosis / portal hypertension were also similar in obese and control groups .", "label": "", "metadata": {}, "score": "39.329174"}
{"text": "[Links ] .Teli MR , James OF , Burt AD , Bennett MK , Day CP .The natural history of nonalcoholic fatty liver : a follow - up study .", "label": "", "metadata": {}, "score": "39.953453"}
{"text": "An imbalance between the mechanisms may modify the rate of fat oxidation and fat removal from the liver .Many molecular defects at these different steps have been described in NAFLD .", "label": "", "metadata": {}, "score": "40.17633"}
{"text": "However , its effect on postprandial chylomicron metabolism in obese subjects on a weight - loss diet has not yet been investigated ... .Image analysis of liver biopsy samples measures fibrosis and predicts clinical outcome .", "label": "", "metadata": {}, "score": "40.32682"}
{"text": "4 , pp .909 - 916 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. Zelber - Sagi , D. Nitzan - Kaluski , R. Goldsmith et al . , \" Long term nutritional intake and the risk for non - alcoholic fatty liver disease ( NAFLD ) : a population based study , \" Journal of Hepatology , vol .", "label": "", "metadata": {}, "score": "40.412018"}
{"text": "( Table 3 ) .Transplants included 3 liver - small intestine and 3 isolated small intestine in controls and 1 liver - small intestine and 1 isolated small intestine in obese patients .", "label": "", "metadata": {}, "score": "40.46366"}
{"text": "Therefore , we examined the liver histology of NAFLD patients who had undergone sequential liver biopsies ... .A pilot trial of pentoxifylline in nonalcoholic steatohepatitis .", "label": "", "metadata": {}, "score": "40.47635"}
{"text": "Few tests have yet been developed for the diagnosis of steatosis and steato hepatitis [ 17 - 21 ] .We recently highlighted the potential utility of ST for the prediction of steatosis in patients with NAFLD , as well as in patients infected with HCV , HBV and ALD [ 35 ] .", "label": "", "metadata": {}, "score": "40.516716"}
{"text": "In addition , no secondary causes of hepatic steatosis are present .NAFLD is subdivided into nonalcoholic fatty liver ( NAFLD ) and nonalcoholic steatohepatitis ( NASH ) .", "label": "", "metadata": {}, "score": "40.708397"}
{"text": "REFERENCES .Adams LA , Lymp JF , St Sauver J , Sanderson SO , Lindor KD , Feldstein A , Angulo P. The natural history of nonalcoholic fatty liver disease : a population - based cohort study .", "label": "", "metadata": {}, "score": "40.868103"}
{"text": "There is a need for studies to specifically evaluate the use of prebiotics in NAFLD patients with histological end points .Probiotics ( live microorganisms ) have been found to improve liver enzymes and liver histology in NAFLD patients [ 105 ] .", "label": "", "metadata": {}, "score": "40.906555"}
{"text": "113 - 121 , 2005 .View at Publisher \u00b7 View at Google Scholar . A. Berson , V. De Beco , P. Lett\u00e9ron et al . , \" Steatohepatitis - inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes , \" Gastroenterology , vol .", "label": "", "metadata": {}, "score": "40.915016"}
{"text": "[Links ] .Angulo P. Nonalcoholic fatty liver disease .N Engl J Med .[Links ] .The NAFLD fibrosis score : a noninvasive system that identifies liver fibrosis in patients with NAFLD .", "label": "", "metadata": {}, "score": "40.961075"}
{"text": "In multivariate analysis , age , BMI , arterial hypertension , ALT , insulin resistance , and hepatic necroinflammatory grade were shown to independently predict presence of fibrosis [ 27 , 36 , 57 , 86 , 87 , 89 , 91 ] .", "label": "", "metadata": {}, "score": "40.98255"}
{"text": "Table 1 summarizes 4 early studies using serial liver biopsies to assess disease activity and progression in NAFLD / NASH .Both obesity and BMI were predictive of disease progression [ 55 , 56 ] .", "label": "", "metadata": {}, "score": "41.000816"}
{"text": "Several prospective , epidemiological studies have shown that elevation of liver enzymes and ultrasonographic appearance of hepatic steatosis are predictors of CVD independent of conventional risk factors [ 18 , 19 ] .", "label": "", "metadata": {}, "score": "41.095047"}
{"text": "5 , pp .230 - 236 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. Targher , L. Bertolini , S. Rodella et al . , \" Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients , \" Diabetes Care , vol .", "label": "", "metadata": {}, "score": "41.190212"}
{"text": "4 , pp .820 - 826 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .L. A. Adams , S. Sanderson , K. D. Lindor , and P. Angulo , \" The histological course of nonalcoholic fatty liver disease : a longitudinal study of 103 patients with sequential liver biopsies , \" Journal of Hepatology , vol .", "label": "", "metadata": {}, "score": "41.266808"}
{"text": "These data are consistent with the clinical observation that NAFLD is now the commonest liver disorder seen in liver clinics of Western industrialised countries [ 4 ] .", "label": "", "metadata": {}, "score": "41.46488"}
{"text": "FibroScan , also known as transient elastography , is another noninvasive method to assess liver fibrosis [ 59 ] .This method measures liver stiffness , which was originally designed for the hepatitis C population [ 60 ] , but is now being used in the NAFLD population [ 61 ] .", "label": "", "metadata": {}, "score": "41.54743"}
{"text": "[Links ] .Adams LA , Lymp JF , St Sauver J , et al .The natural history of non - alcoholic fatty liver disease : a population - based cohort study .", "label": "", "metadata": {}, "score": "41.59636"}
{"text": "[Links ] .Kruger FC , Daniels C , Swart G , Van Rensburg CJ , Kidd M , Hall P. Correlation of body mass index ( BMI ) with the different types of nonalcoholic fatty liver disease ( NAFLD ) .", "label": "", "metadata": {}, "score": "41.643593"}
{"text": "The histological course of nonalcoholic fatty liver disease : a longitudinal study of 103 patients with sequential liver biopsies .J Hepatol 2005;42:132 - 138 .", "label": "", "metadata": {}, "score": "41.663292"}
{"text": "Current noninvasive approaches for detecting liver fibrosis have limitations and can not yet routinely replace biopsy for diagnosing significant fibrosis ... .Childhood adiposity trajectories and risk of nonalcoholic fatty liver disease in adolescents .", "label": "", "metadata": {}, "score": "41.725067"}
{"text": "[Links ] .Angulo P , Hui , JM , Marchesini G , et al .The NAFLD fibrosis score : a non - invasive system that identifies liver fibrosis in patients with NAFLD .", "label": "", "metadata": {}, "score": "42.110344"}
{"text": "[Links ] .Perrault J , McGill DB , Ott BJ , Taylor WF .Liver biopsy : complications in 1000 inpatients and outpatients .", "label": "", "metadata": {}, "score": "42.13331"}
{"text": "12 , pp .1342 - 1359 , 2012 .View at Publisher \u00b7 View at Google Scholar .L. A. Adams , S. Harmsen , J. L. S. Sauver et al . , \" Nonalcoholic fatty liver disease increases risk of death among patients with diabetes : a community - based cohort study , \" The American Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "42.19209"}
{"text": "Table 3 and 4 summarizes these findings .With the increasing prevalence of obesity worldwide , NAFLD has became the most common cause of liver disease in developed countries ( 11 ) .", "label": "", "metadata": {}, "score": "42.202225"}
{"text": "4 However , a liver biopsy sampling error can result in substantial misdiagnosis and staging inaccuracies .7 The main concern regarding liver biopsies is the lack of resources , largely because of the large number of subjects affected by NAFLD .", "label": "", "metadata": {}, "score": "42.23954"}
{"text": "PubMed .BMC Gastroenterology 2006 , 6 : 6 .View Article PubMed .Imbert - Bismut F , Ratziu V , Pieroni L , Charlotte F , Benhamou Y , Poynard T : Biochemical markers of liver fibrosis in patients with hepatitis C virus infection : a prospective study .", "label": "", "metadata": {}, "score": "42.28741"}
{"text": "Clinicopathological features of liver injury in patients with type 2 diabetes mellitus and comparative study of histologically proven nonalcoholic fatty liver diseases with or without type 2 diabetes mellitus .", "label": "", "metadata": {}, "score": "42.42254"}
{"text": "View Abstract .[ 12 ] Charatcharoenwitthaya P , et al .The spontaneous course of liver enzymes and its correlation in nonalcoholic fatty liver disease .", "label": "", "metadata": {}, "score": "42.4299"}
{"text": "Gastroenterology .View Abstract .[ 8 ] Vernon G , et al .Systematic review : the epidemiology and natural history of non - alcoholic fatty liver disease and non - alcoholic steatohepatitis in adults .", "label": "", "metadata": {}, "score": "42.48798"}
{"text": "This technique has been validated across different liver diseases , including NAFLD [ 22 ] .In the elderly population , TE is a promising noninvasive method of quantifying liver fibrosis in NAFLD .", "label": "", "metadata": {}, "score": "42.529762"}
{"text": "2010;CD007340 .[PubMed ] [ DOI ] Arq .Gastroenterol .vol.47 no.2 S\u00e3o Paulo Apr./June 2010 .Evaluation of the nonalcoholic fat liver disease fibrosis score for patients undergoing bariatric surgery .", "label": "", "metadata": {}, "score": "42.541862"}
{"text": "12 , pp .3239 - 3246 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed . Y. Yilmaz , \" Systematic review : caspase - cleaved fragments of cytokeratin 18-the promises and challenges of a biomarker for chronic liver disease , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "42.56183"}
{"text": "[Links ] .McGill DB , Rakela J , Zinmeister AR , et al .A 21 yr experience with major hemorrhage after percutaneous liver biopsy .", "label": "", "metadata": {}, "score": "42.612274"}
{"text": "View Article PubMed .Poynard T , Ratziu V , Benhamou Y , Thabut D , Moussalli J : Biomarkers as a first - line estimate of injury in chronic liver diseases : time for a moratorium on liver biopsy ?", "label": "", "metadata": {}, "score": "42.68826"}
{"text": "85 - 94 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .N. C. Leite , G. F. Salles , A. L. E. Araujo , C. A. Villela - Nogueira , and C. R. L. Cardoso , \" Prevalence and associated factors of non - alcoholic fatty liver disease in patients with type-2 diabetes mellitus , \" Liver International , vol .", "label": "", "metadata": {}, "score": "42.79126"}
{"text": "[PubMed ] [ DOI ] .Cal\u00e8s P , Lain\u00e9 F , Boursier J , Deugnier Y , Moal V , Oberti F , Hunault G , Rousselet MC , Hubert I , Laafi J. Comparison of blood tests for liver fibrosis specific or not to NAFLD .", "label": "", "metadata": {}, "score": "42.869316"}
{"text": "6 , pp .1117 - 1123 , 2000 .View at Google Scholar .T. Gramlich , D. E. Kleiner , A. J. McCullough , C. A. Matteoni , N. Boparai , and Z. M. Younossi , \" Pathologic features associated with fibrosis in nonalcoholic fatty liver disease , \" Human Pathology , vol .", "label": "", "metadata": {}, "score": "42.883087"}
{"text": "Similarly , T2D was found in 2.5 % of women with fatty liver compared to 0.4 % who did not develop fatty liver on ultrasound over the 5-years studied period [ 42 ] .", "label": "", "metadata": {}, "score": "42.937996"}
{"text": "124 - 131 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. Targher , L. Bertolini , R. Padovani et al . , \" Prevalence of non - alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes , \" Journal of Hepatology , vol .", "label": "", "metadata": {}, "score": "42.972954"}
{"text": "11 , pp .1195 - 1202 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. Targher , F. Marra , and G. Marchesini , \" Increased risk of cardiovascular disease in non - alcoholic fatty liver disease : causal effect or epiphenomenon ? \"", "label": "", "metadata": {}, "score": "42.9989"}
{"text": "Diagnostic value of biochemical markers(Fibro Test- Fibro SURE ) for the prediction of liver fibrosis in patients with nonalcoholic fatty liver disease .BMC Gastroenterol 2006;6:6 .", "label": "", "metadata": {}, "score": "42.999092"}
{"text": "NAFLD : Non - alcoholic fatty liver disease ; NASH :Nonalcoholic steatohepatitis ; TZDS :Thiazolidinediones .Currently , weight loss and lifestyle modification should be used as first line therapy .", "label": "", "metadata": {}, "score": "43.00449"}
{"text": "Links ] .Rosenberg WM , Voelker M , Thiel R , et al .Serum markers detect the presence of liver fibrosis : a cohort study .", "label": "", "metadata": {}, "score": "43.04318"}
{"text": "The inability of liver biopsy to meet this challenge makes the development of non - invasive , readily available and easy to perform serum markers a high priority .", "label": "", "metadata": {}, "score": "43.250237"}
{"text": "The incidence of fatty liver , fibrosis , and cirrhosis was similar in the two groups .The explanation for these findings may rest in several important differences in the obese and non - obese SBS patients .", "label": "", "metadata": {}, "score": "43.27099"}
{"text": "Imaging studies , although being of help in to determining the presence and amount of fatty infiltration of liver , can not be used accurately determine the severity of liver damage .", "label": "", "metadata": {}, "score": "43.416843"}
{"text": "Yoneda et al [ 59 ] investigated the usefulness of the transient elastography in NAFLD patients .They found that there is a significant correlation between liver stiffness and fibrosis stage , which was confirmed by liver biopsy [ 59 ] .", "label": "", "metadata": {}, "score": "43.439156"}
{"text": "PubMed ] [ DOI ] .Sorbi D , Boynton J , Lindor KD .The ratio of aspartate aminotransferase to alanine aminotransferase : potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease .", "label": "", "metadata": {}, "score": "43.55333"}
{"text": "2012 Jul;24(7):805 - 10 .View Abstract .[ 15 ] Irie M , et al .Levels of the oxidative stress marker \u03b3 - glutamyltranspeptidase at different stages of nonalcoholic fatty liver disease .", "label": "", "metadata": {}, "score": "43.639256"}
{"text": "[Links ] .Dam - Larsen S , Franzmann M , Andersen IB , Christoffersen P , Jensen LB , S\u00f8rensen TIA , Becker U , Bendtsen F. Long term prognosis of fatty liver : risk of chronic liver disease and death .", "label": "", "metadata": {}, "score": "43.68383"}
{"text": "391 - 396 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Hamaguchi , N. Takeda , C. Nagata et al . , \" Nonalcolholic fatty liver disease is a novel predictor cardiovascular disease , \" World Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "43.689278"}
{"text": "2001 June 12(6):318 - 329 View Abstract .[20 ] Khoshbaten M , et al .N - acetylcysteine improves liver function in patients with non - alcoholic Fatty liver disease .", "label": "", "metadata": {}, "score": "43.73781"}
{"text": "Nutr .[ Google Scholar ] .Riley , T.R. ; Taheri , M. ; Scherbman , J.R. Does weight loss history affect fibrosis in the setting of chronic liver disease ?", "label": "", "metadata": {}, "score": "43.767525"}
{"text": "74 - 80 , 1990 .View at Google Scholar .S. A. Harrison , S. Torgerson , and P. H. Hayashi , \" The natural history of nonalcoholic fatty liver disease : a clinical histopathological study , \" American Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "43.836895"}
{"text": "[PubMed ] [ DOI ] .Lewis JR , Mohanty SR .Nonalcoholic fatty liver disease : a review and update .Dig Dis Sci .", "label": "", "metadata": {}, "score": "44.071037"}
{"text": "Liver biopsies were routinely stained with hematoxylin and eosin and Gomori 's trichrome .A single liver pathologist , who did not have access to the clinical history nor to the fibrosis score , read the biopsies .", "label": "", "metadata": {}, "score": "44.07322"}
{"text": "[11 ] Patients are more likely to come to attention because laboratory testing revealed elevated liver aminotransferases or hepatic steatosis was detected incidentally on abdominal imaging .", "label": "", "metadata": {}, "score": "44.07753"}
{"text": "Although there is no specific treatment currently approved to treat liver injury in NAFLD , many are being developed .The diagnosis of advanced fibrosis or NASH could be very important for motivating patients to make diet or lifestyle modifications , for the intensive treatment of complications of the metabolic syndrome or for providing weight in favor of anti - obesity surgery .", "label": "", "metadata": {}, "score": "44.083633"}
{"text": "We evaluated the accuracy of non - invasive markers and liver biopsy in predicting morbidity and mortality in CHC patients ... .DNA methylation of the IGF2/H19 imprinting control region and adiposity distribution in young adults .", "label": "", "metadata": {}, "score": "44.126865"}
{"text": "This study demonstrated the application of the NAFLD score , based on simple clinical and biochemical parameters , in the morbid obese patient group .The absence and the presence of advanced fibrosis were predicted in 133 ( 84 % ) of the patients and in 129 ( 97 % ) it was correct .", "label": "", "metadata": {}, "score": "44.174095"}
{"text": "[Links ] .Wai C , Greenson JK , Fontana RJ , Kalbfleisch JD , Marrero JA , Conjeevaram HS , Lok AS .A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology .", "label": "", "metadata": {}, "score": "44.2259"}
{"text": "NAFLD ranges from simple steatosis to nonalcoholic steatohepatitis ( NASH ) and potentially cirrhosis [ 6 ] .NASH is the picture of hepatocellular injury and inflammation of the liver [ 7 ] .", "label": "", "metadata": {}, "score": "44.33174"}
{"text": "Biopsy was performed in 11 ( 21 % ) controls and 5 ( 19 % ) obese patients .Fatty liver was a radiographic diagnosis .", "label": "", "metadata": {}, "score": "44.39991"}
{"text": "Liver biopsies were fixed , paraffin - embedded , and stained with at least hematoxylin - eosin - safran , iron staining , and Masson 's trichrome or picrosirius red for collagen .", "label": "", "metadata": {}, "score": "44.463154"}
{"text": "The histological course of nonalcoholic fatty liver disease : a longitudinal study of 103 patients with sequential liver biopsies .Leon A Adams Division of Gastroenterology and Hepatology , Mayo Clinic College of Medicine , 200 First Street SW , Rochester , MN 55905 , USA J Hepatol 42:132 - 8 .", "label": "", "metadata": {}, "score": "44.60267"}
{"text": "Liver biopsy remains the best diagnostic tool for confirming NAFLD and evaluating necroinflammation / fibrosis , as well as the most sensitive and specific means of providing important prognostic information .", "label": "", "metadata": {}, "score": "44.666637"}
{"text": "[PubMed ] [ DOI ] .Oh MK , Winn J , Poordad F. Review article : diagnosis and treatment of non - alcoholic fatty liver disease .", "label": "", "metadata": {}, "score": "44.724194"}
{"text": "This study had 78 participants , 22 that were biopsy proven NAFLD .In the NAFLD group , plasma levels and lipid peroxidation markers ( malondialdehyde and 4-hydroxynonenal ) improved [ 106 ] .", "label": "", "metadata": {}, "score": "44.7908"}
{"text": "[PubMed ] [ DOI ] .Wu SD , Wang JY , Li L. Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model : a comparative study .", "label": "", "metadata": {}, "score": "44.91813"}
{"text": "The NAFLD fibrosis score accuracy was determined by calculating sensitivity , specificity , positive predictive value , negative predictive value and likelihood ratios taking into consideration the prevalence of advanced liver fibrosis in the studied group .", "label": "", "metadata": {}, "score": "44.936245"}
{"text": "The presence of advanced fibrosis do not change the surgical plan , indeed , it is and additional indication for bariatric surgery .However , the surgical procedure must carry out a slow and progressive weight loss since more aggressive bariatric surgery with dramatic weight loss and malnutrition may worse their liver disease .", "label": "", "metadata": {}, "score": "44.93808"}
{"text": "[Links ] .Poynard T , McHutchison J , Manns M , Myers RP , Albrecht J. Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin .", "label": "", "metadata": {}, "score": "44.95366"}
{"text": "J. Physicol .Gastrointest .Liver Physiol .2007 , 292 , G518-G525 .[ Google Scholar ] .Beymer , C. ; Kowdlay , K.V. ; Langnas , A. ; Edmonson , P. ; Dellinger , E.P. ; Flum , D.R. Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery .", "label": "", "metadata": {}, "score": "44.956955"}
{"text": "Clinical studies have investigated the use of metformin in the treatment of NAFLD , specifically looking at liver histology and aminotransferases .Nair et al [ 79 ] conducted a pilot study to investigate the efficiency and safety of metformin in NAFLD patients .", "label": "", "metadata": {}, "score": "44.97645"}
{"text": "Also , is associated with an increased risk of kidney disease in subjects with multiple CVD risk factors and tends to be considered as an independent CVD marker [ 7 ] .", "label": "", "metadata": {}, "score": "45.010212"}
{"text": "None had decompensated liver disease .The mean AST / ALT ratio for the different groups is illustrated in Figs 1a and 1b , showing a trend towards a higher value for patients with advanced fibrosis .", "label": "", "metadata": {}, "score": "45.01358"}
{"text": "The majority of patients undergoing bariatric surgery did not present advanced fibrosis , 136 or 86 % , so the low cutoff point of -1.455 was very accurate to exclude this form of fibrosis with a good negative predictive value of 97.2 % .", "label": "", "metadata": {}, "score": "45.02781"}
{"text": "Hepatology .[PubMed ] [ DOI ] .Zelber - Sagi S , Nitzan - Kaluski D , Goldsmith R , Webb M , Blendis L , Halpern Z , Oren R. Long term nutritional intake and the risk for non - alcoholic fatty liver disease ( NAFLD ) : a population based study .", "label": "", "metadata": {}, "score": "45.07203"}
{"text": "BMC Gastroenterol .[PubMed ] [ DOI ] .Bedogni G , Bellentani S , Miglioli L , Masutti F , Passalacqua M , Castiglione A , Tiribelli C. The Fatty Liver Index : a simple and accurate predictor of hepatic steatosis in the general population .", "label": "", "metadata": {}, "score": "45.178337"}
{"text": "5 , pp .716 - 724 , 2000 .View at Publisher \u00b7 View at Google Scholar .V. Ratziu , P. Giral , F. Charlotte et al . , \" Liver fibrosis in overweight patients , \" Gastroenterology , vol .", "label": "", "metadata": {}, "score": "45.205364"}
{"text": "10 , pp .1579 - 1584 , 2007 .View at Google Scholar .G. N. Ioannou , N. S. Weiss , E. J. Boyko , D. Mozaffarian , and S. P. Lee , \" Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "45.22457"}
{"text": "In addition , these studies have determined that the use of statins producing liver injury is rare [ 97 ] , and that statins are safe to use in NAFLD / NASH patients with dyslipidemia [ 98 , 101 ] .", "label": "", "metadata": {}, "score": "45.23607"}
{"text": "1995 Nov;22(5):1399 - 403 .View Abstract .[26 ] Gaby AR .Nonalcoholic fatty liver disease in Nutritional Medicine , pg 493 .[ 27 ] Gaby AR .", "label": "", "metadata": {}, "score": "45.239357"}
{"text": "13 % ) and cirrhosis / portal hypertension ( 19 % vs .21 % ) were similar in obese and control groups .Overall , end stage liver disease ( ESLD ) was similar in obese and control groups ( 19 % vs .", "label": "", "metadata": {}, "score": "45.322693"}
{"text": "[PubMed ] [ DOI ] .Schreuder TC , Verwer BJ , van Nieuwkerk CM , Mulder CJ .Nonalcoholic fatty liver disease : an overview of current insights in pathogenesis , diagnosis and treatment .", "label": "", "metadata": {}, "score": "45.33526"}
{"text": "The development of non - invasive measures to assess inflammation and fibrosis are commonly used in practice , with liver biopsy being used only in specific cases or within research protocol .", "label": "", "metadata": {}, "score": "45.34057"}
{"text": "4 , pp .139 - 142 , 2010 .View at Google Scholar .G. L. Vega , M. Chandalia , L. S. Szczepaniak , and S. M. Grundy , \" Effects of N-3 fatty acids on hepatic triglyceride content in humans , \" Journal of Investigative Medicine , vol .", "label": "", "metadata": {}, "score": "45.355484"}
{"text": "The study also assessed the effect of ezetimibe on CE levels ... .Treatment extension may benefit female genotype 1 chronic hepatitis C patients with complete early virological response to peginterferon - alpha-2b and ribavirin combination therapy .", "label": "", "metadata": {}, "score": "45.360466"}
{"text": "The Fatty Liver Index is an algorithm based on four markers ; BMI , waist circumference , triglyceride and \u03b3 - glutamyltransferase ( GGT ) [ 26 ] , which is confirmed to accurately identify NAFLD [ 49 , 50 ] .", "label": "", "metadata": {}, "score": "45.380703"}
{"text": "[Links ] .BMC Gastroenterol .[Links ] .Sanyal AJ .AGA technical review on nonalcoholic fatty liver disease .Gastroenterology .[", "label": "", "metadata": {}, "score": "45.472504"}
{"text": "Descritores : Cirrose hep\u00e1tica .F\u00edgado gorduroso .Obesidade m\u00f3rbida .Cirurgia bari\u00e1trica .The increasing prevalence of obesity , diabetes and metabolic syndrome promoted nonalcoholic fat liver disease ( NAFLD ) to the most common cause of chronic liver disease worldwide ( 4 , 7 , 18 , 29 ) .", "label": "", "metadata": {}, "score": "45.515793"}
{"text": "124 - 131 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed \u00b7 View at Scopus . D. N. Amarapurkar , E. Hashimoto , L. A. Lesmana , J. D. Sollano , P. J. Chen , and K. L. Goh , \" How common is non - alcoholic fatty liver disease in the Asia - Pacific region and are there local differences ? \"", "label": "", "metadata": {}, "score": "45.524754"}
{"text": "Hepatology .[PubMed ] [ DOI ] .Dowman JK , Tomlinson JW , Newsome PN .Systematic review : the diagnosis and staging of non - alcoholic fatty liver disease and non - alcoholic steatohepatitis .", "label": "", "metadata": {}, "score": "45.536167"}
{"text": "[PubMed ] [ DOI ] .Solga S , Alkhuraishe AR , Clark JM , Torbenson M , Greenwald A , Diehl AM , Magnuson T. Dietary composition and nonalcoholic fatty liver disease .", "label": "", "metadata": {}, "score": "45.539085"}
{"text": "[PubMed ] [ DOI ] .Targher G , Bertolini L , Padovani R , Rodella S , Tessari R , Zenari L , Day C , Arcaro G. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients .", "label": "", "metadata": {}, "score": "45.556038"}
{"text": "11 - 12 , pp .1103 - 1109 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed . S. Chitturi , V. W. S. Wong , and G. Farrell , \" Nonalcoholic fatty liver in Asia : firmly entrenched and rapidly gaining ground , \" Journal of Gastroenterology and Hepatology , vol .", "label": "", "metadata": {}, "score": "45.560966"}
{"text": "113 - 119 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Kotronen , L. Juurinen , A. Hakkarainen et al . , \" Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects , \" Diabetes Care , vol .", "label": "", "metadata": {}, "score": "45.56195"}
{"text": "The identification of fibrosis is essential for the prognosis of liver disease and can be done using a panel of markers or scores instead of liver biopsy .", "label": "", "metadata": {}, "score": "45.60286"}
{"text": "[PubMed ] [ DOI ] .Santos VN , Lanzoni VP , Szejnfeld J , Shigueoka D , Parise ER .A randomized double - blind study of the short - time treatment of obese patients with nonalcoholic fatty liver disease with ursodeoxycholic acid .", "label": "", "metadata": {}, "score": "45.62874"}
{"text": "[PubMed ] [ DOI ] .Marchesini G , Bugianesi E , Forlani G , Cerrelli F , Lenzi M , Manini R , Natale S , Vanni E , Villanova N , Melchionda N. Nonalcoholic fatty liver , steatohepatitis , and the metabolic syndrome .", "label": "", "metadata": {}, "score": "45.647987"}
{"text": "2042 - 2047 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed . E. Fassio , E. \u00c1lvarez , N. Dom\u00ednguez , G. Landeira , and C. Longo , \" Natural history of nonalcoholic steatohepatitis : a longitudinal study of repeat liver biopsies , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "45.665558"}
{"text": "View Article PubMed .View Article PubMed .Cales P , Oberti F , Michalak S , Hubert - Fouchard I , Rousselet MC , Konate A , Gallois Y , Ternisien C , Chevailler A , Lunel F : A novel panel of blood markers to assess the degree of liver fibrosis .", "label": "", "metadata": {}, "score": "45.68521"}
{"text": "1020 - 1023 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. Perseghin , G. Lattuada , F. De Cobelli et al . , \" Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "45.694008"}
{"text": "Am J Med Sci .[PubMed ] [ DOI ] .Ekstedt M , Franz\u00e9n LE , Mathiesen UL , Holmqvist M , Bodemar G , Kechagias S. Statins in non - alcoholic fatty liver disease and chronically elevated liver enzymes : a histopathological follow - up study .", "label": "", "metadata": {}, "score": "45.696568"}
{"text": "745 - 752 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .T. Yamada , M. Fukatsu , S. Suzuki , T. Wada , T. Yoshida , and T. Joh , \" Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup , \" Journal of Gastroenterology and Hepatology , vol .", "label": "", "metadata": {}, "score": "45.750168"}
{"text": "5 , pp .1145 - 1151 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. Targher , L. Bertolini , R. Padovani et al . , \" Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease , \" Diabetes Care , vol .", "label": "", "metadata": {}, "score": "45.769684"}
{"text": "[Links ] .Bedogni G , Miglioli L , Masutti F , Tiribelli C , Marchesini G , Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease : The Dionysos nutrition and liver study .", "label": "", "metadata": {}, "score": "45.962708"}
{"text": "[Links ] .Bedogni G , Miglioli L , Masutti F , Tiribelli C , Marchesini G , Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease : the Dionysos nutrition and liver study .", "label": "", "metadata": {}, "score": "45.962708"}
{"text": "However the decrease of apolipoprotein A1 in NASH was much lower than in patients with ASH .In our NASH population there was a much lower prevalence of cirrhosis , as well as severe steato - hepatitis in comparison with the population of ASH [ 36 ] .", "label": "", "metadata": {}, "score": "45.99806"}
{"text": "Liver Dis .[ Google Scholar ] .Thompson , J.S. ; Weseman , R. ; Rochling , F. ; Grant , W. ; Botha , J. ; Langnas , A. ; Mercer , D. Pre - Resection BMI Influences Postresection BMI in Short Bowel Syndrome .", "label": "", "metadata": {}, "score": "46.031883"}
{"text": "Links ] .Matteoni CA , Younossi ZM , Gramlich T , Boparai N , Liu YC , McCullough AJ .Nonalcoholic fatty liver disease : a spectrum of clinical and pathological severity .", "label": "", "metadata": {}, "score": "46.09301"}
{"text": "[Links ] .Gholam PM , Flancbaum L , Machan JT , Charney DA , Kotler DP .Nonalcoholic fatty liver disease in severely obese subjects .", "label": "", "metadata": {}, "score": "46.195305"}
{"text": "Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction .Leon A Adams Division of Gastroenterology and Hepatology , Mayo Clinic and Foundation , Rochester , Minnesota , USA Hepatology 39:909 - 14 .", "label": "", "metadata": {}, "score": "46.232796"}
{"text": "[PubMed ] [ DOI ] .Aller R , De Luis DA , Izaola O , Conde R , Gonzalez Sagrado M , Primo D , De La Fuente B , Gonzalez J. Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients : a double blind randomized clinical trial .", "label": "", "metadata": {}, "score": "46.24567"}
{"text": "91 - 100 , 2001 .View at Google Scholar \u00b7 View at Scopus . D. L. White , F. Kanwal , and H. B. El - Serag , \" Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer , based on systematic review , \" Clinical Gastroenterology and Hepatology , vol .", "label": "", "metadata": {}, "score": "46.24578"}
{"text": "10 , pp .1441 - 1447 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Kotronen and H. Yki - J\u00e4rvinen , \" Fatty liver : a novel component of the metabolic syndrome , \" Arteriosclerosis , Thrombosis , and Vascular Biology , vol .", "label": "", "metadata": {}, "score": "46.30686"}
{"text": "The degree of aminotransferase elevation does not predict the degree of hepatic inflammation or fibrosis , and a normal alanine aminotransferase does not exclude clinically important histologic injury .", "label": "", "metadata": {}, "score": "46.308464"}
{"text": "The gut microbiome may play a role in the development of nonalcoholic fatty liver disease ( NAFLD ) [ 15 ] .The obesity gut microbiome might also promote other types of liver injury .", "label": "", "metadata": {}, "score": "46.399734"}
{"text": "Its severe form , nonalcoholic steatohepatitis may cause liver fibrosis .The diagnosis of advanced fibrosis has great value during the pre operative evaluation for bariatric surgery .", "label": "", "metadata": {}, "score": "46.404305"}
{"text": "[PubMed ] [ DOI ] .Matteoni CA , Younossi ZM , Gramlich T , Boparai N , Liu YC , McCullough AJ .Nonalcoholic fatty liver disease : a spectrum of clinical and pathological severity .", "label": "", "metadata": {}, "score": "46.472145"}
{"text": "Hepatobiliary disease was evaluated by serum liver function tests , radiologic imaging ( ultrasound and computed tomography ) , endoscopic findings ( portal hypertension ) , and histologic evaluation of liver biopsies .", "label": "", "metadata": {}, "score": "46.612156"}
{"text": "View Article PubMed .Bugianesi E , Leone N , Vanni E , Marchesini G , Brunello F , Carucci P , Musso A , De Paolis P , Capussotti L , Salizzoni M , Rizzetto M : Expanding the natural history of nonalcoholic steatohepatitis : From cryptogenic cirrhosis to hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "46.64722"}
{"text": "Nonalcoholic fatty liver disease .Gastroenterology .[Links ] .Coco B , Oliveri F , Maina AM , Ciccorossi P , Sacco R , Colombatto P , Bonino F , Brunetto MR .", "label": "", "metadata": {}, "score": "46.714745"}
{"text": "A similar study used NAFLD patients with elevated liver enzymes and central obesity to assess the effectiveness of lifestyle interventions .Patients were randomly assigned to either low ( 3 sessions/4 wk ) or moderate ( 6 sessions/10 wk ) physical activity intensity groups and were compared to a control group .", "label": "", "metadata": {}, "score": "46.740463"}
{"text": "Age , body mass index , hyperglycemia , platelet count , albumin and AST / ALT ratio were applied to the score formula .Scores above 0.676 were indicative of advanced liver fibrosis and scores under -1,455 absence of advanced liver fibrosis .", "label": "", "metadata": {}, "score": "46.783493"}
{"text": "Fatty liver .Obesity , morbid .Bariatric surgery .CONTEXTO : Pacientes com obesidade m\u00f3rbida apresentam risco significativo para doen\u00e7a hep\u00e1tica gordurosa n\u00e3o - alco\u00f3lica e para suas formas mais graves , a esteatohepatite e a cirrose hep\u00e1tica .", "label": "", "metadata": {}, "score": "46.821735"}
{"text": "View Article PubMed .Poynard T , Ratziu V , Bedossa P : Appropriateness of liver biopsy .Can J Gastroenterol 2000 , 14 : 543 - 8 .", "label": "", "metadata": {}, "score": "46.83198"}
{"text": "Toshihide Shima Department of Gastroenterology and Hepatology , Saiseikai Suita Hospital , Suita , Japan J Gastroenterol 48:515 - 25 .Our study aimed to clarify the clinicopathological features of liver injury and the characteristics of nonalcoholic fatty liver disease ( NAFLD ) in DM patients ... .", "label": "", "metadata": {}, "score": "46.861095"}
{"text": "Thus , they would remain at risk for obesity related liver disease and other inflammatory complications related to the metabolic syndrome .Obese patients were less likely to require long term PN compared to non - obese patients .", "label": "", "metadata": {}, "score": "46.86469"}
{"text": "The links between NAFLD and metabolic syndrome / prediabetes / T2D seem likely to reflect the operation of shared pathogenic factors , as we and others have reviewed [ 10 - 12 ] .", "label": "", "metadata": {}, "score": "46.88285"}
{"text": "51 , no .11 , pp .1947 - 1953 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . S. E. Baumeister , H. V\u00f6lzke , P. Marschall et al . , \" Impact of fatty liver disease on health care utilization and costs in a general population : a 5-year observation , \" Gastroenterology , vol .", "label": "", "metadata": {}, "score": "46.919434"}
{"text": "Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C : a Japanese multi - center study .", "label": "", "metadata": {}, "score": "46.95"}
{"text": "In general , fatty liver is more prevalent in men than women up to the age of 60 years .Beyond menopause , the prevalence of fatty liver rises sharply in women and exceeds that observed in their male counterparts [ 5 , 13 , 36 ] .", "label": "", "metadata": {}, "score": "47.08199"}
{"text": "View at Publisher \u00b7 View at Google Scholar .V. Nobili , M. Manco , R. Devito et al . , \" Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease : a randomized , controlled trial , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "47.093796"}
{"text": "The relationship between hypertension and NAFLD has also been investigated .Higher prevalence of NAFLD in nonobese nondiabetic hypertensive patients with normal liver enzymes compared with adjusted nonhypertensive subjects .", "label": "", "metadata": {}, "score": "47.096703"}
{"text": "As discussed before , there is a very strong correlation between metabolic syndrome and the subsequent development of NAFLD conversely , presence of hepatic steatosis is predictive for development of metabolic syndrome [ 13 , 25 , 36 , 51 ] .", "label": "", "metadata": {}, "score": "47.143356"}
{"text": "R. K. Schindhelm , J. M. Dekker , G. Nijpels et al . , \" Alanine aminotransferase predicts coronary heart disease events : a 10-year follow - up of the Hoorn Study , \" Atherosclerosis , vol .", "label": "", "metadata": {}, "score": "47.158363"}
{"text": "Conflict of Interest .The authors declare no conflict of interest .References .Cavicchi , M. ; Beau , P. ; Crenn , P. ; Degott , C. ; Messing , B. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure .", "label": "", "metadata": {}, "score": "47.17536"}
{"text": "163 - 172 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .P. Angulo , J. C. Keach , K. P. Batts , and K. D. Lindor , \" Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "47.18523"}
{"text": "[PubMed ] [ DOI ] .Chatrath H , Vuppalanchi R , Chalasani N. Dyslipidemia in patients with nonalcoholic fatty liver disease .Semin Liver Dis .", "label": "", "metadata": {}, "score": "47.34465"}
{"text": "374 - 381 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .T. D. Filippatos and M. S. Elisaf , \" Combination drug treatment in patients with non - alcoholic fatty liver disease , \" World Journal of Hepatology , vol .", "label": "", "metadata": {}, "score": "47.443428"}
{"text": "NAFLD is an increasingly recognized cause of liver - related morbidity and mortality [ 1 - 3 ] .Although the majority of patients do not develop complications , 28 % may develop serious liver sequelae , including end - stage liver disease and hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "47.44773"}
{"text": "[PubMed ] [ DOI ] .Cortez - Pinto H , Camilo ME .Non - alcoholic fatty liver disease / non - alcoholic steatohepatitis ( NAFLD / NASH ) : diagnosis and clinical course .", "label": "", "metadata": {}, "score": "47.45043"}
{"text": "[PubMed ] [ DOI ] .Widhalm K , Ghods E. Nonalcoholic fatty liver disease : a challenge for pediatricians .Int J Obes ( Lond ) .", "label": "", "metadata": {}, "score": "47.46603"}
{"text": "View Article PubMed .Younossi ZM , Gramlich T , Liu YC , Matteoni C , Petrelli M , Goldblum J , Rybicki L , McCullough AJ : Non - alcoholic fatty liver disease : assessment of variability in pathologic interpretations .", "label": "", "metadata": {}, "score": "47.469048"}
{"text": "The fatty acid composition of plasma cholesteryl esters and estimated desaturase activities in patients with nonalcoholic fatty liver disease and the effect of long - term ezetimibe therapy on these levels .", "label": "", "metadata": {}, "score": "47.525894"}
{"text": "[Links ] .Beymer C , Kowdley KV , Larson A , Edmonson P , Dellinger EP , Flum DR .Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery .", "label": "", "metadata": {}, "score": "47.56452"}
{"text": "305 , no .16 , pp .1659 - 1668 , 2011 .View at Google Scholar .P. Riley , D. Sudarshi , M. Johal et al . , \" Weight loss , dietary advice and statin therapy in non - alcoholic fatty liver disease : a retrospective study , \" International Journal of Clinical Practice , vol .", "label": "", "metadata": {}, "score": "47.58957"}
{"text": "N Engl J Med 2002 , 346 : 1221 - 31 .View Article PubMed .Charlton M : Nonalcoholic fatty liver disease : a review of current understanding and future impact .", "label": "", "metadata": {}, "score": "47.677967"}
{"text": "The accuracy calculation took into consideration the prevalence of advanced fibrosis of 14 % .The absence and the presence of advanced fibrosis were predicted in 133 ( 84 % ) of the patients and in 129 ( 97 % ) it was correct .", "label": "", "metadata": {}, "score": "47.692837"}
{"text": "Hepatology 2005 , 41 : 1313 - 21 .View Article PubMed .Bellentani S , Bedogni G , Miglioli L , Tiribelli C : The epidemiology of fatty liver .", "label": "", "metadata": {}, "score": "47.69303"}
{"text": "We retrospectively reviewed 79 adult patients with SBS evaluated at our center between 1990 and 2008 .Records were reviewed to determine patient age and gender , underlying cause of resection , presence of other risk factors for liver disease , status of the intestinal remnant and other digestive organs , presence of hepatobiliary disease pre and post resection , and nutritional management and outcome .", "label": "", "metadata": {}, "score": "47.719727"}
{"text": "Gastroenterology .[PubMed ] [ DOI ] .Raman M , Ahmed I , Gillevet PM , Probert CS , Ratcliffe NM , Smith S , Greenwood R , Sikaroodi M , Lam V , Crotty P. Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease .", "label": "", "metadata": {}, "score": "47.764984"}
{"text": "Nonalcoholic fatty liver disease .Leon A Adams Division of Gastroenterology and Hepatology , Mayo Clinic and College of Medicine , Rochester , Minn 55905 , USA CMAJ 172:899 - 905 .", "label": "", "metadata": {}, "score": "47.865257"}
{"text": "[PubMed ] [ DOI ] .Masterton GS , Plevris JN , Hayes PC .Review article : omega-3 fatty acids - a promising novel therapy for non - alcoholic fatty liver disease .", "label": "", "metadata": {}, "score": "48.00251"}
{"text": "The content of diet slimming is of no particular importance ( advising to avoid alcohol ) , if lead to weight loss .However , although weight loss appears to be beneficial , rapid weight loss after gastroplasty has been associated with increased hepatitis despite reductions in steatosis on liver biopsy [ 47 ] .", "label": "", "metadata": {}, "score": "48.02095"}
{"text": "These subjects more often died from cardiovascular ( . , impaired endothelial function , and lower concentrations of adiponectin [ 4 , 22 ] .IMT is strongly associated with degree of hepatic steatosis , necroinflammation , and fibrosis among NAFLD patients ( . ) after adjustment for all confounders associated with the presence and severity of coronary atherosclerosis and cardiovascular disease [ 23 ] .", "label": "", "metadata": {}, "score": "48.103275"}
{"text": "OBJECTIVE :To evaluate the nonalcoholic fat liver disease fibrosis score in morbidly obese patients undergoing Roux - en - Y gastric bypass in our population .", "label": "", "metadata": {}, "score": "48.17286"}
{"text": "Hepatology .[PubMed ] [ DOI ] .Vernon G , Baranova A , Younossi ZM .Systematic review : the epidemiology and natural history of non - alcoholic fatty liver disease and non - alcoholic steatohepatitis in adults .", "label": "", "metadata": {}, "score": "48.175316"}
{"text": "Guha et al .20 determined that the addition of established simple markers to the ELF panel augmented the diagnostic performance and that liver biopsy could be avoided in 88 % of cases .", "label": "", "metadata": {}, "score": "48.23947"}
{"text": "The diagnosis and management of non - alcoholic fatty liver disease : practice Guideline by the American Association for the Study of Liver Diseases , American College of Gastroenterology , and the American Gastroenterological Association .", "label": "", "metadata": {}, "score": "48.318108"}
{"text": "Liver biopsy , therefore , has been recommended for confirming its diagnosis and for providing prognostic information [ 7 ] .There are several drawbacks in using liver biopsy for this purpose [ 8 ] .", "label": "", "metadata": {}, "score": "48.355648"}
{"text": "References .Sanyal AJ : AGA technical review on nonalcoholic fatty liver disease .Gastroenterology 2002 , 123 : 1705 - 25 .View Article PubMed .", "label": "", "metadata": {}, "score": "48.397583"}
{"text": "6 , pp .1979 - 1987 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. L. Fracanzani , L. Valenti , E. Bugianesi et al . , \" Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels : a role for insulin resistance and diabetes , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "48.53287"}
{"text": "NAFLD pathology ranges from simple steatosis to a necroinflammatory fibrosing disorder called steatohepatitis ( SH ) , the latter associated with high risk of developing cirrhosis , often occuring in the seventh to ninth decades of life .", "label": "", "metadata": {}, "score": "48.545776"}
{"text": "Nobili et al [ 80 ] found that metformin was no more effective than lifestyle interventions in improving liver enzymes or histology .Additionally , other studies have also failed to prove benefits of using metformin to improve liver histology [ 4 , 81 ] .", "label": "", "metadata": {}, "score": "48.58294"}
{"text": "View Article PubMed .Sorrentino P , Tarantino G , Conca P , Perrella A , Terracciano ML , Vecchione R , Gargiulo G , Gennarelli N , Lobello R : Silent non - alcoholic fatty liver disease - a clinical - histological study .", "label": "", "metadata": {}, "score": "48.58551"}
{"text": "J Viral Hepat .[Links ] .Colloredo G , Guido M , Sonzogni A , Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis : the smaller the sample , the milder the disease .", "label": "", "metadata": {}, "score": "48.60331"}
{"text": "[PubMed ] [ DOI ] .Mirza MS .Obesity , Visceral Fat , and NAFLD :Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease .", "label": "", "metadata": {}, "score": "48.653202"}
{"text": "The only significant differences observed were related to the inclusion criteria , with more metabolic risk factors , more steatosis and more advanced fibrosis in the included than the non - included patients ( Table 1 ) .", "label": "", "metadata": {}, "score": "48.72682"}
{"text": "[PubMed ] [ DOI ] .Cotrim HP , Daltro C. Liver : Does bariatric surgery reduce the severity of NAFLD ?Nat Rev Gastroenterol Hepatol .", "label": "", "metadata": {}, "score": "48.737366"}
{"text": "[14 ] , [ 15 ] .Radiographic findings in patients with NAFLD include increased echogenicity on ultrasound , decreased hepatic attenuation on computed tomography ( CT ) , and an increased fat signal on magnetic resonance imaging ( MRI ) .", "label": "", "metadata": {}, "score": "48.749844"}
{"text": "4 , pp .713 - 718 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. A. Caserta , G. M. Pendino , A. Amante et al . , \" Cardiovascular risk factors , nonalcoholic fatty liver disease , and carotid artery intima - media thickness in an adolescent population in southern Italy , \" The American Journal of Epidemiology , vol .", "label": "", "metadata": {}, "score": "48.753174"}
{"text": "View at Publisher \u00b7 View at Google Scholar .B. J. Park , Y. J. Kim , D. H. Kim et al . , \" Visceral adipose tissue area is an independent risk factor for hepatic steatosis , \" Journal of Gastroenterology and Hepatology , vol .", "label": "", "metadata": {}, "score": "48.80288"}
{"text": "PubMed ] [ DOI ] .McCarthy EM , Rinella ME .The role of diet and nutrient composition in nonalcoholic Fatty liver disease .J Acad Nutr Diet .", "label": "", "metadata": {}, "score": "48.80743"}
{"text": "Other studies showed an increased abundance of E. coli associated with higher blood alcohol levels [ 39 ] or differences in IM associated with differences in volatile organic compounds [ 38 ] .", "label": "", "metadata": {}, "score": "48.845802"}
{"text": "[PubMed ] [ DOI ] .Adams LA , Angulo P , Lindor KD .Nonalcoholic fatty liver disease .CMAJ .[PubMed ] [ DOI ] .", "label": "", "metadata": {}, "score": "48.847786"}
{"text": "However , liver - related mortality ranks third in the causes of death .The risk of liver - related death is even higher in the subgroup of patients with NASH compared to those with SS ( 2 - 10 % for NASH versus 0 - 2 % for SS ) ( Table 2 ) [ 57 , 75 - 77 ] .", "label": "", "metadata": {}, "score": "48.871143"}
{"text": "Hepatology .[PubMed ] [ DOI ] .Treeprasertsuk S , Bj\u00f6rnsson E , Enders F , Suwanwalaikorn S , Lindor KD .NAFLD fibrosis score : a prognostic predictor for mortality and liver complications among NAFLD patients .", "label": "", "metadata": {}, "score": "48.932465"}
{"text": "Thus , the factors increasing risk of cholelithiasis preoperatively may remain after developing SBS .Obese SBS patients also had a higher incidence of preexisting fatty liver .", "label": "", "metadata": {}, "score": "49.005882"}
{"text": "The positive predictive values of these 2 tests were low .According to Guha et al ., 20 the addition of the ELF panel to the NFS increased the positive predictive value for advanced fibrosis .", "label": "", "metadata": {}, "score": "49.00701"}
{"text": "Non - alcoholic fatty liver disease ( NAFLD ) is the most common cause of liver disease worldwide , with a prevalence of 15%-30 % in Western populations [ 1 - 4 ] .", "label": "", "metadata": {}, "score": "49.0508"}
{"text": "A E- Editor : Ma S .References .Clark JM , Diehl AM .Hepatic steatosis and type 2 diabetes mellitus .Curr Diab Rep .", "label": "", "metadata": {}, "score": "49.120354"}
{"text": "Others have proposed that a \" second hit , \" or additional oxidative injury , is required to manifest the necroinflammatory component of steatohepatitis .Hepatic iron , leptin , antioxidant deficiencies , and intestinal bacteria have all been suggested as potential oxidative stressors .", "label": "", "metadata": {}, "score": "49.15991"}
{"text": "Our results showed a rate of 92 % of fibrosis in morbidly obese patients subjected to Roux - en - Y gastric bypass .Brazilian data from patients undergoing bariatric surgery showed a wide range of fibrosis rate from 25 % up to 89,5 % in wedge biopsies ( 14 , 16 , 17 , 19 ) .", "label": "", "metadata": {}, "score": "49.234932"}
{"text": "CONCLUSION .The increase in NAFLD has and will continue to burden the health care system , especially because of its ties to obesity , IR and metabolic syndrome .", "label": "", "metadata": {}, "score": "49.238014"}
{"text": "View Article PubMed .Haukeland JW , Konopski Z , Linnestad P , Azimy S , Marit Loberg E , Haaland T , Birkeland K , Bjoro K : Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non - alcoholic fatty liver disease .", "label": "", "metadata": {}, "score": "49.2726"}
{"text": "ST has demonstrated high predictive values for the diagnosis of steatosis in patients with NAFLD , chronic hepatitis C , chronic hepatitis B , and ALD [ 35 ] .", "label": "", "metadata": {}, "score": "49.362457"}
{"text": "Non - alcoholic fatty liver disease ( NAFLD ) is the most common cause of chronic liver disease in the world , 1 - 3 affecting about a third of the USA 's population .", "label": "", "metadata": {}, "score": "49.38109"}
{"text": "6 , pp .W736-W742 , 2011 .View at Publisher \u00b7 View at Google Scholar .J. B. Krasnoff , P. L. Painter , J. P. Wallace , N. M. Bass , and R. B. Merriman , \" Health - related fitness and physical activity in patients with nonalcoholic fatty liver disease , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "49.4951"}
{"text": "Chronic hepatitis C ( CHC ) genotype 1b patients with high viral load are resistant to peginterferon ( PEG - IFN ) and ribavirin ( RBV ) combination therapy , especially older and female patients ... .", "label": "", "metadata": {}, "score": "49.51725"}
{"text": "Links ] .Bianchi L. Liver biopsy in elevated liver functions tests ?An old question revisited .J Hepatol 2001;35:290 - 294 .[Links ] .", "label": "", "metadata": {}, "score": "49.521408"}
{"text": "[PubMed ] [ DOI ] .Koehler EM , Schouten JN , Hansen BE , Hofman A , Stricker BH , Janssen HL .External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population - based study .", "label": "", "metadata": {}, "score": "49.523033"}
{"text": "Mild steatosis is not associated with an increased risk mortality compared with general population [ 72 ] .In type 2 diabetics , presence of NAFLD is associated with increased total mortality , regardless of classic risk factors [ 73 ] .", "label": "", "metadata": {}, "score": "49.56878"}
{"text": "811 - 826 , 2012 .View at Publisher \u00b7 View at Google Scholar .F. H. Luyckx , C. Desaive , A. Thiry et al . , \" Liver abnormalities in severely obese subjects : effect of drastic weight loss after gastroplasty , \" International Journal of Obesity , vol .", "label": "", "metadata": {}, "score": "49.597797"}
{"text": "View Article PubMed .Ratziu V , Bonyhay L , Di Martino V , Charlotte F , Cavallaro L , Sayegh - Tainturier MH , Giral P , Grimaldi A , Opolon P , Poynard T : Survival , liver failure , and hepatocellular carcinoma in obesity - related cryptogenic cirrhosis .", "label": "", "metadata": {}, "score": "49.598644"}
{"text": "The diagnosis of NAFLD often comes to light because of detection of abnormal liver tests , particularly raised serum alanine aminotransferase ( ALT ) and gamma - glutamyl transpeptidase ( GGT ) and serum ferritin .", "label": "", "metadata": {}, "score": "49.599964"}
{"text": "However , those obese patients that were receiving PN were at greatest risk for ESLD .In this context PN may present another example of a \" second hit \" in patients with preexisting steatosis than can lead to the development of steatohepatitis and subsequent fibrosis [ 7 , 8 ] .", "label": "", "metadata": {}, "score": "49.654316"}
{"text": "[Links ] .Stratopoulos C , Papakonstantinou A , Terzis I , Spiliadi C , Dimitriades G , Komesidou V , Kitsanta P , Argyrakos T , Hadjiyannakis E. Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity .", "label": "", "metadata": {}, "score": "49.6994"}
{"text": "Ratziu V , Charlotte F , Heurtier A , Gombert S , Giral P , Bruckert E , Grimaldi A , Capron F , Poynard T , for the LIDO Study Group : Sampling variability of liver biopsy in nonalcoholic fatty liver disease .", "label": "", "metadata": {}, "score": "49.708755"}
{"text": "Prospective and retrospective studies have found that bariatric surgery improved insulin resistance , steatosis and inflammation [ 112 ] .Moschen et al [ 113 ] prospectively found that weight loss after bariatric surgery improved insulin resistance , liver function tests and histology in 18 NAFLD patients .", "label": "", "metadata": {}, "score": "49.766388"}
{"text": "In obese patients undergoing bariatric surgery , hepatic steatosis is decreased from 53 % to 32 % , three months after surgery as overall mortality [ 49 , 50 ] .", "label": "", "metadata": {}, "score": "49.850796"}
{"text": "[PubMed ] [ DOI ] .Yoneda M , Yoneda M , Fujita K , Inamori M , Tamano M , Hiriishi H , Nakajima A. Transient elastography in patients with non - alcoholic fatty liver disease ( NAFLD ) .", "label": "", "metadata": {}, "score": "49.88695"}
{"text": "Metabolic syndrome was also independently associated with cardiovascular events , but simultaneous inclusion of NAFLD and metabolic syndrome in a multivariate model revealed that NAFLD but not metabolic syndrome retained a statistically significant correlation with CVD [ 19 ] .", "label": "", "metadata": {}, "score": "49.947548"}
{"text": "However , a recent Cochrane review concluded that there is insufficient data due to a lack of well - designed randomized control study trials to determine if bariatric surgery is an effective treatment for NAFLD [ 115 ] .", "label": "", "metadata": {}, "score": "49.966248"}
{"text": "6 , pp .900 - 907 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .T. Yamauchi , J. Kamon , H. Waki et al . , \" Globular adiponectin protected ob / ob mice from diabetes and ApoE - deficient mice from atherosclerosis , \" Journal of Biological Chemistry , vol .", "label": "", "metadata": {}, "score": "49.993546"}
{"text": "Takeshi Okanoue Center of Gastroenterology and Hepatology , Saiseikai Suita Hospital , Osaka , Japan J Gastroenterol Hepatol 26:153 - 62 .Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C : a Japanese multi - center study .", "label": "", "metadata": {}, "score": "50.054626"}
{"text": "Only 1 patient ( 0.9 % ) of the 110 patients with the score below the low cutoff point was incorrectly staged .Thus , the advanced fibrosis was excluded with high accuracy ( negative predictive value of 97.2 % ) .", "label": "", "metadata": {}, "score": "50.063705"}
{"text": "Association between liver - specific gene polymorphisms and their expression levels with nonalcoholic fatty liver disease .Leon A Adams School of Medicine and Pharmacology , University of Western Australia UWA Perth , Australia Hepatology 57:590 - 600 .", "label": "", "metadata": {}, "score": "50.085674"}
{"text": "91 - 100 , 2001 .View at Google Scholar .C. Garc\u00eda - Monz\u00f3n , E. Mart\u00edn - P\u00e9rez , O. L. Iacono et al . , \" Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated obesity , \" Journal of Hepatology , vol .", "label": "", "metadata": {}, "score": "50.186005"}
{"text": "Advanced fibrosis may not reduce in more than 60 % of patients after bariatric surgery , and these patients will have higher risks for cirrhosis and hepatocarcinoma , and they must be followed in the postoperative period ( 27 , 37 ) .", "label": "", "metadata": {}, "score": "50.26174"}
{"text": "Surg .[ Google Scholar ] [ CrossRef ] .Frantzides , C.T. ; Carlson , M.A. ; Moore , R.E. ; Zografakis , J.G. ; Madan , A.K. ; Puumala , S. ; Keshavarzian , A. Effect of body mass index on nonalcoholic fatty liver disease in patients undergoing minimally invasive bariatric surgery .", "label": "", "metadata": {}, "score": "50.322853"}
{"text": "[Links ] .Garcia - Monson C , Martin - Perez E , Iacono OL , et al .Characterization of pathogenic and prognostic factors of non - alcoholic steatohepatitis associated with obesity .", "label": "", "metadata": {}, "score": "50.348557"}
{"text": "The independent association among NAFLD and CVD is supported by another large study following type 2 diabetics for 6.5 years [ 30 ] .Significant association of NAFLD with incident CVD ( hazart ratio 1.96 ( 1.4 - 2.7 ) , . ) by adjustment for sex , age , smoking , diabetes duration , HbA1c , LDL - cholesterol and medications was found [ 30 ] .", "label": "", "metadata": {}, "score": "50.359978"}
{"text": "METHODS .One hundred and fifty - eight patients with morbid obesity that had undergone bariatric surgery were retrospectively evaluated .During the pre operative evaluation , a complete history and physical examination was undertaken to exclude other causes of liver disease other than obesity .", "label": "", "metadata": {}, "score": "50.40899"}
{"text": "Am J Gastroenterol .[Links ] .Haynes P , Liangpunsakul S , Chalasani N. Nonalcoholic fatty liver disease in individuals with severe obesity .", "label": "", "metadata": {}, "score": "50.441498"}
{"text": "S. Chitturi and G. C. Farrell , \" Etiopathogenesis of nonalcoholic steatohepatitis , \" Seminars in Liver Disease , vol .21 , no . 1 , pp .", "label": "", "metadata": {}, "score": "50.445107"}
{"text": "Aminotransferase levels do not correlate with underlying biological activity and can even be normal in advanced disease .12 - 14 An aspartate aminotransferase - to - alanine aminotransferase ( AST / ALT ) ratio of more than 1 may suggest advanced fibrosis or cirrhosis .", "label": "", "metadata": {}, "score": "50.488697"}
{"text": "The first recruited 91 inpatients from 3 rehabilitation hospitals in Israel [ 34 ] , and the second recruited 351 outpatients from a tertiary liver clinic in UK [ 37 ] .", "label": "", "metadata": {}, "score": "50.49444"}
{"text": "[Links ] .Rockey DC , Bissel DM .Noninvasive measures of liver fibrosis .Hepatology 2006;43:S113-S120 .[Links ] .", "label": "", "metadata": {}, "score": "50.519463"}
{"text": "Mild steatosis , in the majority of cases , remains stable without any further complication ( 15 , 38 ) .However , patients with fibrosis have a higher risk for cirrhosis , portal hypertension , hepatocarcinoma and death ( 1 , 2 , 9 , 10 , 32 , 34 , 38 ) .", "label": "", "metadata": {}, "score": "50.52208"}
{"text": "S105-S118 , 2009 .View at Google Scholar \u00b7 View at Scopus .M. Tobari , E. Hashimoto , S. Yatsuji , N. Torii , and K. Shiratori , \" Imaging of nonalcoholic steatohepatitis : advantages and pitfalls of ultrasonography and computed tomography , \" Internal Medicine , vol .", "label": "", "metadata": {}, "score": "50.54148"}
{"text": "There is experimental evidence that obesity is associated with increased intestinal permeability and increased portal lipopolysaccharide levels which might contribute to liver inflammatory damage [ 16 ] .", "label": "", "metadata": {}, "score": "50.555046"}
{"text": "Cadranel JF , Rufat P , Degos F : Practices of liver biopsy in France : results of a prospective nationwide survey .For the Group of Epidemiology of the French Association for the Study of the Liver ( AFEF ) .", "label": "", "metadata": {}, "score": "50.648735"}
{"text": "2001 Sep;96(9):2711 - 7 .View Abstract .[ 25 ] Buchman AL , et al .Choline deficiency : a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation .", "label": "", "metadata": {}, "score": "50.671"}
{"text": "[PubMed ] [ DOI ] .Haukeland JW , Konopski Z , Eggesb\u00f8 HB , von Volkmann HL , Raschpichler G , Bj\u00f8ro K , Haaland T , L\u00f8berg EM , Birkeland K. Metformin in patients with non - alcoholic fatty liver disease : a randomized , controlled trial .", "label": "", "metadata": {}, "score": "50.701027"}
{"text": "Age - Related Changes in Body Composition , and Consequences for Metabolic Syndrome .There is an age - linked increase in abdominal adiposity and fat deposition in muscles ( skeletal and cardiac ) , liver , and bone marrow [ 46 ] .", "label": "", "metadata": {}, "score": "50.71917"}
{"text": "J Clin Invest .[PubMed ] [ DOI ] .Dowman JK , Tomlinson JW , Newsome PN .Pathogenesis of non - alcoholic fatty liver disease .", "label": "", "metadata": {}, "score": "50.74463"}
{"text": "[PubMed ] [ DOI ] .Capanni M , Calella F , Biagini MR , Genise S , Raimondi L , Bedogni G , Svegliati - Baroni G , Sofi F , Milani S , Abbate R. Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non - alcoholic fatty liver disease : a pilot study .", "label": "", "metadata": {}, "score": "50.766888"}
{"text": "[PubMed ] [ DOI ] .Pratt DS , Kaplan MM .Evaluation of abnormal liver - enzyme results in asymptomatic patients .N Engl J Med .", "label": "", "metadata": {}, "score": "50.793114"}
{"text": "[Links ] .Bugianessi E , Leone N , Vanni E , et al .Expanding the natural history of non - alcoholic steatohepatitis : from cryptogenic cirrhosis to hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "50.835236"}
{"text": "Among carbohydrates , specifically fructose might contribute to NAFLD progression .Fructose intake has been linked to increasing hepatic fat , inflammation and possibly fibrosis [ 33 ] .", "label": "", "metadata": {}, "score": "50.857353"}
{"text": "The NAFLD fibrosis score can be used in pre operative evaluation of patients undergoing bariatric surgery .The great advantage this score is the use of easily obtained variables .", "label": "", "metadata": {}, "score": "50.882584"}
{"text": "[PubMed ] [ DOI ] .Tandra S , Vuppalanchi R. Use of statins in patients with liver disease .Curr Treat Options Cardiovasc Med .", "label": "", "metadata": {}, "score": "50.91497"}
{"text": "NAFLD is associated with other medical conditions such as metabolic syndrome , obesity , cardiovascular disease and diabetes .NASH can only be diagnosed through liver biopsy , but noninvasive techniques have been developed to identify patients who are most likely to have NASH or fibrosis , reducing the need for liver biopsy and risk to patients .", "label": "", "metadata": {}, "score": "50.934563"}
{"text": "The NFS was validated by Angulo et al .19 for use in patients with NAFLD .Our results were similar by showing that subjects with advanced fibrosis had a NFS significantly different from that in subjects without advanced fibrosis .", "label": "", "metadata": {}, "score": "50.95457"}
{"text": "Therefore , hepatic steatosis , diabetes , and metabolic syndrome are part of the same disease process ultimately leading to increased cardiovascular morbidity and mortality risk .", "label": "", "metadata": {}, "score": "50.995796"}
{"text": "Related links .Share .SAMJ , S. Afr . med .j. vol.101 n.7 Cape Town Jul. 2011 .APRI : a simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD / NASH .", "label": "", "metadata": {}, "score": "51.006386"}
{"text": "The pathogenesis of hepatic steatosis is not clearly known , but its main characteristics are considered insulin resistance , mitochondrial dysfunction , increased free fatty acids reflux from adipose tissue to the liver , hepatocyte lipotoxicity , stimulation of chronic necroinflammation , and fibrogenic response .", "label": "", "metadata": {}, "score": "51.050236"}
{"text": "By 1999 , 21 % of liver transplant recipients were in people aged 60 years or older [ 123 , 124 ] .Studies have also shown that , with careful selection , there are no differences in survival or length of hospital stay for individuals over 60 years old compared to their younger counterparts [ 124 ] .", "label": "", "metadata": {}, "score": "51.12072"}
{"text": "Nonalcoholic fatty liver disease and diabetes mellitus : pathogenesis and treatment .Briohny W Smith School of Medicine and Pharmacology , Sir Charles Gairdner Hospital Unit , University of Western Australia , Nedlands , WA 6009 , Australia Nat Rev Endocrinol 7:456 - 65 .", "label": "", "metadata": {}, "score": "51.164894"}
{"text": "Res .Pract .[ Google Scholar ] .Brun , P. ; Castagliuolo , I. ; Di Leo , V. ; Buda , A. ; Pinzani , M. ; Palu , G. ; Martines , D. Increased intestinal permeability in obese mice : New evidence in the pathogenesis of nonalcoholic steatohepatitis .", "label": "", "metadata": {}, "score": "51.167595"}
{"text": "This weight loss improves insulin sensitivity and reduces the frequency and severity of metabolic syndrome , diabetes and its complications [ 97 ] .With respect to NAFLD / NASH , follow - up liver biopsies have shown a reduction in hepatic necroinflammatory activity including resolution of NASH in the majority of cases and reduced hepatic fibrosis in some [ 119 , 120 ] .", "label": "", "metadata": {}, "score": "51.216415"}
{"text": "Dietary and genetic factors may condition the metabolic adaptation of the liver to this harmful environment .Compensated steatosis exacerbates hepatic insulin resistance , stimulates VLDL secretion , and increases mitochondrial beta - oxidation .", "label": "", "metadata": {}, "score": "51.26658"}
{"text": "PubMed ] [ DOI ] .Bedogni G , Miglioli L , Masutti F , Tiribelli C , Marchesini G , Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease : the Dionysos nutrition and liver study .", "label": "", "metadata": {}, "score": "51.331234"}
{"text": "Hepatology .[Links ] .Brunt EM .Grading and staging the histopathological lesions of chronic hepatitis : the Knodell histology activity index and beyond .", "label": "", "metadata": {}, "score": "51.342113"}
{"text": "Hepatic steatosis in chronic hepatitis C patients infected with genotype 2 is associated with insulin resistance , hepatic fibrosis and affects cumulative positivity of serum hepatitis C virus RNA in peginterferon and ribavirin combination therapy .", "label": "", "metadata": {}, "score": "51.365227"}
{"text": "McGill DB , Rakela J , Zinsmeister AR , Ott BJ : A 21-year experience with major hemorrhage after percutaneous liver biopsy .Gastroenterology 1990 , 99 : 1396 - 400 .", "label": "", "metadata": {}, "score": "51.43534"}
{"text": "The European Liver Fibrosis Study Group panel of ECMrelated components from which an algorithm was developed , is also not readily available and will be expensive , especially in developing countries .", "label": "", "metadata": {}, "score": "51.436028"}
{"text": "[Links ] .Charlton M. Nonalcoholic fatty liver disease : a review of current understanding and future impact .Clin Gastroenterol Hepatol .[Links ] .", "label": "", "metadata": {}, "score": "51.458366"}
{"text": "It has been shown that increased liver enzymes predict T2DM independent of obesity [ 16 ] .In another study , metabolic changes ( lipid , liver enzymes , blood pressure , and body weight ) potentially associated with conversion to diabetes were investigated , it was found that in subjects who converted to new - onset diabetes , ALT ( . )", "label": "", "metadata": {}, "score": "51.48043"}
{"text": "[Links ] .Bugianesi E , Leone N , Vanni E , Marchesini G , Brunello F , Carucci P , Musso A , De Paolis P , Capussotti L , Salizzoni M , Rizzetto M. Expanding the natural history of nonalcoholic steatohepatitis : from cryptogenic cirrhosis to hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "51.53738"}
{"text": "Hepatology .View Abstract .[ 2 ] Caldwell SH .The spectrum expanded : cryptogenic cirrhosis and the natural history of non - alcoholic fatty liver disease .", "label": "", "metadata": {}, "score": "51.5493"}
{"text": "Other therapies .Due to the rise in NAFLD cases , as well as other compounding diseases , additional therapies have been investigated and used in clinical practice , such as ursodeoxycholic acid ( UDCA ) , omega-3 polyunsaturated fatty acids ( N -3 PUFA ) , statins and pre and probiotics .", "label": "", "metadata": {}, "score": "51.588932"}
{"text": "Nonalcoholic fatty liver disease ( NAFLD ) is hepatic steatosis associated with metabolic abnormalities such as overweight / central obesity , insulin resistance , type 2 diabetes ( T2D ) , and dyslipidemia .", "label": "", "metadata": {}, "score": "51.59308"}
{"text": "The results showed that UDCA was able to reduce liver enzymes , though there was no effect on liver fat content [ 94 ] .Lindor et al [ 93 ] conducted a large randomized trial using UDCA ( receiving between 13 - 15 mg / kg per day ) on NASH diagnosed patients and found that there was no significant differences between the placebo and UDCA groups .", "label": "", "metadata": {}, "score": "51.667965"}
{"text": "Being a serum marker , NT has the advantage of giving a more global estimate of liver steato - hepatitis throughout the whole liver .The first validation group included patients from a tertiary care center , which makes it liable to referral selection bias , but the second validation group was most representative of less specialized centers .", "label": "", "metadata": {}, "score": "51.672302"}
{"text": "View Article PubMed .Ratziu V , Giral P , Charlotte F , Bruckert E , Thibault V , Theodorou I , Khalil L , Turpin G , Opolon P , Poynard T : Liver fibrosis in overweight patients .", "label": "", "metadata": {}, "score": "51.672768"}
{"text": "Weight loss of only 5 - 10 % ( e.g. , 3.7 kg in a 75 kg man ) decreases liver fat by 40 % in both nondiabetic and diabetic subjects [ 60 , 95 ] .", "label": "", "metadata": {}, "score": "51.704636"}
{"text": "We validated the performance of FIB4 index in a Japanese cohort with NAFLD ... .Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan .Takeshi Okanoue Center of Gastroenterology and Hepatology , Saiseikai Suita Hospital , Osaka , Japan J Gastroenterol Hepatol 26:153 - 62 .", "label": "", "metadata": {}, "score": "51.71868"}
{"text": "NAFLD may progress to cirrhosis and is likely an important cause of cryptogenic cirrhosis .[ 1 ] , [ 2 ] NALFD is now the most common cause of abnormal liver biochemistry in North America and likely in the UK and is also known to be associated with some drugs , genetic defects , obesity , insulin resistance and type 2 diabetes .", "label": "", "metadata": {}, "score": "51.74055"}
{"text": "View Abstract .[ 23 ] Malaguarnera M , et al .L - carnitine supplementation to diet : a new tool in treatment of nonalcoholic steatohepatitis - a randomized and controlled clinical trial .", "label": "", "metadata": {}, "score": "51.749"}
{"text": "80 - 86 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. R. van Werven , T. C. M. A. Schreuder , E. O. Aarts et al . , \" Hepatic steatosis in morbidly obese patients undergoing gastric bypass surgery : assessment with open - system 1H - MR spectroscopy , \" The American Journal of Roentgenology , vol .", "label": "", "metadata": {}, "score": "51.830223"}
{"text": "The pathogenesis of hepatic steatosis remains poorly understood but its main characteristics are considered insulin resistance and mitochondrial dysfunction [ 6 ] .If insulin resistance precedes NAFLD or the opposite remains unanswered .", "label": "", "metadata": {}, "score": "51.832596"}
{"text": "e1-e11 , 2001 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. H. Chen , M. H. Huang , J. C. Yang et al . , \" Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan : metabolic significance of nonalcoholic fatty liver disease in nonobese adults , \" Journal of Clinical Gastroenterology , vol .", "label": "", "metadata": {}, "score": "51.862137"}
{"text": "The results were that ALT , AST and gamma - glutamyl transferase levels decreased [ 108 ] .Pre and probiotics have been proven to be useful in the NAFLD population .", "label": "", "metadata": {}, "score": "51.876175"}
{"text": "4 , pp .1158 - 1165 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .N. A. Johnson , T. Sachinwalla , D. W. Walton et al . , \" Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "51.886196"}
{"text": "However , with the exception of a small subset of patients with significant heart disease , there is no significant difference in the observed - to - expected mortality ratio [ 121 ] .", "label": "", "metadata": {}, "score": "52.02537"}
{"text": "5 , pp .652 - 660 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .P. N. Bromley , I. Hilmi , K. C. Tan , R. Williams , and D. Potter , \" Orthotopic liver transplantation in patients over 60 years old , \" Transplantation , vol .", "label": "", "metadata": {}, "score": "52.031693"}
{"text": "This is not surprising given similar risk factors for NAFLD and cardiovascular diseases .Most cases of NAFLD occur in overweight or obese individuals , and there are particular strong links to central obesity , T2D , atherogenic dyslipidemia , and hypertension , each of which are elements of metabolic syndrome [ 8 , 9 ] .", "label": "", "metadata": {}, "score": "52.042793"}
{"text": "Results .There were no differences in age , gender , or cause of resection between the two groups ( Table 1 ) .The incidence of hepatitis and cirrhosis was similar prior to SBS in both groups .", "label": "", "metadata": {}, "score": "52.160954"}
{"text": "1971 Feb;9(1):1 - 11 .View Abstract .[17 ] Tetri LH , et al .Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high - fructose corn syrup equivalent .", "label": "", "metadata": {}, "score": "52.165634"}
{"text": "Role of liver biopsy and serum markers of liver fibrosis in non - alcoholic fatty liver disease .Leon A Adams School of Medicine and Pharmacology , The University of Western Australia , Liver Transplant Unit , Sir Charles Gairdner Hospital , Nedlands , Australia Clin Liver Dis 11:25 - 35 , viii .", "label": "", "metadata": {}, "score": "52.19732"}
{"text": "Diabetes Care .[PubMed ] [ DOI ] .Gut .[PubMed ] [ DOI ] .St George A , Bauman A , Johnston A , Farrell G , Chey T , George J. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors .", "label": "", "metadata": {}, "score": "52.25804"}
{"text": "472 - 479 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. K. Chae , S. G. Park , S.-O. Song et al . , \" Pentoxifylline attenuates methionine- and choline - deficient - diet - induced steatohepatitis by suppressing TNF- \u03b1 expression and endoplasmic reticulum stress , \" Experimental Diabetes Research , vol .", "label": "", "metadata": {}, "score": "52.311043"}
{"text": "6 , pp .1325 - 1330 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. Donati , B. Stagni , F. Piscaglia et al . , \" Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes : role of insulin resistance , \" Gut , vol .", "label": "", "metadata": {}, "score": "52.350716"}
{"text": "[PubMed ] [ DOI ] .Harrison SA , Torgerson S , Hayashi P , Ward J , Schenker S. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis .", "label": "", "metadata": {}, "score": "52.355774"}
{"text": "NAFLD covers a spectrum ranging from simple steatosis to steato - hepatitis ( NASH ) and cirrhosis .Of the UK population about 33 % have NAFLD , and 2 - 5 % have NASH .", "label": "", "metadata": {}, "score": "52.405403"}
{"text": "2010 Jun;105(6):1338 - 45 .View Abstract .[ 24 ] Abdelmalek MF , et al .Betaine , a promising new agent for patients with nonalcoholic steatohepatitis : results of a pilot study .", "label": "", "metadata": {}, "score": "52.40982"}
{"text": "J Gastroenterol Hepatol .[Links ] .Garcia - Monzon C , Martin - Perez E , Iacono OL , Fernandez - Bermejo M , Majano PL , Apolinario A , Larranaga E , Moreno - Otero R. Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity .", "label": "", "metadata": {}, "score": "52.493134"}
{"text": "Unfortunately , many patients with NAFLD or NASH have normal ALT levels and some of them have advanced liver fibrosis [ 46 - 48 ] .", "label": "", "metadata": {}, "score": "52.528854"}
{"text": "Liver biopsy is currently the gold standard for diagnosing NASH [ 41 ] , as it also establishes the stage of NASH [ 52 ] .", "label": "", "metadata": {}, "score": "52.54004"}
{"text": "Transplant physicians may need to manage weight loss prior to transplantation of the obese and morbidly obese , but also will be required to manage diabetes , osteoporosis , hypertension , dyslipidemia , immunosuppression , and the challenge of polypharmacy from prescriptions these elderly population will inevitably require .", "label": "", "metadata": {}, "score": "52.581856"}
{"text": "As the researchers highlighted , the small sample size is an important limitation to consider [ 107 ] .Another study using a randomized double blind clinical trial evaluated the effects of a different probiotic [ 108 ] .", "label": "", "metadata": {}, "score": "52.61512"}
{"text": "[PubMed ] [ DOI ] .Angulo P. Nonalcoholic fatty liver disease .N Engl J Med .[PubMed ] [ DOI ] .", "label": "", "metadata": {}, "score": "52.621536"}
{"text": "Obese patients were less likely to require PN at each category of remnant length and intestinal anatomy .Pre - resection BMI in controls was significantly lower than in obese patients .", "label": "", "metadata": {}, "score": "52.62176"}
{"text": "[Links ] .Ratziu V , Giral P , Charlotte F , Bruckert E , Thibault V , Theodorou I , Khalil L , Turpin G , Opolon P , Poynard T. Liver fibrosis in overweight patients .", "label": "", "metadata": {}, "score": "52.701797"}
{"text": "Diet , exercise training , and weight loss provide significant clinical benefits and must be considered of first line for treating NAFLD .Introduction .NASH is characterized by biochemical evidence of hepatocellular damage ( elevation of aminotransferase levels ) , histological findings of the type of alcoholic hepatitis ( steatosis , lobular inflammatory cell infiltration , Mallory 's hyaline , and fibrosis ) , and no other cause of liver damage .", "label": "", "metadata": {}, "score": "52.71948"}
{"text": "PubMed ] [ DOI ] .Yan E , Durazo F , Tong M , Hong K. Nonalcoholic fatty liver disease : pathogenesis , identification , progression , and management .", "label": "", "metadata": {}, "score": "52.777733"}
{"text": "DESIGN / METHODS : The cohort consisted of 111 patients with histological diagnoses of NAFLD .The biopsy samples were staged and graded according to the NASH clinical research network ( CRN ) criteria .", "label": "", "metadata": {}, "score": "52.80873"}
{"text": "[Links ] .Spaulding L , Trainer T , Janiec D. Prevalence of non - alcoholic steatohepatitis in morbidly obese subjects undergoing gastric bypass .", "label": "", "metadata": {}, "score": "52.809235"}
{"text": "Suprailiac skinfold thickness predicted NAFLD independently of the body mass index , insulin resistance , and VAT ... .High biological variation of serum hyaluronic acid and Hepascore , a biochemical marker model for the prediction of liver fibrosis .", "label": "", "metadata": {}, "score": "52.828506"}
{"text": "A study on sedentary NAFLD patients examined the effects of resistant exercises on liver lipid levels [ 74 ] .Hallsworth et al [ 74 ] found that after 8 wk ( 3 times per week lasting 45 - 60 min ) of resistance based exercise resulted in a reduction of liver lipids , and improvements of lipid oxidation , glucose control and insulin resistance .", "label": "", "metadata": {}, "score": "52.88533"}
{"text": "In patients with NAFLD / NASH , all cardiovascular risk factors ( obesity , hypertension , hyperglycemia , and hyperlipidemia ) are treated [ 39 , 67 ] .", "label": "", "metadata": {}, "score": "52.903976"}
{"text": "Type II diabetes or fasting glucose level greater than 110 mg / dL was present in 16 % of the patients .Table 2 summarizes demographic and clinical data .", "label": "", "metadata": {}, "score": "53.016846"}
{"text": "[PubMed ] [ DOI ] .Bugianesi E , Marchesini G , Gentilcore E , Cua IH , Vanni E , Rizzetto M , George J. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease : Role of insulin resistance and hepatic steatosis .", "label": "", "metadata": {}, "score": "53.040802"}
{"text": "Conclusions .NAFLD is strongly associated with T2DM and CVD .Within this spectrum , steatosis alone is apparently benign , while nonalcoholic steatohepatitis may progress to cirrhosis and hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "53.078674"}
{"text": "Gastroenterology 2009 , 137 , 532 - 540 .[ Google Scholar ] [ CrossRef ] .Carbonnel , F. ; Cosnes , J. ; Chevret , S. ; Beaugerie , L. ; Ngo , Y. ; Malafosse , M. ; Parc , R. ; Le Quintrec , Y. ; Gendre , J.P. The role of anatomic factors in nutritional autonomy after extensive small bowel resection .", "label": "", "metadata": {}, "score": "53.177097"}
{"text": "Primary liver cancer ( hepatocellular carcinoma , HCC ) is now a recognized complication of NAFLD , usually but not always after development of cirrhosis [ 2 - 5 ] .", "label": "", "metadata": {}, "score": "53.234528"}
{"text": "The identification of NAFLD should be sought as part of routine assessment of diabetic patients , as sought the microvascular complications and CVD , because it is essential for the early diagnosis and proper implementation of lifestyle and pharmaceutical interventions .", "label": "", "metadata": {}, "score": "53.243687"}
{"text": "Systemic hypertension .Dyslipidemia .Insulin resistance or overt diabetes , type 2 and 1 .The pathogenesis of nonalcoholic fatty liver disease has not been fully elucidated .", "label": "", "metadata": {}, "score": "53.278282"}
{"text": "View Article PubMed .Ong JP , Elariny H , Collantes R , Younoszai A , Chandhoke V , Reines HD , Goodman Z , Younossi ZM : Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients .", "label": "", "metadata": {}, "score": "53.30156"}
{"text": "142 - 149 , 1988 .View at Google Scholar \u00b7 View at Scopus . E. E. Powell , W. G. E. Cooksley , R. Hanson , J. Searle , J. W. Halliday , and L. W. Powell , \" The natural history of nonalcoholic steatohepatitis : a follow - up study of forty - two patients for up to 21 years , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "53.348003"}
{"text": "Thoma et al [ 69 ] found that lifestyle modifications that led to weight reduction and/or increased physical activity greatly reduced liver fat and improved insulin sensitivity .", "label": "", "metadata": {}, "score": "53.403786"}
{"text": "There are several limitations to the present study .This is a retrospective study and patients were not evaluated in a uniform fashion .Histology was not routinely obtained or available and thus we are unable to perform a more sophisticated analysis of hepatic pathology .", "label": "", "metadata": {}, "score": "53.440674"}
{"text": "[PubMed ] [ DOI ] .Yoneda M , Yoneda M , Mawatari H , Fujita K , Endo H , Iida H , Nozaki Y , Yonemitsu K , Higurashi T , Takahashi H. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease ( NAFLD ) .", "label": "", "metadata": {}, "score": "53.463676"}
{"text": "[ Google Scholar ] .Hartman , A.L. ; Lough , D.M. ; Barupal , D.K. ; Fiehn , O. ; Fishbein , T. ; Zasloff , M. ; Eisen , J.A. Human gut microbiome adopts an alternative state following small bowel transplantation .", "label": "", "metadata": {}, "score": "53.49614"}
{"text": "Recent advances have allowed for non - invasive techniques to be used to diagnose the level of inflammation / fibrosis ( Figure 1 ) [ 40 ] .", "label": "", "metadata": {}, "score": "53.54298"}
{"text": "[PubMed ] [ DOI ] .Lemoine M , Ratziu V , Kim M , Maachi M , Wendum D , Paye F , Bastard JP , Poupon R , Housset C , Capeau J. Serum adipokine levels predictive of liver injury in non - alcoholic fatty liver disease .", "label": "", "metadata": {}, "score": "53.609478"}
{"text": "Hepatology .[PubMed ] [ DOI ] .Thoma C , Day CP , Trenell MI .Lifestyle interventions for the treatment of non - alcoholic fatty liver disease in adults : a systematic review .", "label": "", "metadata": {}, "score": "53.62154"}
{"text": "However , these findings are not consistent between studies and have been generated through retrospective studies , all amenable to known and unknown biases .ActiTest was developed for the grading of necroinflammation in viral hepatitis C and B. AshTest was developed for the diagnosis of alcoholic - steato - hepatitis in heavy drinkers .", "label": "", "metadata": {}, "score": "53.64588"}
{"text": "This review discusses what current practices are and provides suggestions for future research .Citation : Schwenger KJ , Allard JP .Clinical approaches to non - alcoholic fatty liver disease .", "label": "", "metadata": {}, "score": "53.773663"}
{"text": "In the present study only 25 % ( 63/257 ) of biopsy samples reached the 25 mm minimum recommended by Bedossa et al for HCV [ 44 ] .", "label": "", "metadata": {}, "score": "53.883705"}
{"text": "High saturated fat diets are associated with IR and hepatic inflammation [ 29 ] .Other research has also demonstrated a relationship between increased dietary fat consumption and NAFLD [ 30 , 31 ] .", "label": "", "metadata": {}, "score": "54.002274"}
{"text": "5 , pp .537 - 544 , 2004 .View at Publisher \u00b7 View at Google Scholar .S. Nair , A. M. Diehl , M. Wiseman , G. H. Farr Jr. , and R. P. Perrillo , \" Metformin in the treatment of non - alcoholic steatohepatitis : a pilot open label trial , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "54.02285"}
{"text": "4 , pp .1105 - 1112 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . U. F. H. Leuschner , B. Lindenthal , G. Herrmann et al . , \" High - dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis : a double - blind , randomized , placebo - controlled trial , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "54.02966"}
{"text": "52 - 54 , 2011 .View at Google Scholar .L. Sj\u00f6str\u00f6m , A.-K. Lindroos , M. Peltonen et al . , \" Lifestyle , diabetes , and cardiovascular risk factors 10 years after bariatric surgery , \" The New England Journal of Medicine , vol .", "label": "", "metadata": {}, "score": "54.034546"}
{"text": "222 - 226 , 1998 .View at Google Scholar \u00b7 View at Scopus .S. A. Harrison , W. Fecht , E. M. Brunt , and B. A. Neuschwander - Tetri , \" Orlistat for overweight subjects with nonalcoholic steatohepatitis : a randomized , prospective trial , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "54.04603"}
{"text": "Iyer , A. ; Fairlie , D.P. ; Prins , J.B. ; Hammock , B.D. ; Brown , L. Inflammatory lipid mediators in adipocyte function and obesity .", "label": "", "metadata": {}, "score": "54.101387"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .B. A. Neuschwander - Tetri , \" Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis : the central role of nontriglyceride fatty acid metabolites , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "54.20235"}
{"text": "[PubMed ] [ DOI ] .Miller ER , Pastor - Barriuso R , Dalal D , Riemersma RA , Appel LJ , Guallar E. Meta - analysis : high - dosage vitamin E supplementation may increase all - cause mortality .", "label": "", "metadata": {}, "score": "54.225655"}
{"text": "Bariatric surgery .Obesity is on the rise in today 's society , which is taking a toll on today 's healthcare system .Obesity is associated with metabolic syndrome , cardiovascular disease , insulin resistance and type 2 diabetes resulting in an increased risk of individuals developing NAFLD .", "label": "", "metadata": {}, "score": "54.22865"}
{"text": "103 - 109 .Transplantation 2008 , 85 , 1378 - 1384 .[ Google Scholar ] [ CrossRef ] .Tilg , H. ; Moschen , A.R. ; Kaser , A. Obesity and the microbiota .", "label": "", "metadata": {}, "score": "54.293633"}
{"text": "Abnormal left ventricular energy metabolism , fat accumulated in the epicardial area despite normal left ventricular morphological features , and systolic and diastolic functions , in nondiabetic young with fatty liver compared with nondiabetic matched for anthropometric features without fatty liver .", "label": "", "metadata": {}, "score": "54.35262"}
{"text": "[PubMed ] [ DOI ] .Petta S , Muratore C , Crax\u00ec A. Non - alcoholic fatty liver disease pathogenesis : the present and the future .", "label": "", "metadata": {}, "score": "54.392097"}
{"text": "10 , pp .897 - 905 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed . S. E. Nissen and K. Wolski , \" Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes , \" The New England Journal of Medicine , vol .", "label": "", "metadata": {}, "score": "54.400593"}
{"text": "S. H. Caldwell , E. E. Hespenheide , J. A. Redick , J. C. Iezzoni , E. H. Battle , and B. L. Sheppard , \" A pilot study of a thiazolidinedione , troglitazone , in nonalcoholic steatohepatitis , \" American Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "54.485195"}
{"text": "Diagnosing silent cirrhosis has important consequences in terms of screening for portal hypertension and hepatocellular carcinoma , of preventing complications and of providing a timely indication for liver transplantation .", "label": "", "metadata": {}, "score": "54.4914"}
{"text": "[PubMed ] [ DOI ] .Nobili V , Manco M , Ciampalini P , Alisi A , Devito R , Bugianesi E , Marcellini M , Marchesini G. Metformin use in children with nonalcoholic fatty liver disease : an open - label , 24-month , observational pilot study .", "label": "", "metadata": {}, "score": "54.519028"}
{"text": "The obesity epidemic affects not only recipients , but also potential organ donors , up to a quarter of whom have hepatic steatosis .The prevalence of steatosis in donor livers increases with BMI and age .", "label": "", "metadata": {}, "score": "54.520462"}
{"text": "It has been speculated that this might produce the nutritional advantage manifest by preserved body weight and decreased PN requirements reported previously and further substantiated in the present study [ 11 ] .", "label": "", "metadata": {}, "score": "54.549805"}
{"text": "Chan , S. ; McCowen , K.C. ; Bistrian , B.R. ; Thibault , A. ; Keane - Ellison , M. ; Forse , R.A. ; Babineau , T. ; Burke , P. Incidence , prognosis and etiology of end - stage liver disease in patients receiving home parenteral nutrition .", "label": "", "metadata": {}, "score": "54.577377"}
{"text": "JAMA .[PubMed ] [ DOI ] .Lindor KD , Kowdley KV , Heathcote EJ , Harrison ME , Jorgensen R , Angulo P , Lymp JF , Burgart L , Colin P. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis : results of a randomized trial .", "label": "", "metadata": {}, "score": "54.586597"}
{"text": "Mofrad P , Contos MJ , Haque M , Sargeant C , Fisher RA , Luketic VA , Sterling RK , Shiffman ML , Stravitz RT , Sanyal AJ : Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values .", "label": "", "metadata": {}, "score": "54.65399"}
{"text": "Publications .Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population .Yoshio Sumida Center for Digestive and Liver Diseases , Nara City Hospital , Nara , Japan BMC Gastroenterol 12:2 .", "label": "", "metadata": {}, "score": "54.66907"}
{"text": "Recently , new evidence has linked intestinal microbiota to NALFD pathogenesis .Intestinal microbiota ( IM ) may play a role in the development of NAFLD , however very few human studies have been conducted and most were cross - sectional [ 36 - 39 ] .", "label": "", "metadata": {}, "score": "54.687214"}
{"text": "We examined their effects on alanine aminotransferase ( ALT ) and gamma glutamyltransferase ( GGT ) levels in a population - based cohort ... .Biomarkers of liver fibrosis .", "label": "", "metadata": {}, "score": "54.777267"}
{"text": "The mildest form of NAFLD is simple steatosis , characterised by hepatic fat ( triglyceride , TG ) accumulation alone .In NASH , hepatic necroinflammatory changes are also present and a characteristic perisinusoidal pattern of liver fibrosis is common .", "label": "", "metadata": {}, "score": "54.783726"}
{"text": "5 , pp .2498 - 2502 , 1998 .View at Publisher \u00b7 View at Google Scholar .K. H. Hellemans , J. C. Hannaert , B. Denys et al . , \" Susceptibility of pancreatic beta cells to fatty acids is regulated by LXR / PPAR \u03b1 -dependent stearoyl - coenzyme a desaturase , \" PLoS One , vol .", "label": "", "metadata": {}, "score": "54.803318"}
{"text": "6 , pp .1337 - 1344 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed \u00b7 View at Scopus . A. Uygun , A. Kadayifci , A. T. Isik et al . , \" Metformin in the treatment of patients with non - alcoholic steatohepatitis , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "54.821087"}
{"text": "[ 4 ] , [ 5 ] Other terms that have been used to describe NASH include pseudoalcoholic hepatitis , alcohol - like hepatitis , fatty liver hepatitis , steatonecrosis , and diabetic hepatitis .", "label": "", "metadata": {}, "score": "54.848614"}
{"text": "Such changes could contribute to worsened liver histology of NAFLD in older people .Progression of NAFLD : Lessons from Natural History Studies .Although simple steatosis is generally nonprogressive [ 83 ] , the initial assessment of SS as always being benign is not fully supported by current evidence [ 53 - 56 ] .", "label": "", "metadata": {}, "score": "54.894447"}
{"text": "12 , pp .1107 - 1115 , 2004 .View at Publisher \u00b7 View at Google Scholar . H. Reynaert , A. Geerts , and J. Henrion , \" Review article : the treatment of non - alcoholic steatohepatitis with thiazolidinediones , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "54.900665"}
{"text": "As a result Capanni et al [ 96 ] investigated the effects of N -3 PUFA supplementation ( 1 g / d for 12 mo ) in 56 NAFLD patients .", "label": "", "metadata": {}, "score": "54.911022"}
{"text": "Hepatology .[PubMed ] [ DOI ] .Loguercio C , Federico A , Tuccillo C , Terracciano F , D'Auria MV , De Simone C , Del Vecchio Blanco C. Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases .", "label": "", "metadata": {}, "score": "54.94523"}
{"text": "The majority of research has been conducted using mice - models ; however there have been a limited number of human clinical trials .The majority of studies have investigated risk factors associated with NAFLD .", "label": "", "metadata": {}, "score": "55.00705"}
{"text": "Health cost appears to be greater in NAFLD individuals than in general population .NAFLD and T2DM .From various studies , the prevalence of NAFLD seems higher in type 2 diabetics than in general population , independent of glycemic control [ 10 ] .", "label": "", "metadata": {}, "score": "55.054985"}
{"text": "Overall , this tool is widely used in practice to exclude advanced fibrosis .Another tool used in clinical practice is the FibroMeter .This tool uses age , weight , fasting glucose , AST , ALT , ferritin and platelet count to diagnose significant fibrosis [ 46 , 56 , 57 ] .", "label": "", "metadata": {}, "score": "55.10974"}
{"text": "Prediction of morbidity and mortality in patients with chronic hepatitis C by non - invasive liver fibrosis models .Mohamed A Chinnaratha Department of Gastroenterology Hepatology , Sir Charles Gairdner Hospital , Nedlands , WA , Australia Liver Int 34:720 - 7 .", "label": "", "metadata": {}, "score": "55.293915"}
{"text": "FFA : free fatty acids ; SAT : subcutaneous adipose tissue ; VAT : visceral adipose tissue ; TG : triglyceride .Steatosis occurs when FFA supply to the liver ( from dietary intake , peripheral lipolysis , and de novo lipogenesis ) exceeds hepatic FFA elimination ( via oxidation , re - esterification , and excretion as very low density lipoproteins ( VLDL ) ) .", "label": "", "metadata": {}, "score": "55.317425"}
{"text": "Liver transplantation is recommended in patients with decompensate cirrhosis due NASH as long as underlying comorbidities permit [ 32 ] .Natural History : Prognosis .", "label": "", "metadata": {}, "score": "55.336742"}
{"text": "54 , no .S1 , p. S8 , 2011 .View at Google Scholar .K. Tominaga , E. Fujimoto , K. Suzuki , M. Hayashi , M. Ichikawa , and Y. Inaba , \" Prevalence of non - alcoholic fatty liver disease in children and relationship to metabolic syndrome , insulin resistance , and waist circumference , \" Environmental Health and Preventive Medicine , vol .", "label": "", "metadata": {}, "score": "55.367435"}
{"text": "519 - 525 , 2001 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. J. Sanyal , P. S. Mofrad , M. J. Contos et al . , \" A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis , \" Clinical Gastroenterology and Hepatology , vol .", "label": "", "metadata": {}, "score": "55.373905"}
{"text": "[PubMed ] [ DOI ] .Vos MB , Lavine JE .Dietary fructose in nonalcoholic fatty liver disease .Hepatology .[PubMed ] [ DOI ] .", "label": "", "metadata": {}, "score": "55.417484"}
{"text": "Most patients commonly present in middle - age .There is a need to increase understanding of liver disease and its many causes , to improve patient outcomes and reduce the stigma many patient 's experience .", "label": "", "metadata": {}, "score": "55.496872"}
{"text": "View Article PubMed .Park KS , Lee YS , Park HW , Seo SH , Jang BG , Hwang JY , Cho KB , Hwang JS , Ahn SH , Kang YN , Kim GC : Factors associated or related to with pathological severity of non - alcoholic fatty liver disease .", "label": "", "metadata": {}, "score": "55.526726"}
{"text": "Decreased IP-10 and elevated TGFbeta1 levels are associated with viral clearance following therapy in patients with hepatitis C virus .Silvia Lee Department of Microbiology and Infectious Disease , Royal Perth Hospital , University of Western Australia , Perth , Australia Dis Markers 28:273 - 80 . .003 relative to Hepascore ) .", "label": "", "metadata": {}, "score": "55.527695"}
{"text": "In the Dionysos study , NAFLD was present in 24.5 % , 67 % , and 94 % of the normal weight , overweight , and obese population , respectively [ 25 , 39 ] .", "label": "", "metadata": {}, "score": "55.651344"}
{"text": "5 , pp .780 - 785 , 2008 .View at Google Scholar \u00b7 View at Scopus .L. Juurinen , M. Tiikkainen , A. M. H\u00e4kkinen , A. Hakkarainen , and H. Yki - J\u00e4rvinen , \" Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes , \" The American Journal of Physiology , vol .", "label": "", "metadata": {}, "score": "55.65722"}
{"text": "N -3 PUFAs have been used in the treatment of hyperlipidemia and cardiovascular disease , and more recently in the treatment of NAFLD [ 95 ] .", "label": "", "metadata": {}, "score": "55.70501"}
{"text": "Natl .Acad .Sci .[ Google Scholar ] .Son , G. ; Kremer , M. ; Hines , I.N. Contribution of gut bacteria to liver pathobiology .", "label": "", "metadata": {}, "score": "55.705124"}
{"text": "Aspartate aminotransferase - toplatelet ratio index ( APRI ) is a simpler calculation than NFS , but has never been studied in patients with non - alcoholic fatty liver disease ( NAFLD ) .", "label": "", "metadata": {}, "score": "55.708527"}
{"text": "[ 12 ] The true prevalence of abnormal transaminases among patients with NAFLD is unclear , since many patients with NAFLD are diagnosed because they are noted to have abnormal aminotransferases .", "label": "", "metadata": {}, "score": "55.712074"}
{"text": "Factors responsible for this evolution have been subject to extensive research but still remain incompletely understood .Still , data are fragmented and arise largely from rodents given the natural difficulties of assessing human liver tissue .", "label": "", "metadata": {}, "score": "55.776756"}
{"text": "PubMed .Sakugawa H , Nakayoshi T , Kobashigawa K , Yamashiro T , Maeshiro T , Miyagi S , Shiroma J , Toyama A , Nakayoshi T , Kinjo F , Saito A : Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease .", "label": "", "metadata": {}, "score": "55.85693"}
{"text": "A more important contribution may come from dysregulation or \" failure \" of peripheral adipose tissue storage sites leading to store excess energy as TG , to abnormal lipid partitioning to the liver and other nonphysiological storage sites like muscles [ 12 ] .", "label": "", "metadata": {}, "score": "55.860413"}
{"text": "Non - alcoholic fatty liver disease ( NAFLD ) represents a spectrum of conditions characterized histologically by an excessive accumulation of hepatic fat in the absence of alcohol consumption .", "label": "", "metadata": {}, "score": "55.90114"}
{"text": "Aliment Pharmacol Ther .[PubMed ] [ DOI ] .Federico A , Trappoliere M , Loguercio C. Treatment of patients with non - alcoholic fatty liver disease : current views and perspectives .", "label": "", "metadata": {}, "score": "55.93959"}
{"text": "Complex non - invasive fibrosis models are more accurate than simple models in non - alcoholic fatty liver disease .Leon A Adams School of Medicine and Pharmacology , The University of Western Australia , Western Australia , Australia J Gastroenterol Hepatol 26:1536 - 43 .", "label": "", "metadata": {}, "score": "55.951027"}
{"text": "The presence of inflammation or steatohepatitis depends on a number of factors such as the presence of free fatty acids ( FFA ) , inflammatory cytokines and adipokines , oxidative stress and mitochondrial dysfunction [ 16 ] .", "label": "", "metadata": {}, "score": "55.963493"}
{"text": "Lifestyle changes , mostly focused on weight loss , have been demonstrated to improve liver aminotransferases and histological findings in obese with fatty liver [ 45 ] .", "label": "", "metadata": {}, "score": "55.973675"}
{"text": "In this setting , low plasma adiponectin levels are believed to promote steatosis and fibrosis by allowing unchecked triglycerides synthesis and activation of hepatic stellate cells , respectively .", "label": "", "metadata": {}, "score": "56.016136"}
{"text": "[Links ] .Machado M , Marques - Vidal P , Cortez - Pinto H. Hepatic histology in obese patients undergoing bariatric surgery .J Hepatol .", "label": "", "metadata": {}, "score": "56.017395"}
{"text": "Rev. Endocrinol .[ Google Scholar ] [ CrossRef ] .Dittrick , G.W. ; Thompson , J.S. ; Campos , D. ; Bremers , D. ; Sudan , D. Gallbladder pathology in morbid obesity .", "label": "", "metadata": {}, "score": "56.024994"}
{"text": "Several studies have now shown increasing prevalence of the metabolic syndrome with advancing age [ 49 , 50 ] .Specifically , the odds ratio of developing metabolic syndrome rises from 1.66 to 5.93 in those aged 30 - 39 years to 60 - 69 years , respectively .", "label": "", "metadata": {}, "score": "56.05342"}
{"text": "[ 4 ] Lidwig J , et al .Nonalcoholic steatohepatitis : Mayo Clinic experiences with a hitherto unnamed disease .Mayo Clin Proc .View Abstract .", "label": "", "metadata": {}, "score": "56.142258"}
{"text": "Obese SBS patients were more likely to have type 2 diabetes mellitus than their non - obese counterparts .Insulin resistance is a predictor of NAFLD and advanced hepatic fibrosis in obese patients [ 8 , 17 ] .", "label": "", "metadata": {}, "score": "56.150047"}
{"text": "The negative predictive value was 93 % for APRI and 94 % for NFS .CONCLUSION : APRI compared favourably to NFS and was superior to AST / ALT for the prediction of advanced fibrosis .", "label": "", "metadata": {}, "score": "56.17069"}
{"text": "4 , pp .764 - 774 , 1998 .View at Publisher \u00b7 View at Google Scholar .M. Shimabukuro , Y. T. Zhou , M. Levi , and R. H. Unger , \" Fatty acid - induced \u03b2 cell apoptosis : a link between obesity and diabetes , \" Proceedings of the National Academy of Sciences of the United States of America , vol .", "label": "", "metadata": {}, "score": "56.174118"}
{"text": "Caution needs to be taken when prescribing vitamin E as studies have shown that there is a potential harm for patients .A meta - analysis of 135967 people taking 400 IU / d of vitamin E found that there is an increase of all - cause mortality and therefore its use should be avoided [ 91 ] .", "label": "", "metadata": {}, "score": "56.247112"}
{"text": "[PubMed ] [ DOI ] .Sathiaraj E , Chutke M , Reddy MY , Pratap N , Rao PN , Reddy DN , Raghunath M. A case - control study on nutritional risk factors in non - alcoholic fatty liver disease in Indian population .", "label": "", "metadata": {}, "score": "56.322083"}
{"text": "[PubMed ] [ DOI ] .Jacobs RL , Lingrell S , Zhao Y , Francis GA , Vance DE .Hepatic CTP : phosphocholine cytidylyltransferase - alpha is a critical predictor of plasma high density lipoprotein and very low density lipoprotein .", "label": "", "metadata": {}, "score": "56.352917"}
{"text": "[PubMed ] [ DOI ] .van der Poorten D , Milner KL , Hui J , Hodge A , Trenell MI , Kench JG , London R , Peduto T , Chisholm DJ , George J. Visceral fat : a key mediator of steatohepatitis in metabolic liver disease .", "label": "", "metadata": {}, "score": "56.3926"}
{"text": "St George et al [ 73 ] found that there was a reduction in liver enzymes , which was greater in the moderate - intensity lifestyle intervention group in comparison to the control .", "label": "", "metadata": {}, "score": "56.405952"}
{"text": "Optimizing body weight before transplantation is rarely achieved and may be hazardous in patients with decompensated cirrhosis .Finally , metabolic syndrome is among the most common causes of death after all liver transplants and is likely to be accelerated among patients with NASH as the original cause of endstage liver disease .", "label": "", "metadata": {}, "score": "56.46486"}
{"text": "J Gastroenterol Hepatol .[PubMed ] [ DOI ] .Chavez - Tapia NC , Tellez - Avila FI , Barrientos - Gutierrez T , Mendez - Sanchez N , Lizardi - Cervera J , Uribe M. Bariatric surgery for non - alcoholic steatohepatitis in obese patients .", "label": "", "metadata": {}, "score": "56.490944"}
{"text": "Ageing Changes in Liver and Other Tissues Relevant to NAFLD / NASH .Age - related cellular and organ system changes are not uniform .In this section , we focus on changes within the liver and the pattern of fat distribution , the latter with respect to metabolic characteristics that are relevant to NAFLD .", "label": "", "metadata": {}, "score": "56.53093"}
{"text": "Liver collagen quantification may allow use of small size biopsies and improve the prediction of clinical outcomes .This study evaluated the ability of the collagen proportional area ( CPA ) measurement to predict clinical outcomes ... .", "label": "", "metadata": {}, "score": "56.535072"}
{"text": "All participants were matched for age ; NASH and overweight patients were also matched for BMI and visceral adiposity ( as estimated by abdominal ultrasonography ) [ 25 ] .", "label": "", "metadata": {}, "score": "56.550354"}
{"text": "Statins are used in the medical field to manage dyslipidemia ; and are typically used in patients with cardiovascular disease .NAFLD patients often have dyslipidemia along with other features of metabolic syndrome [ 97 ] .", "label": "", "metadata": {}, "score": "56.60223"}
{"text": "4 , pp .2461 - 2468 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .C. N. Lumeng , J. B. Delproposto , D. J. Westcott , and A. R. Saltiel , \" Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes , \" Diabetes , vol .", "label": "", "metadata": {}, "score": "56.681576"}
{"text": "[Links ] .Mofrad P , Contos MJ , Hague M , et al .Clinical and histological spectrum of non - alcoholic fatty liver disease associated with normal ALT values .", "label": "", "metadata": {}, "score": "56.687424"}
{"text": "Gender - specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease .Oyekoya T Ayonrinde School of Medicine and Pharmacology , University of Western Australia , Perth , Western Australia , Australia Hepatology 53:800 - 9 . .001", "label": "", "metadata": {}, "score": "56.750103"}
{"text": "In 25 ( 16 % ) the score was between the cutoff points and were considered indeterminate , in this group only 1 patient had advanced fibrosis .", "label": "", "metadata": {}, "score": "56.771603"}
{"text": "In 25 ( 16 % ) the score was between the cutoff points and were considered indeterminate , in this group only 1 patient had advanced fibrosis .", "label": "", "metadata": {}, "score": "56.771603"}
{"text": "This has been possible since the validation of a non - invasive test for the diagnosis of steatosis recently published [ 35 ] .Training group .", "label": "", "metadata": {}, "score": "56.783092"}
{"text": "Browning JD , Szczepaniak LS , Dobbins R , et al .Prevalence of hepatic steatosis in an urban population in the United States : impact of ethnicity .", "label": "", "metadata": {}, "score": "56.823387"}
{"text": "1567 - 1573 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus Nonalcoholic Fatty Liver Disease ( NAFLD ) , Why We Need To Be Responsive .", "label": "", "metadata": {}, "score": "56.876156"}
{"text": "New York New York 2002 .View Article .Rockey DC , Bissell DM : Noninvasive measures of liver fibrosis .Hepatology 2006 , 43 : S113 - 20 .", "label": "", "metadata": {}, "score": "56.901855"}
{"text": "184 - 191 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . H. Nomura , S. Kashiwagi , J. Hayashi , W. Kajiyama , S. Tani , and M. Goto , \" Prevalence of fatty liver in a general population of Okinawa , Japan , \" Japanese Journal of Medicine , vol .", "label": "", "metadata": {}, "score": "56.987713"}
{"text": "32 % ) and after SBS ( 80 % vs .Fatty liver was more frequent in the obese group prior to SBS ( 23 % vs .", "label": "", "metadata": {}, "score": "57.018665"}
{"text": "20 Wai et al .21 validated the APRI score in patients with hepatitis C. APRI is a simple calculation of 2 laboratory variables -AST and platelets ; this score can easily be used at the bedside or in an outpatient setting .", "label": "", "metadata": {}, "score": "57.02581"}
{"text": "[PubMed ] [ DOI ] .Parnell JA , Raman M , Rioux KP , Reimer RA .The potential role of prebiotic fibre for treatment and management of non - alcoholic fatty liver disease and associated obesity and insulin resistance .", "label": "", "metadata": {}, "score": "57.14868"}
{"text": "[Links ] .Wieckowska A , McCullough AJ , Feldstein AE .Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis : Present and future .Hepatology 2007;46(2):582 - 589 .", "label": "", "metadata": {}, "score": "57.15495"}
{"text": "RESULTS :The presence of advanced fibrosis could be diagnosed with good accuracy , with a positive predictive value of 83.7 % .The score had a higher accuracy to exclude advanced fibrosis with a negative predictive value of 97 % .", "label": "", "metadata": {}, "score": "57.225586"}
{"text": "[PubMed ] [ DOI ] .Marra F , Bertolani C. Adipokines in liver diseases .Hepatology .[PubMed ] [ DOI ] .", "label": "", "metadata": {}, "score": "57.40657"}
{"text": "Since obese patients who develop SBS remain obese , they may continue to be at risk for obesity related liver disease [ 10 ] .We hypothesized that morbidly obese individuals developing SBS would be at increased risk for developing hepatobiliary complications .", "label": "", "metadata": {}, "score": "57.40782"}
{"text": "[Links ] .Cotrim HP , Freitas LA , Alves E , Almeida A , May DS , Caldwell S. Effects of light - to - moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients .", "label": "", "metadata": {}, "score": "57.42215"}
{"text": "Is There a Role for Liver Transplantation for NASH Cirrhosis in the Elderly ?Currently , 5 - 10 % of liver transplants in the USA are for patients with NASH - related cirrhosis , while NASH is becoming an important predisposing factor for HCC .", "label": "", "metadata": {}, "score": "57.43685"}
{"text": "However , there is increasing recognition that patient and intestinal failure related factors are also important [ 4 ] .Obesity is a low grade systemic inflammatory condition that is frequently associated with insulin resistance , hyperinsulinemia , hypertension , hyperlipidemia and coronary artery disease ( the metabolic syndrome ) [ 5 ] .", "label": "", "metadata": {}, "score": "57.552322"}
{"text": "In patients with non - alcoholic fatty liver disease , NashTest , a simple and non - invasive biomarker reliably predicts the presence or absence of NASH .", "label": "", "metadata": {}, "score": "57.7256"}
{"text": "View Abstract .[16 ] Gaunt IF , et al .Brominated maize oil .I. Short - term toxicity and bromine - storage studies in rats fed brominated maize oil .", "label": "", "metadata": {}, "score": "57.74498"}
{"text": "The use of statins appears to be safe in patients monitored closely , to treat hyperlipidemia [ 39 , 60 ] .The long - term ezetimibe therapy can lead to improvement in metabolic , biochemical , and histological abnormalities of NAFLD [ 61 ] .", "label": "", "metadata": {}, "score": "57.87403"}
{"text": "PubMed ] [ DOI ] .Jarrar MH , Baranova A , Collantes R , Ranard B , Stepanova M , Bennett C , Fang Y , Elariny H , Goodman Z , Chandhoke V. Adipokines and cytokines in non - alcoholic fatty liver disease .", "label": "", "metadata": {}, "score": "57.913094"}
{"text": "The positive and negative predictive values were 34 % and 93 % respectively .This study confirmed that APRI is useful for detecting advanced fibrosis in subjects with NAFLD , and compares favourably with NFS to predict advanced fibrosis .", "label": "", "metadata": {}, "score": "57.92077"}
{"text": "142 - 149 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed \u00b7 View at Scopus .G. de Bruyn and E. A. Graviss , \" A systematic review of the diagnostic accuracy of physical examination for the detection of cirrhosis , \" BMC Medical Informatics and Decision Making , vol .", "label": "", "metadata": {}, "score": "57.92849"}
{"text": "The common metabolic disorders of T2DM and NAFLD can explain the greater success of drugs used to treat diabetes , with the most studies to target the use of drugs that improve insulin resistance .", "label": "", "metadata": {}, "score": "57.955784"}
{"text": "Obese patients developing SBS were at increased risk of developing certain hepatobiliary complications compared to non - obese individuals .In the present study they were almost three times more likely to undergo cholecystectomy after developing SBS .", "label": "", "metadata": {}, "score": "58.05887"}
{"text": "PubMed .Koruk M , Taysi S , Savas MC , Yilmaz O , Akcay F , Karakok M : Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis .", "label": "", "metadata": {}, "score": "58.06079"}
{"text": "Recent Advances in Diagnosis of NAFLD .The diagnosis of NAFLD / NASH is usually suspected in subjects with asymptomatic elevation of aminotransferase level , radiologic findings of fatty liver , or unexplained persistent hepatomegaly .", "label": "", "metadata": {}, "score": "58.099464"}
{"text": "[PubMed ] [ DOI ] .Wieckowska A , Papouchado BG , Li Z , Lopez R , Zein NN , Feldstein AE .Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis .", "label": "", "metadata": {}, "score": "58.124084"}
{"text": "Decompensated NASH cirrhosis may become the number one indication for liver transplantation in the next two decades .This means that patients being considered for transplantation are likely to be much older and have longstanding medical comorbidities related to metabolic syndrome .", "label": "", "metadata": {}, "score": "58.16227"}
{"text": "Adipose Tissue Insulin Resistance and NAFLD .Adipose tissue insulin resistance is associated with increased hepatic fat synthesis , regardless of obesity [ 15 ] .", "label": "", "metadata": {}, "score": "58.199615"}
{"text": "However , as this is the largest group of obese SBS patients reported in the in the literature , the observations made should have significance .", "label": "", "metadata": {}, "score": "58.209885"}
{"text": "View Abstract .[14 ] Banderas DZ , et al .\u03b3 - Glutamyl transferase : a marker of nonalcoholic fatty liver disease in patients with the metabolic syndrome .", "label": "", "metadata": {}, "score": "58.267776"}
{"text": "Obese patients have a higher incidence of pre - existing hepatobiliary disease .As noted previously , obese SBS patients were more likely to develop biliary tract disease preoperatively [ 6 ] .", "label": "", "metadata": {}, "score": "58.304497"}
{"text": "[PubMed ] [ DOI ] .Qureshi K , Clements RH , Abrams GA .The utility of the \" NAFLD fibrosis score \" in morbidly obese subjects with NAFLD .", "label": "", "metadata": {}, "score": "58.392982"}
{"text": "[PubMed ] [ DOI ] .Pacifico L , Celestre M , Anania C , Paolantonio P , Chiesa C , Laghi A. MRI and ultrasound for hepatic fat quantification : relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease .", "label": "", "metadata": {}, "score": "58.403816"}
{"text": "Ann Hepatol .[Links ] .de Oliveira CP , de Mello ES , Alves VA , Saviero SM , Strauss E. Changes in histological criteria lead to different prevalences of nonalcoholic steatohepatitis in severe obesity .", "label": "", "metadata": {}, "score": "58.481865"}
{"text": "Lipotoxicity is also favoured as the major pathway for pancreatic beta cell injury in T2D [ 62 - 66 ] and as part of the process of atherogenesis and cardiac toxicity with metabolic syndrome [ 62 ] .", "label": "", "metadata": {}, "score": "58.56402"}
{"text": "The presence of advanced fibrosis was diagnosed with good accuracy ( positive predictive value of 81.8 % ) .The score sensibility and specificity was 83 % and 97 % respectively .", "label": "", "metadata": {}, "score": "58.637775"}
{"text": "Risk factors of NT failure were hemolysis , Gilbert 's syndrome , acute inflammation , extrahepatic cholestasis and extreme values outside the 98 % percentiles for one component of NT .", "label": "", "metadata": {}, "score": "58.66291"}
{"text": "Methods .160 patients with NAFLD were prospectively included in a training group , 97 were included in a multicenter validation group and 383 controls .", "label": "", "metadata": {}, "score": "58.705"}
{"text": "APRI is a simple and inexpensive calculation making use of the AST value and platelet count .The formula has been validated in patients with hepatitis C but not in patients with NAFLD .", "label": "", "metadata": {}, "score": "58.755405"}
{"text": "Comparisons with biomarkers of alcoholic steato hepatitis ( ASH ) [ 36 ] are important as ASH and NASH share many physio - pathological mechanisms and histological features .", "label": "", "metadata": {}, "score": "58.78509"}
{"text": "The octogenarian liver also has fewer , but larger , hepatocytes , increased polyploidy , and higher binuclear index [ 44 ] , as well as a reduction in mitochondria numbers .", "label": "", "metadata": {}, "score": "58.884983"}
{"text": "Obese patients developing SBS are at increased risk of developing hepatobiliary complications .ESLD was similar in the two groups overall but occurs more frequently in obese patients maintained on chronic PN .", "label": "", "metadata": {}, "score": "58.910515"}
{"text": "53 - 54 , 2004 .View at Google Scholar \u00b7 View at Scopus . F. Angelico , M. Burattin , C. Alessandri , M. Del Ben , and F. Lirussi , \" Drugs improving insulin resistance for non - alcoholic fatty liver disease and/or non - alcoholic steatohepatitis . , \" Cochrane Database of Systematic Reviews , no . 1 , Article ID CD005166 , 26 pages , 2007 .", "label": "", "metadata": {}, "score": "58.929863"}
{"text": "[PubMed ] [ DOI ] .Mazza A , Fruci B , Garinis GA , Giuliano S , Malaguarnera R , Belfiore A. The role of metformin in the management of NAFLD .", "label": "", "metadata": {}, "score": "59.00769"}
{"text": "Liver de novo lipogenesis ( DNL ) [ 19 ] also contributes to the steatosis .De novo lipogenesis is due to the hyperinsulinemia associated with IR , which stimulates the enzymes in the DNL pathway , increasing the production and storage of triglycerides .", "label": "", "metadata": {}, "score": "59.017723"}
{"text": "The polymorphism of certain genes has been shown both in animal model and human studies that plays a significant role [ 34 - 36 ] .", "label": "", "metadata": {}, "score": "59.030144"}
{"text": "An increasing number of morbidly obese individuals are developing SBS .This may be related to complications of bariatric procedures or the treatment of other intestinal disease in obese patients [ 10 , 11 ] .", "label": "", "metadata": {}, "score": "59.05343"}
{"text": "Pathogenesis of NAFLD .The pathogenesis of NAFLD and progression to steatohepatitis have not been fully deciphered .In this section , we will briefly discuss what is known so far , with special reference to aspects relevant to interactions with ageing .", "label": "", "metadata": {}, "score": "59.06642"}
{"text": "Cal\u00e8s et al [ 56 ] compared the FibroMeter to NFS and found that the FibroMeter provides a more reliable diagnosis for significant fibrosis then the NFS .", "label": "", "metadata": {}, "score": "59.094456"}
{"text": "The evolution of fibrosis in NASH has been found in 25%-33 % of the cases [ 69 ] .Factors favoring the evolution to cirrhosis are fibrosis , obesity ( visceral ) , diabetes , and hypertension [ 70 ] .", "label": "", "metadata": {}, "score": "59.160683"}
{"text": "The \" third step \" for the progression from simple \" bland \" steatosis to active necroinflammation depends on the ability of the liver to adapt to longstanding triglyceride accumulation .", "label": "", "metadata": {}, "score": "59.161423"}
{"text": "Surgical treatment of obesity .Prim Care .[PubMed ] [ DOI ] .Moschen AR , Molnar C , Wolf AM , Weiss H , Graziadei I , Kaser S , Ebenbichler CF , Stadlmann S , Moser PL , Tilg H. Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression .", "label": "", "metadata": {}, "score": "59.233704"}
{"text": "For the training groups , the only difference in the present study was the exclusion of patients without histological steatosis , though these have been included in FT training and validation studies [ 25 ] .", "label": "", "metadata": {}, "score": "59.308876"}
{"text": "Links ] Nonalcoholic Fatty Liver Disease , Diabetes Mellitus and Cardiovascular Disease : Newer Data .2nd Medical Department and Diabetes Center , NIMTS Hospital , 12 Monis Petraki , 11521 Athens , Greece .", "label": "", "metadata": {}, "score": "59.330048"}
{"text": "Masato Yoneda Department of Gastroenterology , Yokohama City University Graduate School of Medicine , Yokohama , Japan BMC Gastroenterol 12:16 .Hepatic senescence marker protein-30 is involved in the progression of nonalcoholic fatty liver disease .", "label": "", "metadata": {}, "score": "59.3611"}
{"text": "Surgical rehabilitation ( ostomy closure , intestinal lengthening and intestinal transplantation ) had a similar occurrence in obese and control groups ( 46 % vs .", "label": "", "metadata": {}, "score": "59.36257"}
{"text": "View Article PubMed .Boza C , Riquelme A , Ibanez L , Duarte I , Norero E , Viviani P , Soza A , Fernandez JI , Raddatz A , Guzman S , Arrese M : Predictors of nonalcoholic steatohepatitis ( NASH ) in obese patients undergoing gastric bypass .", "label": "", "metadata": {}, "score": "59.41763"}
{"text": "Patient age , sex , body mass index ( BMI ) , history of diabetes and detailed alcohol consumption history were recorded .Patients who consumed more than 140 g of alcohol per week were excluded .", "label": "", "metadata": {}, "score": "59.456085"}
{"text": "Histology .The same two pathologists reported on each sample that were specially stained to exclude iron and copper overload .These were staged and graded according to the NASH National Institute of Health Chronic Research Network criteria .", "label": "", "metadata": {}, "score": "59.46797"}
{"text": "They concluded that vitamin E is an effective treatment for NASH patients without diabetes [ 89 ] .Harrison et al [ 90 ] also investigated the effects of a combination of vitamin E ( 1000 IU / d ) and vitamin C ( 1000 mg / d ) on liver histology in 45 diagnosed NASH patients over a 6-mo period .", "label": "", "metadata": {}, "score": "59.50746"}
{"text": "The ageing process results in increased prevalence of metabolic syndrome and T2D , possibly via preferential fat distribution to VAT sites .These factors all culminate in dysregulated lipid handling by the liver , causing steatosis and partially explaining the resultant progression of NAFLD to NASH .", "label": "", "metadata": {}, "score": "59.579277"}
{"text": "4 The group that investigated the BAAT ( BMI , ALT , age , triglycerides ) score replaced this test by the FibroTest .17 The FibroTest combines 5 biochemical markers , namely \u03b2 2-macroglobulin , apolipoprotein A1 , haptoglobulin , total bilirubin and gamma - glutamyl transpeptidase ( GGT ) .", "label": "", "metadata": {}, "score": "59.59537"}
{"text": "[Links ] .Fan J , Zhu J , Li X , Chen L , Li L , Dai F , Li F , Chen S. Prevalence of and risk factors for fatty liver in a general population of Shanghai , China .", "label": "", "metadata": {}, "score": "59.615395"}
{"text": "Nonalcoholic fatty liver disease increases risk of death among patients with diabetes : a community - based cohort study .Leon A Adams School of Medicine and Pharmacology , The University of Western Australia , Perth , Western Australia , Australia Am J Gastroenterol 105:1567 - 73 .", "label": "", "metadata": {}, "score": "59.621414"}
{"text": "Among patients with suspected NAFLD , the new generation of biomarkers such as FT , ST and NT will allow better identification of those at risk and reassurance for patients without fibrosis or NASH .", "label": "", "metadata": {}, "score": "59.734978"}
{"text": "These self - perpetuating cycles of inflammation and apoptosis are effected in some ways by adipokines , toxic lipid species , mitochondrial dysfunction , vascular disturbance , and possibly gut bacterial endotoxins [ 26 ] .", "label": "", "metadata": {}, "score": "59.800762"}
{"text": "19 By applying this model , almost 75 % of the 733 patients in this study could have avoided liver biopsy .Guha et al .", "label": "", "metadata": {}, "score": "59.8497"}
{"text": "Regular exercise reduces hepatic and visceral lipids in previously sedentary obese individuals even in absence of weight loss [ 52 ] .Several pharmaceutical interventions have attempted to NAFLD / NASH , with limited benefit overall .", "label": "", "metadata": {}, "score": "59.88159"}
{"text": "Not only the presence of excess weight and obesity , but also the location of fat storage plays a role in NAFLD pathogenesis .Visceral fat stores increase the risk for NAFLD in both obese and non - obese individuals [ 9 ] .", "label": "", "metadata": {}, "score": "59.885128"}
{"text": "NASH is associated with increased risk of death from cardiovascular disease and nonliver malignancies , as well as from liver complications .The practical implication is that clinicians need to consider early interventions to optimise the management of modifiable metabolic risk factors , like glycemic control in T2D , hypertension , and dyslipidemia , each of which could also contribute to disease progression in NAFLD .", "label": "", "metadata": {}, "score": "59.940544"}
{"text": "[PubMed ] [ DOI ] .Daubioul CA , Horsmans Y , Lambert P , Danse E , Delzenne NM .Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis : results of a pilot study .", "label": "", "metadata": {}, "score": "59.97557"}
{"text": "Clinical approaches to non - alcoholic fatty liver disease .Katherine JP Schwenger , Institute of Medical Science , University of Toronto , 1 King 's Circle , Toronto M5S 1A8 , Canada .", "label": "", "metadata": {}, "score": "60.00927"}
{"text": "[PubMed ] [ DOI ] .Machado M , Marques - Vidal P , Cortez - Pinto H. Hepatic histology in obese patients undergoing bariatric surgery .", "label": "", "metadata": {}, "score": "60.01055"}
{"text": "Hepatic senescence marker protein-30 is involved in the progression of nonalcoholic fatty liver disease .Hyohun Park Department of Gastroenterology and Hepatology , Saiseikai Suita Hospital , Kawazonocho 1 2 , Suita , Osaka 564 0013 , Japan J Gastroenterol 45:426 - 34 .", "label": "", "metadata": {}, "score": "60.058086"}
{"text": "PubMed ] [ DOI ] .Iacono A , Raso GM , Canani RB , Calignano A , Meli R. Probiotics as an emerging therapeutic strategy to treat NAFLD : focus on molecular and biochemical mechanisms .", "label": "", "metadata": {}, "score": "60.061478"}
{"text": "An AST : ALT ratio less than 1 is also seen in NAFLD [ 44 ] and supports NASH .However , it is important to note that patients with normal transaminases and liver steatosis on imaging may also have NASH [ 45 ] .", "label": "", "metadata": {}, "score": "60.078056"}
{"text": "[PubMed ] [ DOI ] .Sanyal AJ , Chalasani N , Kowdley KV , McCullough A , Diehl AM , Bass NM , Neuschwander - Tetri BA , Lavine JE , Tonascia J , Unalp A. Pioglitazone , vitamin E , or placebo for nonalcoholic steatohepatitis .", "label": "", "metadata": {}, "score": "60.124813"}
{"text": "119 - 128 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. E. Lavine , J. B. Schwimmer , M. L. Van Natta et al . , \" Nonalcoholic steatohepatitis clinical research network .", "label": "", "metadata": {}, "score": "60.193222"}
{"text": "51 - 58 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .I. Zib , A. N. Jacob , I. Lingvay et al . , \" Effect of pioglitazone therapy on myocardial and hepatic steatosis in insulin - treated patients with type 2 diabetes , \" Journal of Investigative Medicine , vol .", "label": "", "metadata": {}, "score": "60.37495"}
{"text": "However , apart from being an unpleasant and occasionally dangerous test , it is subject to sampling error and observer differences in histopathologic interpretation .Further , reported studies of NASH prevalence may suffer from selection and ascertainment biases as liver biopsies were often performed in specific groups like the morbidly obese and diabetics or among highly selected subjects enrolled in clinical trials [ 21 ] .", "label": "", "metadata": {}, "score": "60.378807"}
{"text": "792 - 798 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. A. Harrison , D. Oliver , H. L. Arnold , S. Gogia , and B. A. Neuschwander - Tetri , \" Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease , \" Gut , vol .", "label": "", "metadata": {}, "score": "60.41893"}
{"text": "Department of Internal Medicine , Faculty of Health Sciences , Stellenbosch University .BACKGROUND : Non - alcoholic steatohepatitis ( NASH ) can lead to cirrhosis and hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "60.46725"}
{"text": "The impact of phlebotomy in nonalcoholic fatty liver disease : A prospective , randomized , controlled trial .Leon A Adams School of Medicine and Pharmacology , University of Western Australia , Crawley , Australia Department of Gastroenterology and Hepatology , Sir Charles Gairdner Hospital , Perth , Australia Hepatology 61:1555 - 64 .", "label": "", "metadata": {}, "score": "60.4697"}
{"text": "Introduction .In 1980 , Ludwig and colleagues introduced the concept of nonalcoholic steatohepatitis ( NASH ) to describe liver histologic changes resembling alcoholic hepatitis in individuals without significant alcohol intake [ 1 ] .", "label": "", "metadata": {}, "score": "60.477646"}
{"text": "The study found that vitamin E supplementation significantly increases the risk of developing prostate cancer in healthy men [ 92 ] .Overall , caution needs to be taken when prescribing vitamin E , especially to diabetic NASH patients , as there is no research to support vitamin E at this time for this population .", "label": "", "metadata": {}, "score": "60.502075"}
{"text": "The mechanisms potentially contributing to hepatic steatosis are summarised in Figure 1 .Figure 1 : Mechanism of hepatic steatosis , adapted from Larter et al .", "label": "", "metadata": {}, "score": "60.549755"}
{"text": "Fibrosis is the final \" fourth step , \" involving chronic activation of hepatic stellate cells in a yet poorly understood cross - talk of Kupffer cells with hepatocytes .", "label": "", "metadata": {}, "score": "60.60611"}
{"text": "18 This panel is also not readily available and will be expensive , especially in developing countries .The NASH fibrosis score ( NFS ) is an algorithm of 6 readily available laboratory and clinical variables including age , hyperglycaemia , BMI , platelet count , albumin , and AST / ALT ratio .", "label": "", "metadata": {}, "score": "60.641342"}
{"text": "Cholestasis and portal inflammation are present in two thirds of intestinal failure patients on PN ; extensive portal fibrosis and cirrhosis develop later in 40 % of such patients [ 3 ] .", "label": "", "metadata": {}, "score": "60.646656"}
{"text": "used proton magnetic resonance spectroscopy ( MRS ) to quantify hepatic triglyceride ( TG ) content of 3 major ethnic groups .Hepatic steatosis ( defined as greater than 5.5 % TG content ) was noted in 31 % overall , with significant ethnic variation-45 % in hispanics , 33 % in whites , and 24 % in blacks [ 28 ] .", "label": "", "metadata": {}, "score": "60.760895"}
{"text": "MANAGEMENT OF NAFLD .The goal of managing NAFLD is to improve steatosis and prevent fibrosis .No standard treatment currently exists , however , treating risk factors such as obesity and IR , remains the focus of managing NAFLD .", "label": "", "metadata": {}, "score": "60.79962"}
{"text": "PubMed .Gray RS , James K , Merriman J , Starkey IR , Elton RA , Clarke BF , Duncan LJ : Alpha 2-macroglobulin and proliferative retinopathy in type 1 diabetes .", "label": "", "metadata": {}, "score": "60.857727"}
{"text": "[ 18 ] .The following nutrients have shown the greatest clinical efficacy in addressing and even reversing the spectrum of NAFLD .References .[ 1 ] Caldwell SH , et al .", "label": "", "metadata": {}, "score": "60.92949"}
{"text": "More research is needed to assess the impact of these treatments on a long - term basis .The objective of this article is to briefly review the diagnosis , management and treatment of this disease in order to aid clinicians in managing these patients .", "label": "", "metadata": {}, "score": "60.968998"}
{"text": "The ROC curve for an APRI of 0.98 and detection of advanced fibrosis was 0.85 , with positive and negative predictive values of 54 % and 94 % respectively .", "label": "", "metadata": {}, "score": "61.010868"}
{"text": "Non - alcoholic fatty liver disease .Briohny W Smith School of Medicine and Pharmacology , Sir Charles Gairdner Hospital Unit , University of Western Australia , Nedlands , Australia Crit Rev Clin Lab Sci 48:97 - 113 .", "label": "", "metadata": {}, "score": "61.092278"}
{"text": "Obese patients were significantly more likely to have diabetes mellitus ( 23 % vs .Incidence of alcohol use , bacterial overgrowth and central line infection was similar ( Table 1 ) .", "label": "", "metadata": {}, "score": "61.105095"}
{"text": "[PubMed ] [ DOI ] .Myers RP , Pomier - Layrargues G , Kirsch R , Pollett A , Duarte - Rojo A , Wong D , Beaton M , Levstik M , Crotty P , Elkashab M. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients .", "label": "", "metadata": {}, "score": "61.1689"}
{"text": "However , special consideration is needed for overweight and obese patients .The use of a FibroScan XL probe has been shown to provide reliable LSM [ 63 , 64 ] .", "label": "", "metadata": {}, "score": "61.191353"}
{"text": "Solga et al [ 107 ] studied the effect of VSL#3 on 4 NAFLD adult subjects in an open pilot study over a 4-mo period .", "label": "", "metadata": {}, "score": "61.240047"}
{"text": "[PubMed ] [ DOI ] .Zelber - Sagi S , Ratziu V , Oren R. Nutrition and physical activity in NAFLD : an overview of the epidemiological evidence .", "label": "", "metadata": {}, "score": "61.33055"}
{"text": "There are studies which highlight diabetes as risk marker for NAFLD / NASH appearance .In a study of 458 Italian patients with histological proven NASH , diabetes was the most significant marker of NASH and fibrosis and in those with normal ALT [ 13 ] .", "label": "", "metadata": {}, "score": "61.35833"}
{"text": "Updated data from the International Diabetes Federation , 2006 .View Abstract .[11 ] Bacon BR , et al .Nonalcoholic steatohepatitis : an expanded clinical entity .", "label": "", "metadata": {}, "score": "61.369873"}
{"text": "View at Google Scholar \u00b7 View at Scopus .G. C. Farrell , \" The liver and the waistline : fifty years of growth , \" Journal of Gastroenterology and Hepatology , vol .", "label": "", "metadata": {}, "score": "61.466606"}
{"text": "( 26 ) ( Table 1 ) .Two cutoff points previously validated were used : values lower than -1.455 exclude advanced fibrosis ( grade III and IV ) , and values above 0,676 indicate the presence of advanced fibrosis .", "label": "", "metadata": {}, "score": "61.504547"}
{"text": "2012 Jul;57(7):1925 - 31 .Epub 2012 Feb 29 .View Abstract .[ 13 ] Mofrad P , et al .Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values .", "label": "", "metadata": {}, "score": "61.627552"}
{"text": "Neuschwander - Tetri BA , Caldwell SH : Nonalcoholic steatohepatitis : Summary of an AASLD Single Topic Conference .Hepatology 2003 , 37 : 1202 - 1219 .", "label": "", "metadata": {}, "score": "61.677036"}
{"text": "IM can be altered by the type of diet consumed and may contribute to NAFLD through several mechanisms .DIAGNOSIS NAFLD .NAFLD should be suspected in individuals who are either obese , diabetic or have metabolic syndrome [ 40 ] .", "label": "", "metadata": {}, "score": "61.709095"}
{"text": "Leave a Reply .Upcoming Event : .Gut Restoration .In Functional Nutrition we often utilise the 5 R programme to support digestive health , restore and repair the gut barrier and tackle ongoing digestive imbalances .", "label": "", "metadata": {}, "score": "61.71277"}
{"text": "However , not only the amount of energy but also the quality of the diet could play an important role for the development and progression of NAFLD .", "label": "", "metadata": {}, "score": "61.766937"}
{"text": "Research has found that IM regulates energy homeostasis and ectopic fat deposition [ 102 ] , which has been related to metabolic diseases .NAFLD is associated with metabolic syndrome , and therefore has been the focus of recent pre - probiotic research .", "label": "", "metadata": {}, "score": "61.783134"}
{"text": "The bulge , booze , and the liver .Leon A Adams Clin Gastroenterol Hepatol 3:1195 - 7 .Treatment of nonalcoholic steatohepatitis : antioxidants or insulin sensitizers ?", "label": "", "metadata": {}, "score": "61.81791"}
{"text": "An ideal biomarker should be simple , reproducible , inexpensive , readily available , and accurate for a particular disease process .Different mechanisms have been proposed including an increased production of reactive oxygen species and mitochondrial outer permeabilization , resulting in a cascade of events leading to inflammation ( TNF- . , tissue elasticity ) [ 41 ] .", "label": "", "metadata": {}, "score": "61.884426"}
{"text": "Mechanisms involved in the pathogenesis are associated with diet and lifestyle , influx of free fatty acids to the liver from adipose tissue due to insulin resistance , hepatic oxidative stress , cytokines production , reduced very low - density lipoprotein secretion and intestinal microbiome .", "label": "", "metadata": {}, "score": "61.989895"}
{"text": "This is an interesting observation that suggests that despite maintaining a higher BMI the obese patients have a reduced tendency to develop hepatic steatosis after developing SBS .", "label": "", "metadata": {}, "score": "62.013245"}
{"text": "This score is based on routinely measured clinical and laboratory variables and was initially used in a population of obese patients and was able to separate patients with and without significant NAFLD .", "label": "", "metadata": {}, "score": "62.039696"}
{"text": "2119 - 2121 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. Musso , R. Gambino , F. De Michieli et al . , \" Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "62.10316"}
{"text": "2010 Winter;10(1):12 - 6 .Epub 2010 Mar 1 .View Abstract .[21 ] Parker HM , et al .Omega-3 supplementation and non - alcoholic fatty liver disease : a systematic review and meta - analysis .", "label": "", "metadata": {}, "score": "62.137302"}
{"text": "View Article PubMed .Kunde SS , Lazenby AJ , Clements RH , Abrams GA : Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women .", "label": "", "metadata": {}, "score": "62.21072"}
{"text": "In particular , central ( or visceral ) adiposity is strongly implicated in the development of both hepatic steatosis and metabolic syndrome [ 17 , 60 , 70 ] .", "label": "", "metadata": {}, "score": "62.230118"}
{"text": "2004 Apr;40(4):578 - 84 .View Abstract .[ 3 ] Sazci A , Ergul E , Aygun C : Methylenetetrahydrofolate reductase gene polymorphisms in patients with nonalcoholic steatohepatitis ( NASH ) .", "label": "", "metadata": {}, "score": "62.237263"}
{"text": "Not surprisingly , this is more common among Asian patients ( even with ethnic - specific criteria ) , though it has also been increasingly recognised in Western Countries [ 4 ] .", "label": "", "metadata": {}, "score": "62.301346"}
{"text": "Therefore , when developing a treatment plan for NAFLD patients , lifestyle modification should be used as a first step in clinical settings .Medical treatment .", "label": "", "metadata": {}, "score": "62.36"}
{"text": "[PubMed ] [ DOI ] .Solga SF , Buckley G , Clark JM , Horska A , Diehl AM .The effect of a probiotic on hepatic steatosis .", "label": "", "metadata": {}, "score": "62.411564"}
{"text": "Screening for HFE and iron overload .John Ombiga Department of Gastroenterology , Fremantle Hospital , Fremantle , Western Australia , Australia Semin Liver Dis 25:402 - 10 .", "label": "", "metadata": {}, "score": "62.422356"}
{"text": "PubMed .Bahcecioglu IH , Yalniz M , Ataseven H , Ilhan N , Ozercan IH , Seckin D , Sahin K : Levels of serum hyaluronic acid , TNF - alpha and IL-8 in patients with nonalcoholic steatohepatitis .", "label": "", "metadata": {}, "score": "62.46599"}
{"text": "Lifestyle interventions .As previously mentioned IR and obesity increase the risk of developing NAFLD and are instrumental in NAFLD progression .In today 's society obesity and IR have been linked to poor diet choices , as well as sedentary lifestyles .", "label": "", "metadata": {}, "score": "62.534973"}
{"text": "Effect of \u03c9-3 fatty acid ethyl esters on apolipoprotein B-48 kinetics in obese subjects on a weight - loss diet : a new tracer kinetic study in the postprandial state .", "label": "", "metadata": {}, "score": "62.542694"}
{"text": "Its reported prevalence varies , depending on the population of the study and using diagnostic criteria .In the general population exceeds 15 % , but it is far greater in the overweight , obese , and in subjects with type 2 diabetes ( T2DM ) as well type 1 diabetics [ 1 - 3 ] .", "label": "", "metadata": {}, "score": "62.69677"}
{"text": "[PubMed ] [ DOI ] .Nair S , Diehl AM , Wiseman M , Farr GH , Perrillo RP .Metformin in the treatment of non - alcoholic steatohepatitis : a pilot open label trial .", "label": "", "metadata": {}, "score": "62.722782"}
{"text": "NAFLD is strongly associated with T2DM and cardiovascular disease ( CVD ) .It is characterized by insulin resistance and mitochondrial dysfunction [ 6 ] .", "label": "", "metadata": {}, "score": "62.73497"}
{"text": "16 ] I also recommend my patients to avoid trans and saturated fats , along with nitrates / nitrates and high fructose corn syrup .[", "label": "", "metadata": {}, "score": "62.819393"}
{"text": "Approximately 60 -90 % of NAFLD - affected subjects have a benign form of the disease not requiring biopsy .The management of patients with NASH and no and minimal fibrosis does not differ , whereas patients with advanced forms of fibrosis must be identified for more intensive management .", "label": "", "metadata": {}, "score": "62.82612"}
{"text": "Between the ages of 20 and 70 , there is a decline in hepatic blood flow ( by 33 % ) , hepatic volume ( up to 25 % ) , and liver function [ 43 ] .", "label": "", "metadata": {}, "score": "62.87687"}
{"text": "5 ] Sheth SG , et al .Nonalcoholic steatohepatitis .Ann Intern Med .View Abstract .[ 6 ] Younossi ZM , et al .", "label": "", "metadata": {}, "score": "63.062294"}
{"text": "Laboratory evaluation included full liver function tests , full blood count , fasting glucose and fasting insulin .APRI was calculated by using the formula : ( AST / upper limit of normal x 100)/platelet count .", "label": "", "metadata": {}, "score": "63.06269"}
{"text": "Table 1 Summary of lifestyle intervention studies : diet and/or physical activity .NAFLD patients have been found to have an increased energy intake when compared to healthy individuals [ 67 ] .", "label": "", "metadata": {}, "score": "63.116295"}
{"text": "2486 - 2497 , 2001 .View at Google Scholar \u00b7 View at Scopus .IDF , \" The IDF consensus worldwide definition of the metabolic syndrome , \" Metabolic Syndrome , pp . 1 - 16 , 2007 .", "label": "", "metadata": {}, "score": "63.125122"}
{"text": "J Nutr .[PubMed ] [ DOI ] .L\u00ea KA , Faeh D , Stettler R , Ith M , Kreis R , Vermathen P , Boesch C , Ravussin E , Tappy L. A 4-wk high - fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans .", "label": "", "metadata": {}, "score": "63.13513"}
{"text": "View Article PubMed .Westwood M , Aplin JD , Collinge IA , Gill A , White A , Gibson JM : alpha 2-macroglobulin : a new component in the insulin - like growth factor / insulin - like growth factor binding protien-1 axis .", "label": "", "metadata": {}, "score": "63.166737"}
{"text": "Patients with NAFLD ( particularly those with NASH ) often have one or more components of the metabolic syndrome : [ 9 ] , [ 10 ] .", "label": "", "metadata": {}, "score": "63.21837"}
{"text": "800 - 803 , 1994 .View at Google Scholar \u00b7 View at Scopus .C. E. Garcia , R. F. L. Garcia , A. D. Mayer , and J. Neuberger , \" Liver transplantation in patients over sixty years of age , \" Transplantation , vol .", "label": "", "metadata": {}, "score": "63.28463"}
{"text": "24 , pp .2457 - 2471 , 2007 .View at Google Scholar \u00b7 View at Scopus .I. Hopper , \" Cardiac effects of non - cardiac drugs , \" Australian Prescriber , vol .", "label": "", "metadata": {}, "score": "63.39931"}
{"text": "PATHOGENESIS .In NAFLD , the accumulation of fat in the liver [ 15 ] is a result of increased delivery of free fatty acid ( FFA ) to the liver , increased synthesis , decreased triglyceride export through very - low density lipoprotein ( VLDL ) and reduced beta - oxidation [ 16 ] .", "label": "", "metadata": {}, "score": "63.415894"}
{"text": "Rising Global Prevalence .Depending on the screening tool and when the study was performed , estimated community prevalence of NAFLD has ranged from 2.8 % to 46 % [ 25 - 27 ] .", "label": "", "metadata": {}, "score": "63.4583"}
{"text": "Nonalcoholic fatty liver disease .Leon A Adams School of Medicine and Pharmacology , The University of Western Australia , Fremantle Hospital Campus , Australia Ann Epidemiol 17:863 - 9 .", "label": "", "metadata": {}, "score": "63.58712"}
{"text": "Efficacy of long - term ezetimibe therapy in patients with nonalcoholic fatty liver disease .Hyohun Park Department of Gastroenterology and Hepatology , Saiseikai Suita Hospital , 1 2 Kawazono cho , Suita , Osaka , 564 0013 , Japan J Gastroenterol 46:101 - 7 .", "label": "", "metadata": {}, "score": "63.687202"}
{"text": "Gut .[PubMed ] [ DOI ] .Attar BM , Van Thiel DH .Current concepts and management approaches in nonalcoholic fatty liver disease .", "label": "", "metadata": {}, "score": "63.751244"}
{"text": "However , bariatric surgery , insulin sensitizing agents , antioxidants and fish oil , may also be considered although further research is necessary to clearly document the effect .", "label": "", "metadata": {}, "score": "63.813427"}
{"text": "Over the last decade , community - based studies have found male predominance of NAFLD from the paediatric population [ 6 ] up to fifth decade of life in adults .", "label": "", "metadata": {}, "score": "63.874672"}
{"text": "[ 6 ] In the United States , studies report a prevalence of NAFLD of 10 to 46 percent , with most biopsy - based studies reporting a prevalence of NASH of 3 to 5 percent .", "label": "", "metadata": {}, "score": "63.888443"}
{"text": "This score can easily be used at the bedside or in an outpatient setting .APRI has not been validated for use in NAFLD / NASH and has not been compared with other non - invasive markers for advanced fibrosis in NAFLD / NASH .", "label": "", "metadata": {}, "score": "63.894638"}
{"text": "Indeed an estimated 15 to 20 % of the Western European population has steatosis [ 15 ] , while more than half of Americans are overweight or obese .", "label": "", "metadata": {}, "score": "63.941437"}
{"text": "Diabetes mellitus ( DM ) was defined as the clinical diagnosis and treatment of type II diabetes .Central line infections were defined as an episode of culture proven infection and antibiotic treatment .", "label": "", "metadata": {}, "score": "64.04568"}
{"text": "Additionally , there is a reduction in bile acid synthesis , with consequent change to bile acid secretion and bile flow .There is an age - related decline in hepatic metabolism of LDL cholesterol , leading to elevated serum cholesterol .", "label": "", "metadata": {}, "score": "64.15294"}
{"text": "Accumulation of fat in the liver represents an imbalance in hepatic lipid turnover .The liver plays a pivotal role in lipid metabolism .It takes up circulating free fatty acids and other lipids that arise from intestinal uptake / dietary sources , from lipolysis of peripheral storage sites ( adipose tissue ) and de novo synthesis ( lipogenesis ) .", "label": "", "metadata": {}, "score": "64.30286"}
{"text": "Yet in medicine today NAFLD is considered as the hepatic manifestation of metabolic syndrome , which is defined notably by increased waist circumference , insulin resistance and dyslipidemia .", "label": "", "metadata": {}, "score": "64.3154"}
{"text": "Methods .Patients .The study included 111 patients with histologically confirmed NAFLD recruited from 3 sites in the Western Cape province of South Africa , i.e. Tygerberg Academic Hospital , and Louis Leipoldt and Durbanville Medi - Clinics .", "label": "", "metadata": {}, "score": "64.32283"}
{"text": "2008 Nov;295(5):G987- 95 .View Abstract .[19 ] Qureshi AA , Sami SA , Salser WA , Khan FA .Synergistic effect of tocotrienol - rich fraction ( TRF(25 ) ) of rice bran and lovastatin on lipid parameters in hypercholesterolemic humans .", "label": "", "metadata": {}, "score": "64.35831"}
{"text": "This is where nutritional and nutraceutical therapies have an enormous role to play .A diet rich in organic fruits and vegetables ( the more varied the colours , the better ) , avoidance of refined , processed , and charred foods are beneficial .", "label": "", "metadata": {}, "score": "64.39577"}
{"text": "PubMed ] [ DOI ] .Athyros VG , Mikhailidis DP , Papageorgiou AA , Symeonidis AN , Pehlivanidis AN , Bouloukos VI , Elisaf M. The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease .", "label": "", "metadata": {}, "score": "64.50041"}
{"text": "In other murine experiments , using C57B/6 mice , Tran et al .found transplanting subcutaneous adipose tissue ( SAT ) to a VAT location , or to a lesser extent to another SAT location , improved insulin sensitivity and reduced body weight of recipient animals .", "label": "", "metadata": {}, "score": "64.50464"}
{"text": "Hepatocyte apoptosis itself triggers regenerative mechanisms to replace dead hepatocytes .However , aberrant repair in some individuals eventually leads to activation of hepatic stellate cells ( HSC ) to myofibroblasts and hepatic recruitment of proinflammatory and profibrogenic immune cells to the liver [ 61 ] .", "label": "", "metadata": {}, "score": "64.55996"}
{"text": "Links ] .Nomura H , Kashiwagi S , Hayashi J , Kajiyama W , Tani S , Goto M. Prevalence of fatty liver in a general population of Okinawa , Japan .", "label": "", "metadata": {}, "score": "64.666855"}
{"text": "The smaller SVR rate in female patients with cEVR compared to males may be overcome by extending treatment even if the RBV dose is lowered due to anemia ... .", "label": "", "metadata": {}, "score": "64.74035"}
{"text": "Involvement of a periodontal pathogen , Porphyromonas gingivalis on the pathogenesis of non - alcoholic fatty liver disease .Masato Yoneda Department of Gastroenterology , Yokohama City University Graduate School of Medicine , Yokohama , Japan BMC Gastroenterol 12:16 .", "label": "", "metadata": {}, "score": "64.81198"}
{"text": "[PubMed ] [ DOI ] .Cortez - Pinto H , de Moura MC , Day CP .Non - alcoholic steatohepatitis : from cell biology to clinical practice .", "label": "", "metadata": {}, "score": "64.86862"}
{"text": "If the person is cirrhotic at time of diagnosis , the risk of developing portal hypertension as a major complication is also high ; 17 % , 23 % , and 52 % at 1 , 3 , and 10 years , respectively [ 84 ] .", "label": "", "metadata": {}, "score": "64.94184"}
{"text": "Among the 11 clinically significant discordances ( two classes difference ) observed , nine were attributable to NT failure ( eight false negatives and one false positive ) and two to biopsy ( false negatives ) .", "label": "", "metadata": {}, "score": "64.99603"}
{"text": "Barrett AJ , Starkey PM : The interaction of alpha 2-macroglobulin with proteinases .Characteristics and specificity of the reaction , and a hypothesis concerning its molecular mechanism .", "label": "", "metadata": {}, "score": "65.02913"}
{"text": "The resulting FFA will be taken up by the liver and can cause lipid peroxidation [ 17 ] .Lipid peroxidation can increase the production of pro - inflammatory cytokines [ 17 ] .", "label": "", "metadata": {}, "score": "65.19896"}
{"text": "[PubMed ] [ DOI ] .Crespo J , Cay\u00f3n A , Fern\u00e1ndez - Gil P , Hern\u00e1ndez - Guerra M , Mayorga M , Dom\u00ednguez - D\u00edez A , Fern\u00e1ndez - Escalante JC , Pons - Romero F. Gene expression of tumor necrosis factor alpha and TNF - receptors , p55 and p75 , in nonalcoholic steatohepatitis patients .", "label": "", "metadata": {}, "score": "65.25334"}
{"text": "Lower fructose intake may help protect against development of nonalcoholic fatty liver in adolescents with obesity .We evaluated associations between fructose and total sugar intake and subsequent diagnosis of NAFL in adolescents with obesity and without obesity in a population - based cohort ... .", "label": "", "metadata": {}, "score": "65.28433"}
{"text": "Authors ' Affiliations .Biochemistry AP - HP Groupe Hospitalier Piti\u00e9 - Salp\u00eatri\u00e8re .Biopredictive , .Hepato - Gastroenterology , H\u00f4pital Creil .Pathology , H\u00f4pital Haut L\u00e9v\u00e8que .", "label": "", "metadata": {}, "score": "65.39646"}
{"text": "Our study confirmed that ALT could neither differentiate between the stage of disease nor the grade of fibrosis .There was a strong tendency in the South African study towards subjects with advanced fibrosis having a higher ratio .", "label": "", "metadata": {}, "score": "65.463165"}
{"text": "Hyperinsulinemia resulting from insulin resistance increases the synthesis of fatty acids in hepatocytes by increasing glycolysis and favors the accumulation of triglycerides within hepatocytes by decreasing hepatic production of apolipoprotein B-100 .", "label": "", "metadata": {}, "score": "65.59741"}
{"text": "Novel proteins identified by proteomic technology and genetic polymorphisms from genome association studies offer the possibility for further refinement and individualization of biomarker fibrosis models in the future ... .", "label": "", "metadata": {}, "score": "65.60044"}
{"text": "The prevalence of NAFLD in the USA population is 30 % and in patients undergoing bariatric surgery is 90 % ( 5 , 17 , 21 , 28 ) .", "label": "", "metadata": {}, "score": "65.6258"}
{"text": "J Hepatol .[PubMed ] [ DOI ] .Adams LA , Feldstein AE .Nonalcoholic steatohepatitis : risk factors and diagnosis .Expert Rev Gastroenterol Hepatol .", "label": "", "metadata": {}, "score": "65.69113"}
{"text": "View Abstract .[ 10 ] Meigs James .Metabolic syndrome and the risk for type 2 diabetes .Expert Rev Endocrin Metab 2006 ; 1:57 .", "label": "", "metadata": {}, "score": "65.71396"}
{"text": "Leon A Adams Department of Gastroenterology and Hepatology , Sir Charles Gairdner Hospital , Perth , Australia Clin Chem 51:1867 - 73 .We sought to create an algorithm of serum markers that accurately and reliably predict liver fibrosis stage among hepatitis C patients ... .", "label": "", "metadata": {}, "score": "65.7494"}
{"text": "Little is known about the interactive effects of ageing and NAFLD , with most studies focusing on the younger population .This paper summarises the epidemiology , pathogenesis , and clinical course of NAFLD , with particular attention to persons over age 60 years .", "label": "", "metadata": {}, "score": "65.77473"}
{"text": "Many studies on non - invasive panels with significant diagnostic value for fibrosis have been published but so far the most studied biomarker is the FT [ 39 ] , having a specific validation in NAFLD [ 25 ] .", "label": "", "metadata": {}, "score": "65.79956"}
{"text": "The three regressions permitted to generate probabilities and to classify the patient in one of the 3 categories .All the parameters were also used to generate security algorithms to detect abnormal values as previously described ( 27 ) .", "label": "", "metadata": {}, "score": "65.86749"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .N. A. Gupta , J. Mells , R. M. Dunham et al . , \" Glucagon - like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "66.04855"}
{"text": "The precise series of events occurring is incompletely understood .Although the mechanisms by which the hepatic fat aggregation is associated with adipose tissue inflammation were not elucidated , macrophages infiltration may contribute to adipose tissue insulin resistance .", "label": "", "metadata": {}, "score": "66.106316"}
{"text": "The sensitivity , specificity , and positive and negative predictive values for APRI and NFS are compared in Table I .The positive predictive value for APRI was 54 % , as opposed to 34 % for NFS .", "label": "", "metadata": {}, "score": "66.29002"}
{"text": "This would be of great value in clinical trial situations where the investigator might want to enroll those with severe disease first or perhaps for identifying patients at greatest risk for progression .", "label": "", "metadata": {}, "score": "66.31726"}
{"text": "AshTest was designed for the diagnosis of patients with severe alcoholic steato hepatitis needing specific treatment [ 36 ] and does not have significant diagnostic value for the diagnosis of NASH ( data not shown ) .", "label": "", "metadata": {}, "score": "66.383644"}
{"text": "However , none of these studies looked at patients greater than 70 years old .Table 1 : Disease progression in NAFLD / NASH and risk factors predicting disease progression [ 53 - 56 ] .", "label": "", "metadata": {}, "score": "66.57791"}
{"text": "We sought associations between NAFLD diagnosed during adolescence and earlier life trajectories of anthropometry , in a population - based cohort of predominantly Caucasian adolescents ... .", "label": "", "metadata": {}, "score": "66.65596"}
{"text": "Int .Med .[ Google Scholar ] .Thompson , J.S.The role of prophylactic cholecystectomy in the short bowel syndrome .Arch .Surg .", "label": "", "metadata": {}, "score": "66.657776"}
{"text": "Rosiglitazone has been withdrawn from the European market due to increased rates of myocardial infarction , but not overall cardiovascular mortality in a meta - analysis of approximately 35,000 patients from 56 randomised controlled trials [ 112 ] .", "label": "", "metadata": {}, "score": "66.71517"}
{"text": "You will see a range of delicious recipes demonstrated to support gut healing and for lowering inflammation in the digestive tract and we will discuss different dietary approaches that may be beneficial for resolving ongoing gut symptoms all Addendum Article Book Review Case Report Comment Commentary Communication Concept Paper Conference Report Correction Creative Data Descriptor Discussion Editorial Erratum Essay Interesting Images Letter New Book Received Obituary Opinion Project Report Reply Retraction Review Short Note Technical Note .", "label": "", "metadata": {}, "score": "66.86063"}
{"text": "J Clin Pathol .[PubMed ] [ DOI ] .Maroni L , Guasti L , Castiglioni L , Marino F , Contini S , Macchi V , De Leo A , Gaudio G , Tozzi M , Grandi AM .", "label": "", "metadata": {}, "score": "66.933304"}
{"text": "Recent therapies such as pioglitazone and vitamin E have been shown to be beneficial .Omega 3 polyunsaturated fatty acids and statins may offer additional benefits .", "label": "", "metadata": {}, "score": "66.96907"}
{"text": "The APRI was significantly higher in the advanced fibrosis group .The AUC for APRI is illustrated in Fig .4 .The AUC for APRI was 0.85 with a cut - off of 0.98 , giving a sensitivity of 75 % and a specificity of 86 % .", "label": "", "metadata": {}, "score": "67.012085"}
{"text": "N Engl J Med .[PubMed ] [ DOI ] .Lutchman G , Modi A , Kleiner DE , Promrat K , Heller T , Ghany M , Borg B , Loomba R , Liang TJ , Premkumar A. The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis .", "label": "", "metadata": {}, "score": "67.02183"}
{"text": "796 - 805 , 2011 .View at Publisher \u00b7 View at Google Scholar .American Diabetes Association , \" Clinical practice recommendations , \" Diabetes Care , vol .", "label": "", "metadata": {}, "score": "67.13615"}
{"text": "With recent advances in technology , advanced imaging techniques ( sonographic and magnetic elastography , magnetic spectroscopy ) provide important information for diagnosis and usually diagnosis is based on these [ 40 ] .", "label": "", "metadata": {}, "score": "67.1812"}
{"text": "AUROCs were higher , though not significantly , in patients with non - fragmented biopsies than in those with fragmented biopsies .( Tables 4 and 5 ) .", "label": "", "metadata": {}, "score": "67.242355"}
{"text": "Hyohun Park Department of Gastroenterology and Hepatology , Saiseikai Suita Hospital , Osaka , Japan Clin Chim Acta 411:1735 - 40 .Treatment extension may benefit female genotype 1 chronic hepatitis C patients with complete early virological response to peginterferon - alpha-2b and ribavirin combination therapy .", "label": "", "metadata": {}, "score": "67.27051"}
{"text": "[PubMed ] [ DOI ] .Aithal GP , Thomas JA , Kaye PV , Lawson A , Ryder SD , Spendlove I , Austin AS , Freeman JG , Morgan L , Webber J. Randomized , placebo - controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis .", "label": "", "metadata": {}, "score": "67.376724"}
{"text": "Surg .[ Google Scholar ] [ CrossRef ] .\u00a9 2012 by the authors ; licensee MDPI , Basel , Switzerland .Mechanisms and Implications of Age - Related Changes in the Liver : Nonalcoholic Fatty Liver Disease in the Elderly .", "label": "", "metadata": {}, "score": "67.45971"}
{"text": "The algorithm of NT excluded patients with steatosis predicted by ST .When screened patients without histological steatosis were included in a sensitivity analysis the diagnostic value of NT was not different than in patients with steatosis only .", "label": "", "metadata": {}, "score": "67.53368"}
{"text": "Similarly , a literature review conducted by Masterton et al [ 95 ] , found that in animal studies N -3 PUFA reduced hepatic steatosis , improved insulin sensitivity and biochemical markers of inflammation ; human studies yielded similar results .", "label": "", "metadata": {}, "score": "67.719154"}
{"text": "Conclusions .Advanced age is associated with disease severity and fibrosis progression ; a relatively high proportion of individuals with progressive forms of NAFLD develop cirrhosis by the time there are in their 70s or beyond , although more data are required on the exact risks .", "label": "", "metadata": {}, "score": "67.80812"}
{"text": "Biometrics 1988 , 44 : 837 - 45 .View Article PubMed .Zhou X , Obuchowski N , McClish D : In : Statistical Methods in Diagnostic Medicine .", "label": "", "metadata": {}, "score": "67.86667"}
{"text": "ROS also induce the formation of cytokines tumor necrosis factor- .induced by ROS further impairs the flow of electrons along the respiratory chain in mitochondria .", "label": "", "metadata": {}, "score": "67.93599"}
{"text": "Therefore NASH was the only important histological feature for which no biomarkers were available .The objective of the current study was to validate the diagnostic utility of a new panel of biomarkers , NashTest ( NT ) , for the detection of NASH in patients with NAFLD in order to reduce the need for liver biopsy .", "label": "", "metadata": {}, "score": "67.94436"}
{"text": "The second endpoint was the determination of the pathologist of whether the NASH is present or not .Serum biochemical markers .SteatoTest ( ST ) is a new panel ( SteatoTest , Biopredictive , Paris , France , patent pending ) , recently published , combining the 6 components of the FibroTest - ActiTest adjusted for age , gender and BMI , plus AST , serum glucose , triglycerides and cholesterol .", "label": "", "metadata": {}, "score": "67.98058"}
{"text": "If there is no presumed steatosis the result of NashTest is Non NASH .If there is a steatosis the other algorithms are computed .The next algorithms included all the components of the FibroTest and of the SteatoTest , using specific weights in three logistic regression formula , one for the diagnosis of no NASH , one for borderline NASH and one for the diagnostic of NASH .", "label": "", "metadata": {}, "score": "67.996765"}
{"text": "Hepatology .[Links ] .Liu X , Lazenby AJ , Clements RH , Jhala N , Abrams GA .Resolution of nonalcoholic steatohepatits after gastric bypass surgery .", "label": "", "metadata": {}, "score": "68.05058"}
{"text": "As discussed earlier , the accompanying hyperinsulinemia promotes de novo hepatic lipogenesis [ 79 ] , further promoting lipid overload in hepatocytes .What Drives Progression to Steatohepatitis ( NASH )", "label": "", "metadata": {}, "score": "68.05812"}
{"text": "It is noted that with all above , diagnosis of significant fibrosis may be satisfactory , but that of steatosis and NASH without fibrosis is problematic .", "label": "", "metadata": {}, "score": "68.1418"}
{"text": "B pathway and cause insulin resistance .Inhibition of muscle insulin signaling and insulin resistance inhibits insulin action on adipose glucose uptake and lipid synthesis , further increasing the rate of FFA release into the circulation , and contributes to the development of insulin resistance and type 2 diabetes [ 15 ] .", "label": "", "metadata": {}, "score": "68.21601"}
{"text": "Diagnosis for NASH is confirmed when a liver biopsy shows the presence of perilobular inflammation , or the presence of hepatocyte ballooning , Mallory hyaline and acidophil bodies with or without fibrosis .", "label": "", "metadata": {}, "score": "68.219666"}
{"text": "The results found that oligofructose promoted weight loss and improved glucose regulation [ 103 ] .Daubioul et al [ 104 ] also used oligofructose ( 16 g / d for 8 wk ) in a randomized double - blind crossover study and investigated the effects of oligofructose on glucose and lipid metabolism in 7 NASH patients .", "label": "", "metadata": {}, "score": "68.3457"}
{"text": "[Links ] .Fan JG , Zhu J , Li XJ , et al .Prevalence of and risk factors for fatty liver in the general population of Shanghai , China .", "label": "", "metadata": {}, "score": "68.50784"}
{"text": "Clin Gastroenterol Hepatol .2011 Jun;9(6):524 - 530 .e1 ; quiz e60 .Epub 2011 Mar 25 .View Abstract .[ 7 ] Williams CD , et al .", "label": "", "metadata": {}, "score": "68.64538"}
{"text": "View Abstract .[ 22 ] Sanyal AJ , et al .Pioglitazone , vitamin E , or placebo for nonalcoholic steatohepatitis .N Engl J Med .", "label": "", "metadata": {}, "score": "68.6805"}
{"text": "Future studies need to have larger high - quality clinical trials with rigorous methodology in order to establish standards of care .Footnotes .P- Reviewers : Chiu KW , Das UN , Williams GM S- Editor :", "label": "", "metadata": {}, "score": "68.681915"}
{"text": "Pre SBS ; # vs .Obese patients were more likely to have undergone cholecystectomy prior to SBS ( 42 % vs .Obese patients were also more likely to undergo cholecystectomy after developing SBS ( 80 % vs .", "label": "", "metadata": {}, "score": "68.799164"}
{"text": "The overall prevalence of NAFLD is reported 12.5 % , increasing to 23.0 % in overweight / obese , higher in boys than in girls [ 4 ] .", "label": "", "metadata": {}, "score": "68.89844"}
{"text": "The role of other adipokines , like visfatin , leptin and resistin are still controversial [ 25 - 27 ] .Potential pathways are promotion of IR , oxidative stress and inflammation as well as fibrogenesis [ 28 ] .", "label": "", "metadata": {}, "score": "68.9252"}
{"text": "Therefore statin use should be considered for NAFLD / NASH patients with dyslipidemia , but at this time , should not be used for the specific treatment of NAFLD / NASH .", "label": "", "metadata": {}, "score": "69.12856"}
{"text": "Alcohol avoidance is recommended .In my opinion and experience , I have routinely screened my patients with high normal GGT levels , in isolation or in conjunction with high normal or elevated AST and/or ALT levels with a liver ultrasound and have frequently seen evidence of NASH and NAFL on the radiology report .", "label": "", "metadata": {}, "score": "69.13824"}
{"text": "The ROC for NFS gave an area under curve ( AUC ) of 0.77 and a cut - off value of -1.3 with a sensitivity of 76 % and specificity of 69 % .", "label": "", "metadata": {}, "score": "69.15741"}
{"text": "The final result is adipocyte insulin resistance and the chronic release of FFA with toxic effects in distant tissues such as muscle , liver , and pancreatic .", "label": "", "metadata": {}, "score": "69.412506"}
{"text": "ALT , AST / ALT ratio , APRI and NFS were performed for each group , and compared for predictiveness of advanced NAFLD .Statistical analysis .", "label": "", "metadata": {}, "score": "69.41989"}
{"text": "The cornerstone of the management of NAFLD is to correct the disturbed metabolic milieu by encouraging an active lifestyle so as to counteract increases in body weight and improve insulin sensitivity .", "label": "", "metadata": {}, "score": "69.46819"}
{"text": "PubMed ] [ DOI ] .Capristo E , Miele L , Forgione A , Vero V , Farnetti S , Mingrone G , Greco AV , Gasbarrini G , Grieco A. Nutritional aspects in patients with non - alcoholic steatohepatitis ( NASH ) .", "label": "", "metadata": {}, "score": "69.608345"}
{"text": "Declarations .Acknowledgements .T. Poynard has grants from the Association pour la Recherche sur le Cancer ( ARECA ) and the Association de Recherche sur les Maladies Virales H\u00e9patiques .", "label": "", "metadata": {}, "score": "69.7041"}
{"text": "[PubMed ] [ DOI ] .Sandrin L , Tanter M , Gennisson JL , Catheline S , Fink M. Shear elasticity probe for soft tissues with 1-D transient elastography .", "label": "", "metadata": {}, "score": "69.762024"}
{"text": "In summary , obesity is an important factor in the outcome of SBS .Obese patients maintain a higher BMI and are less likely to require long term PN than non - obese individuals .", "label": "", "metadata": {}, "score": "69.76623"}
{"text": "PubMed .Kleiner DE , Brunt EM , Van Natta M , Behling C , Contos MJ , Cummings OW , Ferrell LD , Liu YC , Torbenson MS , Unalp - Arida A , Yeh M , McCullough AJ , Sanyal AJ : Nonalcoholic Steatohepatitis Clinical Research Network .", "label": "", "metadata": {}, "score": "69.85481"}
{"text": "With these limitations in mind , in an effort to organize the current understanding of NAFLD and NASH , a framework is proposed on the progression from adipose tissue insulin resistance to NAFLD and NASH [ 31 ] .", "label": "", "metadata": {}, "score": "69.88745"}
{"text": "196 - 199 , 2004 .View at Publisher \u00b7 View at Google Scholar . D. E. Larson - Meyer , L. K. Heilbronn , L. M. Redman et al . , \" Effect of calorie restriction with or without exercise on insulin sensitivity , \u03b2 -cell function , fat cell size , and ectopic lipid in overweight subjects , \" Diabetes Care , vol .", "label": "", "metadata": {}, "score": "70.06857"}
{"text": "NAFLD is becoming a public health issue due to its increased prevalence .It is important to recognize the disease early to prevent its progression .", "label": "", "metadata": {}, "score": "70.26364"}
{"text": "Exercise and dietary restriction can be very effective in carefully selected patients and should be used in a multidisciplinary approach , involving physiotherapists , dieticians , and occupational therapists to overcome potential physical limitations in older patients , such as osteoarthritis or decreasing mobility from other causes .", "label": "", "metadata": {}, "score": "70.28225"}
{"text": ": Patients developing the short bowel syndrome ( SBS ) are at risk for hepatobiliary disease , as are morbidly obese individuals .We hypothesized that morbidly obese SBS individuals would be at increased risk for developing hepatobiliary complications .", "label": "", "metadata": {}, "score": "70.5356"}
{"text": "Laurin J : Motion - all patients with NASH need to have a liver biopsy : arguments against the motion .Can J Gastroenterol 2002 , 16 : 722 - 6 .", "label": "", "metadata": {}, "score": "70.722046"}
{"text": "Belfort et al [ 86 ] studied the effects of a hypocaloric diet ( 500 kcal reduction ) and 45 mg of pioglitazone per day on 55 NASH patients with impaired glucose tolerance or type 2 diabetes .", "label": "", "metadata": {}, "score": "70.7556"}
{"text": "Insulin resistance leads to hepatocyte steatosis by stimulation of insulin secretion and by increased lipolysis in adipose tissue , which increases circulating fatty acids .Increased uptake of circulating free fatty acids ( FFA ) by hepatocytes leads to mitochondrial beta - oxidation overload , with the consequent accumulation of fatty acids within hepatocytes .", "label": "", "metadata": {}, "score": "70.77054"}
{"text": "The authors gratefully acknowledge Derrick Van Rooyen for his help with the preparation of this paper .References .J. Ludwig , T. R. Viggiano , D. B. McGill , and B. J. Ott , \" Nonalcoholic steatohepatitis .", "label": "", "metadata": {}, "score": "70.80197"}
{"text": "Amanda J Hooper Department of Core Clinical Pathology and Biochemistry , Royal Perth Hospital , Perth , Australia J Lipid Res 52:593 - 617 .Identifying the genetic determinants of hepatic steatosis will lead to a better understanding of the pathogenesis and progression of NAFLD ... .", "label": "", "metadata": {}, "score": "70.81102"}
{"text": "FC and BLB carried out histological analyses .DJ and FIB carried out the biochemical analyses .MM participated in the statistical analysis .JM , LB , MT , DT , JFC , VdL participated in the management of patients and coordination .", "label": "", "metadata": {}, "score": "70.85338"}
{"text": "Follow up ranged from 12 to 220 months , with mean follow up of 50 months for controls and 56 months for obese SBS patients .", "label": "", "metadata": {}, "score": "70.858696"}
{"text": "Leon A Adams School of Medicine and Pharmacology , The University of Western Australia UWA , Australia J Gastroenterol Hepatol 27:1520 - 7 .We aimed to use a candidate gene approach to examine the association between FLD and single nucleotide polymorphisms ( SNPs ) in lipid metabolism genes in the adolescent population - based Western Australian Pregnancy ( Raine ) Cohort ... .", "label": "", "metadata": {}, "score": "70.89389"}
{"text": "The prevalence and severity of NAFLD is also influenced by presence of metabolic risk factors , such as overweight / obesity and T2D. The prevalence of NAFLD and NASH in T2D are 76 % and 22 % , respectively [ 27 ] .", "label": "", "metadata": {}, "score": "70.95922"}
{"text": "Surg .[ Google Scholar ] [ CrossRef ] .Mathurin , P. ; Hollebecque , A. ; Arnalsteen , L. ; Buob , D. ; Leteurtre , E. ; Caiazzo , R. ; Pigeyre , M. ; Verkindt , H. ; Dharancy , S. ; Louvet , A. ; et al .", "label": "", "metadata": {}, "score": "71.16306"}
{"text": "The most significant components of NT were the metabolic factors ( mostly weight , triglycerides and glucose ) , as previously observed [ 17 - 21 ] , but also A2 M and apoA1 .", "label": "", "metadata": {}, "score": "71.1935"}
{"text": "Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia .Andrew Mitchell Western Australian Liver Transplant Service , Sir Charles Gairdner Hospital , Nedlands , Australia Liver Transpl 14:210 - 3 .", "label": "", "metadata": {}, "score": "71.28842"}
{"text": "5,6 There is no difference in the management of patients with NASH with minimal forms of fibrosis and without fibrosis .However , patients with NASH and advanced forms of fibrosis must be identified as they will require more intensive management .", "label": "", "metadata": {}, "score": "71.40987"}
{"text": "All the biochemical components had been prospectively assessed and assays were performed on fresh serum .NT was computed only if ST demonstrated a steatosis .", "label": "", "metadata": {}, "score": "71.59688"}
{"text": "The beneficial effects on hepatic steatosis are likely a consequence of increased insulin sensitivity through reduced peripheral lipolysis , inhibition of lipid synthesis , and stimulation of FA oxidation [ 97 ] .", "label": "", "metadata": {}, "score": "71.83243"}
{"text": "Ratziu et al [ 85 ] studied the treatment and safety of rosiglitazone in NASH patients .The treatment group received 4 mg / d for the first month , and then 8 mg / d for 11 mo [ 85 ] .", "label": "", "metadata": {}, "score": "71.862595"}
{"text": "Texture - based classification of liver fibrosis using MRI .Michael J House School of Physics , The University of Western Australia , Crawley , Western Australia , Australia J Magn Reson Imaging 41:322 - 8 .", "label": "", "metadata": {}, "score": "71.92647"}
{"text": "Weight loss is the only therapy with reasonable evidence suggesting it is beneficial and safe .Conventionally , the following strategies are typically employed .Weight loss for patients who are overweight or obese .", "label": "", "metadata": {}, "score": "71.963974"}
{"text": "The Fas ligand on one hepatocyte can interact with Fas on another hepatocyte , causing fractional killing [ 32 ] .Elevated levels of triacylglycerol ( TAG ) , diacylglycerol ( DAG ) and free cholesterol , NF- .", "label": "", "metadata": {}, "score": "71.99027"}
{"text": "Recent studies use diet , physical activity and behavior modification to help promote weight loss in NAFLD patients [ 69 ] .A randomized controlled trial conducted by Promrat et al [ 68 ] used a combination of diet , physical activity and behavior modification to trigger 7%-10 % weight loss in obese NASH patients .", "label": "", "metadata": {}, "score": "72.034676"}
{"text": "20 % ) and obese patients ( 86 % vs .Overall , the incidence of ESLD was similar in obese and control groups ( 19 % vs .", "label": "", "metadata": {}, "score": "72.17146"}
{"text": "Alpha 2 -macroglobulin , apolipoprotein A1 , and haptoglobin were measured using an automatic nephelometer ( BNII , Dade Behring ; Marburg , Germany ) .", "label": "", "metadata": {}, "score": "72.17336"}
{"text": "PubMed ] [ DOI ] .NIH conference .Gastrointestinal surgery for severe obesity .Consensus Development Conference Panel .Ann Intern Med .[PubMed ] [ DOI ] .", "label": "", "metadata": {}, "score": "72.501755"}
{"text": "23 - 28 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .J. C. Nisbet , J. M. Sturtevant , and J. B. Prins , \" Metformin and serious adverse effects , \" Medical Journal of Australia , vol .", "label": "", "metadata": {}, "score": "72.57039"}
{"text": "Yi Huang School of Medicine and Pharmacology , University of Western Australia , Perth , WA , Australia Liver Int 33:1249 - 56 .Collagen proportional area ( CPA ) determined by quantitative digital image analysis better quantifies liver fibrosis than histological stage ; however , its clinical use has been limited by non - standardized methods ... .", "label": "", "metadata": {}, "score": "72.58525"}
{"text": "Diagnostic performance of a rapid magnetic resonance imaging method of measuring hepatic steatosis .Michael J House School of Physics , The University of Western Australia , Crawley , Australia PLoS ONE 8:e59287 .", "label": "", "metadata": {}, "score": "72.61014"}
{"text": "Many factors that regulate VLDL metabolism may promote steatosis .The adipocyte is a dynamic endocrine organ and nutrient sensor that tightly regulates energy supply .", "label": "", "metadata": {}, "score": "72.72182"}
{"text": "-receptors with moderate biochemical and histological response are studied [ 59 ] .Sought treatment options for NASH , especially when is accompanied by fibrosis , but there are not large randomized trials .", "label": "", "metadata": {}, "score": "72.723236"}
{"text": "[PubMed ] [ DOI ] .Stumvoll M , Nurjhan N , Perriello G , Dailey G , Gerich JE .Metabolic effects of metformin in non - insulin - dependent diabetes mellitus .", "label": "", "metadata": {}, "score": "72.762665"}
{"text": "View Article PubMed .Talwalkar JA : Motion - all patients with NASH need to have a liver biopsy : arguments for the motion .Can J Gastroenterol 2002 , 16 : 718 - 21 .", "label": "", "metadata": {}, "score": "72.99242"}
{"text": "Table 4 .Concordance between NASH predicted by NashTest and predicted by biopsy .ROC curves of NT for predicting NASH or borderline NASH are illustrated in Figures 1 to 3 .", "label": "", "metadata": {}, "score": "73.1508"}
{"text": "Conversely , Lutchman et al [ 87 ] found that discontinuing TZD therapy resulted in NASH recurrence , indicating that long - term use is necessary for successful treatment .", "label": "", "metadata": {}, "score": "73.233154"}
{"text": "The deleterious metabolic effect of increased VAT can be partially explained by dysregulation of adipocytokines ( TNF- \u03b1 , leptin , resistin , and most notably adiponectin ) .", "label": "", "metadata": {}, "score": "73.28378"}
{"text": "Intensive insulin therapy in type 2 diabetic patients with NAFLD / NASH appears to significantly decrease on steatosis [ 64 ] .GLP-1 receptors were detected on human hepatocytes and treatment with exendin-4 quantitatively reduced triglyceride stores compared with control - treated cells [ 65 ] .", "label": "", "metadata": {}, "score": "73.35245"}
{"text": "Study population .The populations screened for inclusion in the present study were the same as those used in previously published validation studies for FT in NAFLD .", "label": "", "metadata": {}, "score": "73.48718"}
{"text": "Estes valores foram comparados com os achados de biopsia hep\u00e1tica realizados no intra - operat\u00f3rio .RESULTADOS : A presen\u00e7a de fibrose avan\u00e7ada foi diagnosticada com boa precis\u00e3o , valor preditivo positivo de 83,7 % .", "label": "", "metadata": {}, "score": "73.68431"}
{"text": "The mean age of the cohort was 52 years ( confidence interval ( CI ) 50 - 54 yrs ) ; mean BMI was 35 ( CI 34 - 36 ) ; and 43 % were type II diabetics .", "label": "", "metadata": {}, "score": "73.731285"}
{"text": "Insulin resistance in adipose tissue allows inappropriately sustained lipolysis with release of FFA , which are shunted to the liver at times when the liver is programmed for lipogenesis rather than for fat disposal [ 66 ] .", "label": "", "metadata": {}, "score": "74.17826"}
{"text": "View Article PubMed .Chu CT , Rubenstein DS , Enghild JJ , Pizzo SV : Mechanism of insulin incorporation into alpha 2-macroglobulin : implications for the study of peptide and growth factor binding .", "label": "", "metadata": {}, "score": "74.252106"}
{"text": "Several studies have been conducted to further analyze the benefits of administering high doses of vitamin E to NASH patients .One notable study is the PIVENS clinical trial , which administered high doses of vitamin E ( 800 IU / d for 96 d ) in non - diabetic patients [ 89 ] .", "label": "", "metadata": {}, "score": "74.4"}
{"text": "All data are means ( se ) and proportions ( n [ % ] ) .ALT , alanine aminotransferase ; AST , aspartate aminotransferase ; GGT , \u03b3 - glutamyl - transpeptidase .", "label": "", "metadata": {}, "score": "74.419815"}
{"text": "UDCA has been studied in clinical trials to determine its effectiveness on the NAFLD population .UDCA is a naturally occurring secondary bile acid that has been used in clinical trials to determine its effectiveness for treatment of patients with NAFLD / NASH [ 93 ] .", "label": "", "metadata": {}, "score": "74.48526"}
{"text": "Body mass index is a stronger predictor of alanine aminotransaminase levels than alcohol consumption .Leon A Adams School of Medicine and Pharmacology , Fremantle Hospital Campus , The University of Western Australia , Fremantle , Australia J Gastroenterol Hepatol 23:1089 - 93 .", "label": "", "metadata": {}, "score": "74.610565"}
{"text": "Pre - resection BMI was significantly lower in controls ( 26 vs .BMI at 1 , 2 , and 5 years was decreased in controls but persistently increased in obese patients .", "label": "", "metadata": {}, "score": "74.66555"}
{"text": "Competing interests .TP is the inventor of the patented tests ( Fibrotest , ActiTest , SteatoTest , NashTest and AshTest ) , is a consultant , and has a capital interest in Biopredictive , the company marketing these tests .", "label": "", "metadata": {}, "score": "74.688774"}
{"text": "In another study , NAFLD subjects ' survival was found lower compared with matched controls after a mean followup of 13.7 years [ 21 ] .", "label": "", "metadata": {}, "score": "74.96422"}
{"text": "[Links ] .Ruhl CE , Everhart JE .Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States .", "label": "", "metadata": {}, "score": "75.02939"}
{"text": "It seems that NASH can predict a more atherogenic risk profile in a manner that is partly independent of the contribution of visceral adiposity .In a study , the differential contribution of NASH and visceral adiposity to nontraditional cardiovascular risk biomarkers in adult men was assessed [ 25 ] .", "label": "", "metadata": {}, "score": "75.236206"}
{"text": "[PubMed ] [ DOI ] .Bellentani S , Saccoccio G , Masutti F , Croc\u00e8 LS , Brandi G , Sasso F , Cristanini G , Tiribelli C. Prevalence of and risk factors for hepatic steatosis in Northern Italy .", "label": "", "metadata": {}, "score": "75.27555"}
{"text": "It is interesting that , the addition of pioglitazone to insulin therapy , in type 2 diabetics , reduced myocardial and hepatic steatosis [ 28 ] .", "label": "", "metadata": {}, "score": "75.811745"}
{"text": "There was no consensual limit .The prevalence of patients with metabolic risk factors and moderate alcohol consumption is important in many countries and should be also analyzed in diagnostic studies .", "label": "", "metadata": {}, "score": "76.08553"}
{"text": "The velocity of the wave , which is correlated with liver stiffness , is measured by ultrasound .The stiffer the liver the greater the degree of fibrosis [ 62 ] .", "label": "", "metadata": {}, "score": "76.10268"}
{"text": "PubMed ] [ DOI ] .Yilmaz Y , Ulukaya E , Dolar E. A \" biomarker biopsy \" for the diagnosis of NASH : promises from CK-18 fragments .", "label": "", "metadata": {}, "score": "76.20567"}
{"text": "Leon A Adams Indian J Gastroenterol 23:127 - 8 .Vitamins E and C for the treatment of NASH : duplication of results but lack of demonstration of efficacy .", "label": "", "metadata": {}, "score": "76.28735"}
{"text": "To reduce the observer variability related to the NASH definition , we used the recent NAS scoring system recommended by Kleiner et al [ 14 ] .", "label": "", "metadata": {}, "score": "76.62749"}
{"text": "Management of hepatocellular carcinoma in Japan : consensus - based clinical practice manual proposed by the Japan Society of Hepatology .Masatoshi Kudo Department of Gastroenterology and Hepatology , Kinki University School of Medicine , Osaka Sayama , Osaka , Japan Oncology 72:2 - 15 .", "label": "", "metadata": {}, "score": "76.6709"}
{"text": "Hepatology .[PubMed ] [ DOI ] .Spencer MD , Hamp TJ , Reid RW , Fischer LM , Zeisel SH , Fodor AA .", "label": "", "metadata": {}, "score": "76.704155"}
{"text": "View Article PubMed .Comp Hepatol 2005 , 4 : 10 .View Article PubMed .J Hepatol 2006 , 52 : 1887 - 96 .", "label": "", "metadata": {}, "score": "76.74115"}
{"text": "Both SREBP1 and ChREBP activate fatty acid synthase ( FAS ) , the rate limiting step in biosynthesis of long chain fatty acids , while SREBP2 regulates cholesterol biosynthesis .", "label": "", "metadata": {}, "score": "76.743515"}
{"text": "A2 M is a protease inhibitor but also has multiple functions as a binding , carrier and targeting protein [ 40 ] .In patients with NAFLD we previously demonstrated a very significant association between A2 M and insulin levels , a hallmark of insulin resistance [ 25 ] .", "label": "", "metadata": {}, "score": "76.752335"}
{"text": "The area under curve ( AUC ) for the FibroTest as predictive of advanced fibrosis is 0.87 .Unfortunately , the FibroTest is expensive and not widely available .", "label": "", "metadata": {}, "score": "76.77313"}
{"text": "Idade , \u00edndice de massa corporal , hiperglicemia , albumina , contagem de plaquetas e raz\u00e3o AST / ALT foram aplicados \u00e0 f\u00f3rmula do escore de fibrose .", "label": "", "metadata": {}, "score": "76.82736"}
{"text": "NT was developed using patented algorithms combining 13 parameters : age , sex , height , weight , and serum levels of triglycerides , cholesterol , alpha2macroglobulin , apolipoprotein A1 , haptoglobin , gamma - glutamyl - transpeptidase , transaminases ALT , AST , and total bilirubin .", "label": "", "metadata": {}, "score": "76.97125"}
{"text": "Pioglitazone appears to be the safer alternative .Troglitazone has been withdrawn worldwide due to significant fatal hepatotoxicity .Bariatric Surgery .Earlier approaches to obesity included jejunoileal bypass surgery , which was abandoned owing to unacceptable risks of liver failure .", "label": "", "metadata": {}, "score": "77.01846"}
{"text": "Control group .A total of 383 prospectively included blood donors or healthy volunteers from the training enter were used as controls .This protocol was carried out in compliance with the Helsinki Declaration .", "label": "", "metadata": {}, "score": "77.16226"}
{"text": "[PubMed ] [ DOI ] .Caldwell SH , Argo CK , Al - Osaimi AM .Therapy of NAFLD : insulin sensitizing agents .", "label": "", "metadata": {}, "score": "77.265366"}
{"text": "26 , pp .2683 - 2693 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .P. E. O'Brien , J. B. Dixon , W. Brown et al . , \" The laparoscopic adjustable gastric band ( Lap - Band \u00ae ): a prospective study of medium - term effects on weight , health and quality of life , \" Obesity Surgery , vol .", "label": "", "metadata": {}, "score": "77.51538"}
{"text": "2011 Aug;34(3):274 - 85 .Epub 2011May 30 .View Abstract .[ 9 ] Alberti KG , Eckel RH , Grundy SM , et al .", "label": "", "metadata": {}, "score": "77.70158"}
{"text": "At\u00e9 o momento , a biopsia hep\u00e1tica \u00e9 o procedimento com maior precis\u00e3o para tal diagn\u00f3stico .OBJETIVO : Avaliar o escore de fibrose hep\u00e1tica em doen\u00e7a hep\u00e1tica gordurosa n\u00e3o - alco\u00f3lica em pacientes com obesidade m\u00f3rbida na popula\u00e7\u00e3o brasileira .", "label": "", "metadata": {}, "score": "77.76225"}
{"text": "Introduction .Patients developing the short bowel syndrome ( SBS ) are at risk for hepatobiliary complications , especially if receiving parenteral nutrition ( PN ) [ 1 ] .", "label": "", "metadata": {}, "score": "77.77436"}
{"text": "[PubMed ] [ DOI ] .Berg AH , Combs TP , Scherer PE .ACRP30/adiponectin : an adipokine regulating glucose and lipid metabolism .", "label": "", "metadata": {}, "score": "78.140015"}
{"text": "I MB ChB , MMed ( Int ) , PhD ( Int ) , Cert Gastro ( SA ) .Gastroenterology Unit , Durbanville Medi - Clinic , Cape Town II BA ( Cur ) ( Nursing Science ) .", "label": "", "metadata": {}, "score": "78.15435"}
{"text": "[PubMed ] [ DOI ] .Zhou G , Myers R , Li Y , Chen Y , Shen X , Fenyk - Melody J , Wu M , Ventre J , Doebber T , Fujii N. Role of AMP - activated protein kinase in mechanism of metformin action .", "label": "", "metadata": {}, "score": "78.360794"}
{"text": "Three months into the treatment , aminotransferase decreased , which was related to an improvement in insulin sensitivity [ 79 ] .However , this improvement was not sustained for the duration of the treatment ; therefore Nair et al [ 79 ] concluded that metformin should not be used for the treatment of NAFLD .", "label": "", "metadata": {}, "score": "78.46219"}
{"text": "Briohny W Smith School of Medicine and Pharmacology , Sir Charles Gairdner Hospital Unit , University of Western Australia , Nedlands , WA 6009 , Australia Nat Rev Endocrinol 7:456 - 65 .", "label": "", "metadata": {}, "score": "78.486374"}
{"text": "However , it is used after imaging techniques , laboratory abnormalities and/or non - invasive methods suggest the presence and severity of NASH [ 46 , 52 ] .", "label": "", "metadata": {}, "score": "78.51966"}
{"text": "The sensitivity and specificity of APRI were compared with NFS and aspartate aminotransferase - to - alanine aminotransferase ( AST / ALT ) ratio .RESULTS :", "label": "", "metadata": {}, "score": "78.615944"}
{"text": "[Links ] .Hepatology .[Links ] .Gunneson TJ , Menon KVN , Wiesner RH , Daniels JA , Hay JE , Charlton MR , Brandhagen DJ , Rosen CB , Porayko MK .", "label": "", "metadata": {}, "score": "78.81761"}
{"text": "There is currently no established treatment for NAFLD or NASH , although weight loss is recommended [ 39 ] .Several pharmaceutical interventions have been evaluated but none has been approved for general use .", "label": "", "metadata": {}, "score": "78.829956"}
{"text": "AUC , sensitivity , specificity , positive predictive value ( ppv ) and negative predictive value ( npv ) were reported .Results .Patient demographics .", "label": "", "metadata": {}, "score": "78.92001"}
{"text": "In the validation group there was clinically significant discordance in eight patients ( 8 % ) : all were predicted to have no NASH with NT and NASH at biopsy .", "label": "", "metadata": {}, "score": "78.928154"}
{"text": "[PubMed ] [ DOI ] .Mouzaki M , Comelli EM , Arendt BM , Bonengel J , Fung SK , Fischer SE , McGilvray ID , Allard JP .", "label": "", "metadata": {}, "score": "79.03998"}
{"text": "Not surprisingly , anthropometric indices such as body mass index ( BMI ) and waist circumference do not accurately reflect total and regional adiposity as well as they do in younger patients [ 46 ] .", "label": "", "metadata": {}, "score": "79.09293"}
{"text": "The area under the ROC curves ( AUROC ) , sensitivity ( Se ) , specificity ( Sp ) , and positive and negative predictive values ( PPV , NPV ) were assessed .", "label": "", "metadata": {}, "score": "79.10852"}
{"text": "Lifestyle Changes .While lifestyle changes are widely promoted , adherence remains a major issue .A program of cognitive behavioural therapy remains the most effective tool to obtain long - term adherence .", "label": "", "metadata": {}, "score": "79.349724"}
{"text": "As insulin resistance is central to NAFLD , agents that improve insulin sensitivity appear promising .To date , two classes of insulin sensitising agents , metformin , and thiazolidinediones ( TZDs ) have been evaluated .", "label": "", "metadata": {}, "score": "79.96029"}
{"text": "There was a very low triglyceride level ( 0.1 and 0.3 mmol / L ) in two patients suggesting two instances of NT 's false negatives .", "label": "", "metadata": {}, "score": "80.134995"}
{"text": "The biopsy size in the training group was longer with more portal tracts than in the validation group ( Table 1 ) .Diagnosis of NASH .", "label": "", "metadata": {}, "score": "80.15471"}
{"text": "MDA and HNE cause cell death ; cross - link proteins , leading to the formation of Mallory 's hyaline , and activate stellate cells promoting collagen synthesis .", "label": "", "metadata": {}, "score": "80.387856"}
{"text": "Statistical analysis used Fisher 's exact test , the chi - square test , Student 's t test , the Mann - Whitney test , and variance analysis used the Bonferroni all - pair wise and Tukey - Kramer multiple - comparison tests to take into account the multiple comparisons and multiple logistic regression for multivariate analysis .", "label": "", "metadata": {}, "score": "80.591736"}
{"text": "Possible deviations from the assumptions were checked and highlighted in cases where they caused a problem .The non - parametric Mann - Whitney U - test was then used .", "label": "", "metadata": {}, "score": "80.62335"}
{"text": "RESULTS .Patient population : 158 patients were analyzed and the mean age was 36 years ( \u00b1 10 years ) , and 77 % were females .", "label": "", "metadata": {}, "score": "80.64158"}
{"text": "Abbreviations .ROC : . receiver operating characteristic .AST : . aspartate aminotransferase .NPV : . negative predictive value .PPV : . positive predictive value .", "label": "", "metadata": {}, "score": "80.70577"}
{"text": "Rae Chi Huang School of Medicine and Pharmacology , University of Western Australia UWA , Nedlands , Australia School of Paediatrics and Child Health , UWA , Nedlands , Australia Hepatology 58:1306 - 14 .", "label": "", "metadata": {}, "score": "81.19912"}
{"text": "Rae Chi Huang School of Medicine and Pharmacology , University of Western Australia UWA , Nedlands , Australia School of Paediatrics and Child Health , UWA , Nedlands , Australia Hepatology 58:1306 - 14 .", "label": "", "metadata": {}, "score": "81.19912"}
{"text": "The AUC for NFS is illustrated in Fig .6 .The AUC for NFS was 0.77 given at a cut - off of -1.31 .", "label": "", "metadata": {}, "score": "81.518936"}
{"text": "Currently , metformin use for NASH is not recommended [ 100 , 105 ] .Thiazolidinediones are PPAR- \u03b3 agonists that exert insulin - sensitizing actions on adipocytes and in the liver .", "label": "", "metadata": {}, "score": "81.6107"}
{"text": "Table 6 .Controls .Among the 383 controls 26/383 ( 7 % ) had steatosis estimated by SteatoTest and none had NASH .Discussion .", "label": "", "metadata": {}, "score": "81.63566"}
{"text": "2006 ; 40 Suppl 1 : S61-S66 .[PubMed ] [ DOI ] .Gastroenterology .[PubMed ] [ DOI ] .", "label": "", "metadata": {}, "score": "81.80015"}
{"text": "Insulin resistance is found in virtually every patient with NASH and in approximately 60 % of all patients with NAFLD .The pathogenesis of insulin resistance involves a combination of genetic polymorphisms that influence insulin secretion and many acquired factors , such as sedentary lifestyle , medications , chronic illnesses , ageing , and other environmental factors which promote obesity and immobility [ 26 , 78 ] .", "label": "", "metadata": {}, "score": "81.83442"}
{"text": "In general , TZDs used to treat NASH have been well tolerated , but significant weight gain ( 2 - 6 kg ) predominantly in the SAT area occurs in up to 72 % of patients and this is a concern .", "label": "", "metadata": {}, "score": "81.91954"}
{"text": "[PubMed ] [ DOI ] .Van Wagner LB , Rinella ME .The role of insulin - sensitizing agents in the treatment of nonalcoholic steatohepatitis .", "label": "", "metadata": {}, "score": "81.9559"}
{"text": "TZDs also increase serum adiponectin levels , with improved insulin sensitivity .More recently , Ratziu et al .extended duration of rosiglitazone for an additional 2 years in 53 patients with liver biopsy - proven NASH .", "label": "", "metadata": {}, "score": "82.1851"}
{"text": "View Article PubMed .View Article PubMed .View Article PubMed .View Article PubMed .Am J Gast 2005 , 100 : 1970 - 80 .", "label": "", "metadata": {}, "score": "82.295715"}
{"text": "Increased TNF - \u03b1 and IL-6 are also associated with IR by interfering with insulin signaling [ 7 , 22 ] .On the other hand , adiponectin [ 7 , 22 ] is produced by the adipose tissue and is an anti - inflammatory adipokine that can increase insulin sensitivity [ 23 ] .", "label": "", "metadata": {}, "score": "82.48477"}
{"text": "Diagnostic values of NT for predicting borderline NASH and NASH in different groups , are given in Table 4 for the concordance with biopsy results , and in Table 5 for sensitivity , specificity and predictive values .", "label": "", "metadata": {}, "score": "82.7218"}
{"text": "[Links ] .de Andrade AR , Cotrim HP , Alves E , Soares D , Rocha R , Almeida A , Almeida CG , de Freitas LA .", "label": "", "metadata": {}, "score": "82.753845"}
{"text": "Further studies on the efficacy of such interventions in clinical and histological outcomes in NAFLD / NASH will be of interest .Pharmacotherapy - The Insulin Sensitisers .", "label": "", "metadata": {}, "score": "83.19558"}
{"text": "TZD are peroxisomal proliferator activated receptor - \u03b3 ( PPAR - \u03b3 ) agonists that are used primarily in the type 2 diabetes population to help improve insulin sensitivity within the liver , muscle and adipose tissue , promote hepatic fatty acid oxidation and decrease hepatic lipogenesis [ 82 , 83 ] .", "label": "", "metadata": {}, "score": "83.438"}
{"text": "2008 ; 18 : 1507 - 1508 ; author reply 1509 - 1510 .[PubMed ] [ DOI ] . 1 Donnelly KL , Smith CI , Schwarzenberg SJ , Jessurun J , Boldt MD , Parks EJ .", "label": "", "metadata": {}, "score": "83.45109"}
{"text": "Pentoxifylline inhibits TNF alpha production .We therefore conducted a 12-month pilot trial to assess the efficacy and safety of pentoxifylline ( 1,600 mg / day ) among 20 patients with NASH ... .", "label": "", "metadata": {}, "score": "83.54673"}
{"text": "All patients and controls gave verbal informed consent for the use of data and serum for research purposes and this was approved by the ethical committee of Paris Piti\u00e9 Salp\u00eatri\u00e8re Hospital .", "label": "", "metadata": {}, "score": "83.56642"}
{"text": "Centre for Statistical Consultation , Stellenbosch University IV MB ChB , MMed ( Anat Path ) .Department of Anatomical Pathology , Faculty of Health Sciences , Stellenbosch University V PhD ( Hum Genet ) .", "label": "", "metadata": {}, "score": "83.60075"}
{"text": "A scoring system recently published by Kleiner et al [ 14 ] was used .We used two definitions of NASH .The main endpoint was steatohepatitis defined as a NAS score of 5 or greater .", "label": "", "metadata": {}, "score": "83.84505"}
{"text": "Compliance to modest caloric restriction and increased physical activity result in both sustained weight loss and improved cardiorespiratory fitness , the latter assessed by the peak oxygen consumption ( VO 2 max ) .", "label": "", "metadata": {}, "score": "84.02654"}
{"text": "[PubMed ] [ DOI ] .Klein EA , Thompson IM , Tangen CM , Crowley JJ , Lucia MS , Goodman PJ , Minasian LM , Ford LG , Parnes HL , Gaziano JM .", "label": "", "metadata": {}, "score": "84.1713"}
{"text": "Induction of hepatic insulin resistance is following lipid infusion and correlates closely with increase in plasma FAA [ 15 ] .From Insulin Resistance to NASH .", "label": "", "metadata": {}, "score": "84.34381"}
{"text": "AUROC curves were calculated including FT quantitative values using an empirical non - parametric method according to Delong et al [ 37 ] and compared using the method of Zhou et al [ 38 ] .", "label": "", "metadata": {}, "score": "84.69168"}
{"text": "[PubMed ] [ DOI ] .Angulo P , Hui JM , Marchesini G , Bugianesi E , George J , Farrell GC , Enders F , Saksena S , Burt AD , Bida JP .", "label": "", "metadata": {}, "score": "84.818405"}
{"text": "Author contributions : Schwenger KJP performed and wrote the literature review ; Allard JP supervised and edited .Correspondence to : Johane P Allard , MD , FRCPC , Department of Medicine , Toronto General Hospital , University Health Network , 585 University Avenue , Suite 9-N-973 , Toronto M5 G 2C4 , Canada .", "label": "", "metadata": {}, "score": "84.96026"}
{"text": "[Links ] .Brasil .Conselho Federal de Medicina .1766/05 Normas seguras para o tratamento cir\u00fargico da obesidade m\u00f3rbida , definindo indica\u00e7\u00f5es , procedimentos aceitos e equipe .", "label": "", "metadata": {}, "score": "85.046555"}
{"text": "The area under receiver operating characteristic ( ROC ) curve for APRI was 0.85 with an optimal cut - off of 0.98 , giving a sensitivity of 75 % and a specificity of 86 % .", "label": "", "metadata": {}, "score": "85.09536"}
{"text": "[PubMed ] [ DOI ] .Li Z , Yang S , Lin H , Huang J , Watkins PA , Moser AB , Desimone C , Song XY , Diehl AM .", "label": "", "metadata": {}, "score": "85.705475"}
{"text": "Clinical and laboratory data were collected either before or on the day of the liver biopsy .BMI was calculated using the formula : weight in kg / height in metres2 .", "label": "", "metadata": {}, "score": "86.72075"}
{"text": "Serum ALT increase is not only insensitive , but also nonspecific ; values may remain within the normal range in up to 80 % of patients with biopsy - proven NAFLD and up to 30 % of NASH [ 19 ] .", "label": "", "metadata": {}, "score": "86.812744"}
{"text": "55 , no . 7 , pp .434 - 438 , 1980 .View at Google Scholar \u00b7 View at Scopus . 285 , no .", "label": "", "metadata": {}, "score": "86.819725"}
{"text": "[PubMed ] [ DOI ] .de L\u00e9dinghen V , Wong VW , Vergniol J , Wong GL , Foucher J , Chu SH , Le Bail B , Choi PC , Chermak F , Yiu KK .", "label": "", "metadata": {}, "score": "87.16607"}
{"text": "[PubMed ] [ DOI ] .Lazo M , Solga SF , Horska A , Bonekamp S , Diehl AM , Brancati FL , Wagenknecht LE , Pi - Sunyer FX , Kahn SE , Clark JM .", "label": "", "metadata": {}, "score": "87.50534"}
{"text": "[PubMed ] [ DOI ] .Ziol M , Handra - Luca A , Kettaneh A , Christidis C , Mal F , Kazemi F , de L\u00e9dinghen V , Marcellin P , Dhumeaux D , Trinchet JC .", "label": "", "metadata": {}, "score": "87.62729"}
{"text": "Lucinda J Black Telethon Institute for Child Health Research , The University of Western Australia , Perth , Western Australia , Australia J Gastroenterol Hepatol 29:1215 - 22 .", "label": "", "metadata": {}, "score": "87.88948"}
{"text": "4 , pp .679- 684 , 2001 .View at Google Scholar \u00b7 View at Scopus Genomes and Genes .Species .Takeshi Okanoue .", "label": "", "metadata": {}, "score": "87.99922"}
{"text": "Insulin is covalently bound to A2 M [ 42 ] in plasma and A2 M is a binding protein of Insulin - like Growth Factor Binding Protein-1 ( IGFBP-1 ) which modifies the IGFBP-1/IGF interaction [ 43 ] .", "label": "", "metadata": {}, "score": "88.187836"}
{"text": "Value of the index Nash - NashTest for the diagnostic of NASH as stated by the pathologist independent of NAS score .Each index is a specific logistic regression combining parameters weighted according to their diagnostic values .", "label": "", "metadata": {}, "score": "88.19333"}
{"text": "Leon A Adams Division of Gastroenterology and Hepatology , Mayo Clinic and College of Medicine , Rochester , MN 55905 , USA J Clin Gastroenterol 40:S34 - 8 .", "label": "", "metadata": {}, "score": "88.216225"}
{"text": "Leon A Adams School of Medicine and Pharmacology , University of Western Australia , Sir Charles Gairdner Hospital Unit , Nedlands , WA 6009 , Australia Expert Rev Gastroenterol Hepatol 4:623 - 35 .", "label": "", "metadata": {}, "score": "88.2173"}
{"text": "[PubMed ] [ DOI ] .Promrat K , Kleiner DE , Niemeier HM , Jackvony E , Kearns M , Wands JR , Fava JL , Wing RR .", "label": "", "metadata": {}, "score": "88.448"}
{"text": "[Links ] .Kleiner DE , Brunt EM , Van Natta M , Behling C , Contos MJ , Cummings OW , Ferrell LD , Liu YC , Torbenson MS , Unalp - Arida A , Yeh M , McCullough AJ , Sanyal AJ .", "label": "", "metadata": {}, "score": "88.589516"}
{"text": "[PubMed ] [ DOI ] .Hallsworth K , Fattakhova G , Hollingsworth KG , Thoma C , Moore S , Taylor R , Day CP , Trenell MI .", "label": "", "metadata": {}, "score": "88.64917"}
{"text": "Seng Khee Gan Metabolic Research Centre , School of Medicine and Pharmacology , Royal Perth Hospital Unit , Australia , University of Western Australia , Perth , Australia Curr Opin Lipidol 19:592 - 9 .", "label": "", "metadata": {}, "score": "88.83101"}
{"text": "Overall , pioglitazone is used in the medical community as a treatment for NASH , however , careful consideration is needed when prescribing this pharmacological treatment to patients .", "label": "", "metadata": {}, "score": "89.01105"}
{"text": "MM is a full employee of Biopredictive .Authors ' contributions .TP conceived the study and its design , participated in the coordination , performed the statistical analysis and wrote the article .", "label": "", "metadata": {}, "score": "89.10456"}
{"text": "[Links ] .Furuya CK Jr , de Oliveira CP , de Mello ES , Faintuch J , Raskovski A , Matsuda M , Vezozzo DC , Halpern A , Garrido AB Jr , Alves VA , Carrilho FJ .", "label": "", "metadata": {}, "score": "89.19093"}
{"text": "[PubMed ] [ DOI ] .Furuya CK , de Oliveira CP , de Mello ES , Faintuch J , Raskovski A , Matsuda M , Vezozzo DC , Halpern A , Garrido AB , Alves VA .", "label": "", "metadata": {}, "score": "89.33499"}
{"text": "Leon A Adams School of Medicine , The University of Western Australia , Sir Charles Gairdner Hospital , Perth , Australia Endocr Res 32:59 - 69 .", "label": "", "metadata": {}, "score": "89.46278"}
{"text": "Leon A Adams School of Medicine and Pharmacology , University of Western Australia , Nedlands , WA 6009 , Australia J Gastroenterol Hepatol 26:802 - 9 .", "label": "", "metadata": {}, "score": "89.91895"}
{"text": "Clinically significant discordance between NT and biopsy was defined as a two classification discordance : NASH as predicted by NT and no Nash as observed at biopsy ; or the inverse , no Nash as predicted by NT and Nash as observed at biopsy .", "label": "", "metadata": {}, "score": "89.98073"}
{"text": "Leon A Adams School of Medicine and Pharmacology , The University of Western Australia , Western Australia , Australia J Gastroenterol Hepatol 26:1536 - 43 .", "label": "", "metadata": {}, "score": "89.98736"}
{"text": "Leon A Adams School of Medicine and Pharmacology , University of Western Australia , Nedlands , WA , Australia Am J Gastroenterol 104:861 - 7 .", "label": "", "metadata": {}, "score": "90.0748"}
{"text": "Leon A Adams School of Medicine and Pharmacology , University of Western Australia , Nedlands , WA , Australia Am J Gastroenterol 104:861 - 7 .", "label": "", "metadata": {}, "score": "90.0748"}
{"text": "5 , pp .1584 - 1592 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . 7 , no .", "label": "", "metadata": {}, "score": "90.198135"}
{"text": "ROC curves of the NashTest for the diagnosis of NASH made by pathologist in Training and in Validation Groups .The diagonal line represents that achieved by chance alone ( area under the curve 0.50 ) ; the ideal area under the curve is 1.00 .", "label": "", "metadata": {}, "score": "90.37226"}
{"text": "774 - 788 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .115 , no .5 , pp .", "label": "", "metadata": {}, "score": "90.50032"}
{"text": "Wendy H Oddy Telethon Institute for Child Health Research , Centre for Child Health Research , University of Western Australia , Perth , Western Australia , Australia Am J Gastroenterol 108:778 - 85 .", "label": "", "metadata": {}, "score": "90.52028"}
{"text": "Pharmacological treatment has been studied in this population , specifically insulin - sensitizing agents .Two insulin - sensitizing agents , metformin and thiazolidinediones ( TZD ) , have been investigated in this population , however there are conflicting results .", "label": "", "metadata": {}, "score": "90.62226"}
{"text": "Leon A Adams Department of Gastroenterology and Hepatology , Sir Charles Gairdner Hospital , Perth , Australia Clin Chem 51:1867 - 73 .Detail Information .", "label": "", "metadata": {}, "score": "90.804214"}
{"text": "[PubMed ] [ DOI ] .Browning JD , Szczepaniak LS , Dobbins R , Nuremberg P , Horton JD , Cohen JC , Grundy SM , Hobbs HH .", "label": "", "metadata": {}, "score": "91.48656"}
{"text": "Treatment of risk factors for cardiovascular disease .Pharmacological agents , such as pioglitazone , are not recommended .Numerous other drugs have been examined for the treatment of NASH .", "label": "", "metadata": {}, "score": "91.7942"}
{"text": "Hyohun Park Department of Gastroenterology and Hepatology , Saiseikai Suita Hospital , 1 2 Kawazono cho , Suita , Osaka , 564 0013 , Japan J Gastroenterol 46:101 - 7 .", "label": "", "metadata": {}, "score": "92.47127"}
{"text": "Therefore we checked the utility of the NT for identifying patients with bona fide NASH using the pathologist determination .Because of the biopsy variability , discordances between biomarker and biopsy results must be discussed case by case before attributing the cause of error to biomarkers or to biopsy .", "label": "", "metadata": {}, "score": "92.64949"}
{"text": "Leon A Adams Department of Gastroenterology and Hepatology , Sir Charles Gardiner Hospital , Nedlands , WA , Australia J Gastroenterol Hepatol 21:1758 - 60 .", "label": "", "metadata": {}, "score": "92.737366"}
{"text": "Leon A Adams Department of Gastroenterology and Hepatology , Sir Charles Gardiner Hospital , Nedlands , WA , Australia J Gastroenterol Hepatol 21:1758 - 60 .", "label": "", "metadata": {}, "score": "92.737366"}
{"text": "Em 25 pacientes ( 16 % ) o escore resultou indeterminado entre os pontos de corte .A sensibilidade e a especificidade do escore foram de 83 % e 97 % , respectivamente .", "label": "", "metadata": {}, "score": "93.04029"}
{"text": "Clinical trials of pioglitazone have shown promising results ( partial biochemical and histological efficacy ) but the short - term effect and side effects may limit widespread acceptance [ 56 ] .", "label": "", "metadata": {}, "score": "93.40434"}
{"text": "[Links ] .Browning JD , Szczepaniak LS , Dobbins R , Nuremberg P , Horton JD , Cohen JC , Grundy SM , Hobbs HH .", "label": "", "metadata": {}, "score": "93.49405"}
{"text": "Annette T Y Wong School of Medicine and Pharmacology , Computing and Mathematics , University of Western Australia , Perth , Western Australia , Australia J Nutr 143:437 - 41 .", "label": "", "metadata": {}, "score": "93.72578"}
{"text": "5 , pp .711 - 717 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .107 , no .", "label": "", "metadata": {}, "score": "93.77061"}
{"text": "Leon A Adams School of Medicine and Pharmacology , University of Western Australia , Sir Charles Gairdner Hospital Unit , Nedlands , Western Australia , Australia J Dig Dis 12:10 - 6 .", "label": "", "metadata": {}, "score": "93.80586"}
{"text": "TNF- \u03b1 can activate both nuclear factor - kappa B ( NF \u03ba B ) and c - jun N -terminal kinase ( JNK ) , promoting serine phosphorylation of the insulin receptor substrate which directly impairs insulin signalling .", "label": "", "metadata": {}, "score": "94.58008"}
{"text": "The primary outcome was the diagnosis of NASH in the three categories according to Kleiner et al : NASH , Borderline NASH , No NASH .", "label": "", "metadata": {}, "score": "94.73906"}
{"text": "Cases with NAS of 0 to 2 were considered not diagnostic of NASH ; on the other hand , cases with scores of 5 or greater were diagnosed as NASH .", "label": "", "metadata": {}, "score": "95.315056"}
{"text": "Leon A Adams School of Medicine and Pharmacology , Fremantle Hospital Campus , The University of Western Australia , Fremantle , Australia J Gastroenterol Hepatol 23:1089 - 93 .", "label": "", "metadata": {}, "score": "96.131424"}
{"text": "[PubMed ] [ DOI ] .Jiang ZY , Xu CY , Chang XX , Li WW , Sun LY , Yang XB , Yu LF .", "label": "", "metadata": {}, "score": "96.51227"}
{"text": "352 - 356 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed \u00b7 View at Scopus .4 , no .", "label": "", "metadata": {}, "score": "96.97255"}
{"text": "22 , no .6 , pp .788 - 793 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "97.46974"}
{"text": "Number Cruncher Statistical Systems 2003 software ( NCSS , Kaysville , Utah , USA ) was used for all analyses .Results .Patients .A total of 160 patients were included in the training group and 97 in the validation group .", "label": "", "metadata": {}, "score": "98.48093"}
{"text": "[PubMed ] [ DOI ] .Zhu L , Baker SS , Gill C , Liu W , Alkhouri R , Baker RD , Gill SR .", "label": "", "metadata": {}, "score": "99.44147"}
{"text": "27 - 38 , 2008 .View at Publisher \u00b7 View at Google Scholar .56 , no .4 , pp .984 - 991 , 2007 .", "label": "", "metadata": {}, "score": "100.21456"}
{"text": "Links ] .Correspondence : Dr. Silvania K. Pimentel Avenida Igua\u00e7u , 1236 - sala 115 80250 - 190 - Curitiba , PR , Brazil .", "label": "", "metadata": {}, "score": "100.71208"}
{"text": "Silvania Klug Pimentel I , V ; Rodrigo Strobel II ; Carolina Gomes Gon\u00e7alves III ; Danielle Giacometti Sakamoto IV ; Fl\u00e1vio Heuta Ivano V ; J\u00falio Cezar Uili Coelho VI .", "label": "", "metadata": {}, "score": "103.24994"}
{"text": "author reply 1148 View Article PubMed .Pre - publication history .Copyright .\u00a9 Poynard et al .2006 .This article is published under license to BioMed Central Ltd.", "label": "", "metadata": {}, "score": "106.72901"}
{"text": "Sanyal AJ , Banas C , Sargeant C , Luketic VA , Sterling RK , Stravitz RT , Shiffman ML , Heuman D , Coterrell A , Fisher RA , Contos MJ , Mills AS .", "label": "", "metadata": {}, "score": "107.10868"}
{"text": "All rights reserved .World J Gastroenterol .Feb 21 , 2014 ; 20(7 ) : 1712 - 1723 Published online Feb 21 , 2014 .", "label": "", "metadata": {}, "score": "109.39724"}
{"text": "+1 - 402 - 559 - 7182 ; Fax :+1 - 402 - 559 - 6749 .Received : 28 June 2012 ; in revised form : 11 September 2012 / Accepted : 18 September 2012 / Published : 26 September 2012 .", "label": "", "metadata": {}, "score": "116.67838"}
{"text": "Telephone :+1 - 416 - 3405159 Fax :+1 - 416 - 3480065 .Received : October 29 , 2013 Revised : December 5 , 2013 Accepted : January 3 , 2014 Published online : February 21 , 2014 .", "label": "", "metadata": {}, "score": "119.54559"}
{"text": "The University of Nebraska Medical Center , Nebraska Medical Center , Omaha , NE 68198 , USA ; Email : .University of the Witwatersrand , Johannesburg , 1 Jan Smuts Avenue , Braamfontein 2000 , Johannesburg , South Africa ; Email : .", "label": "", "metadata": {}, "score": "126.85146"}
{"text": "Received 30 May 2011 ; Accepted 9 July 2011 .Copyright \u00a9 2011Lay Gan et al .This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "136.81781"}
{"text": "Labome .Org \u00a9 2015 All Rights Researved Princeton , New Jersey 08540 , USA This article is an open - access article which was selected by an in - house editor and fully peer - reviewed by external reviewers .", "label": "", "metadata": {}, "score": "137.26128"}
{"text": "Copyright \u00a9 2013 A. N. Mavrogiannaki and I. N. Migdalis .This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "144.93008"}
